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Abstract
The major tasks of the immune system are the protection of the body from
undesired external pathogenic attack and the prevention of further and al-
ready experienced challenges, which are avoided by the establishment of im-
munological memory. At the top of the philogenetic tree, the evolution has
developed a specific (adaptive) immunity which cooperates with the ancestral
innate immunity to control the antigenic insults T-cells are the protagonist of
the adaptive immune response in fighting against intracellular infections and
in the maintenance of self-tolerance. The T-cell repertoire is characterized
by high diversity and size. Moreover, they share and compete each others
for resources such as cytokines, MHC-peptide complexes and immunological
space. The proteasome machinery plays a crucial role in the maintenance
of cell functionality by destroying undesired or unfunctional proteins. More-
over, the proteasome is an important step in the generation of antigenic
peptides which, ones mounted on the MHC molecules, are responsible for
the activation of T-cell during an immune response.
During ageing the immune system undergoes an extended reshaping of
the T-cell repertoire, which is now characterized by a different diversity and
composition. This phenomenon seems to be a major cause for the increase
in the mortality rate for elderly people. In this PHD thesis the study of the
T-cells dynamics and their homeostasis has been investigated. In particular
we focused on the following questions
What is the immunological function of the intracellular protein degrada-
tion? And in particular, what is the immunological function of the protea-
some?
What is the role of the chronic antigenic stimuli on the T-cell dynamics
and homeostasis? Can the reshaping of the immune system during ageing
influence the survival probability of individuals?
Chapter 1 offers an introduction to the immunological aspects which will
be considered along this thesis.
The study presented in Chapter 2 evidenced that the length and the
amount of fragments generated by the proteasome degradation fairly de-
pend on the size of the gates regulating the flux of substrate through the
proteasome. This model captures the known characteristics of proteasomal
degradation, and can therefore help to quantify MHC antigen processing and
presentation.
In Chapter 3 we reviewed several models based on ecological concepts like
competitive exclusion and co-existence in the context of the T- and B-cell
repertoire. Based on this literature, in Chapter 4 we present a model dealing
with the dynamics of cytotoxic T-cells and the role of the antigen presenta-
tion in shaping the T-cell repertoire. We propose that the replacement of
constitutive proteasome with the immunoproteasome, a form of proteasome
which is believed to play a role during an immune response, re-shapes sig-
nificantly the T-cell clone repertoire and helps to mount a fast and effective
immune response.
Chapter 5 has been devoted to the population dynamics of cytotoxic T-
cells over a long timescale. A stochastic differential equation model describing
the maintenance of T-cell memory clones has been proposed. The model
suggests that the size and the conformation of the T-cell pool depends on
the chronic stimulation impinging upon the system over long timescale.
Chapter 6, is an attempt to use T-cell dynamics to understand demo-
graphic data. We test the hypothesis that the shrinkage of the naive T-cell
repertoire over the lifespan is a major cause of mortality for human individu-
als. A model describing the demographic data is proposed and a comparison
with the standard theory of survival curve has been developed.
The conclusions are: the kinetics of the antigen presentation and its quan-
tification are critical aspects for the understanding of the maintenance and
the functionality of the T-cell repertoire. The Immune system takes advan-
tage of the kinetics of proteasome and the competition for resources in the
T-cell repertoire to develop a clever strategy to challenge infections without
expensive production of new resources. Future works are needed to under-
stand how T-cells are extremely efficient weapon against acute infections,
but it seems to cause a reshaping of the immune system with detrimental
effects during ageing.
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Zusammenfassung
Die Hauptaufgabe des Immunsystems ist der Schutz des Körpers gegen den
externen Angriff von Viren, Bakterien und sonstigen potentiellen Krankheits-
erregern, sowie die Vermeidung von weiteren Infektionen durch bereits erfah-
rene Pathogene, die durch die Errichtung eines immunologischen Gedächtnis-
ses vermieden werden. Das Repertoire von T-Zellen ist charakterisiert durch
hohe Diversität und grossem Umfang. Darüberhinaus konkurrieren T-Zellen
um Ressourcen wie zum Beispiel Zytokine, MHC-Peptidkomplexe und immu-
nologischen Raum. Das Proteasom spielt eine wichtige Rolle in der Instand-
haltung von Zellfunktionalität, indem es unerwünschte und nicht funktionelle
Proteine abbaut. Weiterhin stellt das Proteasom einen wichtigen Schritt in
der Produktion von antigenischen Peptiden dar, die, sobald sie von MHC-
Moleküle präsentiert werden, für die Aktivierung von T-Zellen in der Immun-
antwort verantwortlich sind. Während des Alterungsprozesses durchläuft das
Immunsystem eine umfangreiche Veränderung des T-Zell-Repertoires in Di-
versität und Zusammensetzung. Diese Arbeit untersucht die Dynamik und
die Homeostase von T-Zellen. Insbesondere beleuchtet diese Arbeit folgende
Fragen:
• Was ist die immunologische Funktion von intrazellulärer Proteindegra-
dation? Und was ist die immunologische Funktion des Proteasoms?
• Welche Rolle spielen chronisch antigenische Stimuli in der T-Zell-Dynamik
und Homeostase? Kann die Veränderung des Immunsystems während
des Alterungsprozesses die Überlebensratewahrscheinlichkeit von Indi-
viduen beeinflussen ?
Kapitel 1 bietet eine Einführung in grundlegende immunologische Aspekte,
die im Verlaufe dieser Arbeit von Bedeutung sind.
Kapitel 2 präsentiert eine Studie, die belegt, dass die Länge und Grösse
von Fragmenten, die während der Proteasomedegradation entstehen, sehr von
der Grösse der Schranke abhängt, die den Substratfluss durch das Proteasom
steuert. Das hier vorgestellte Modell reproduziert die bekannten Charakte-
ristika von Proteosomedegradation sehr gut und kann daher in der Quan-
tifizierung des antigenischen Umsatzes und deren Präsentation von grossem
Nutzen sein.
Kapitel 3 bietet eine Übersicht über einige ökologisch basierte, bereits
veröffentlichte Modelle wie zum Beispiel die kompetitive Exklusion und Ko-
existenz im Kontext des T- und B-Zell-Repertoires.
Im Kapitel 4 stellen wir die Vermutung an, dass die Ersetzung von kon-
stitutivem Proteasom durch Immunoproteasom, die während einer Immun-
antwort in antigenpräsentierenden Zellen stattfindet, das T-Zell-Repertoire
stark verändert und dabei hilft, eine schnelle und effektive Immunreaktion
zu starten.
Kapitel 5 ist der Populationsdyamik von zytotoxischen T-Zellen über lan-
ge Zeitskalen gewidmet. Ein stochastisches Differentialgleichungsmodell wird
vorgestellt, das die Dynamik von T-Zell-Gedächtnisklone beschreibt. Das Mo-
dell legt nahe, dass der Umfang und die Diversität des T-Zell-Pools von der
chronischen Stimulation abhängt, die auf das System über lange Zeiträume
hinweg einwirkt.
In Kapitel 6 wird ein Modell eingeführt, welches demographische Prozesse
unter Berücksichtigung der T-Zell-Dynamik beschreibt. Wir testen die Hy-
pothese, dass der Rückgang des naiven T-Zell-Repertoires über die Lebens-
spanne eine Hauptursache für die Sterblichkeit des Individuums darstellt. Ein
Vergleich mit der Standardtheorie der Überlebenskurve wird entwickelt.
Die Schlussfolgerungen dieser Dissertation sind: Die Kinetik der antige-
nischen Präsentation und ihre Quantifizierung sind wichtige Aspekte für das
Verstehen der Instandhaltung und Funktionalität des T-Zell-Repertoires. Das
Immunsystem nutzt die Kinetik des Proteasoms und den Wettbewerb um
Ressourcen zwischen den T-Zellen zur Entwicklung von cleveren Strategien
gegen Infektionen aus, ohne dabei auf die Produktion von teueren neuen Res-
sourcen zurückgreifen zu müssen.
Schlagwörter:
Proteasome, Antigen Presentation, T Zell, Ageing
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Chapter 1
Introduction
1.1 The adaptive immune system
The immune system (IS) preserves the integrity of the organism, continu-
ously challenged by internal and external agents (antigens). The large vari-
ety of antigens ranging from mutated cells and parasites to viruses, bacteria
and fungi requires a rapid and efficient antagonistic response of the organ-
ism. At the top of the philogenetic tree, evolution has developed a specific
(clonotypic) immunity, which cooperates with the ancestral innate immunity
to control antigenic insults [Lanzavecchia and Sallusto, 2000]. The innate
system has a vast arsenal of dendritic cells and macrophages with a lim-
ited number of receptors, capable of recognizing and neutralizing classes of
antigens. The increase of complexity in vertebrate organisms stimulated
the development of a system based on two new types of cells, B- and T-
lymphocytes, with three distinct tasks: to recognize the antigens, to destroy
them and to keep track of their structure through a learning process. This
kind of immunological memory paves the way for a more efficient response
to any subsequent antigenic insult caused by an antigen that the organism
has already experienced. This is also the immunological basis of vaccination
strategies.
The diversity of the lymphocyte repertoire changes during the lifespan.
The diversity of the naive pool decreases continuously since it undergoes
an activation and differentiation process. Antigen experienced (AE) cells
suffer clonal expansion, gradually filling the immunological space available.
Competition phenomena were shown to play an important role in shaping
the lymphocyte repertoire.
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Figure 1.1: The proteasome is the major intracellular protease. It is involved
in the maintenance of the cellular physiology and plays a significant role in
the processing of intracellular antigenic peptides.
The lymphocyte repertoire
The adaptive immune system of vertebrate animals has evolved to respond to
different types of perturbations (invading pathogens, stress signals), limiting
self-tissue damage. Adaptive immunity evolved when gene rearrangements
were employed to generate highly diverse lymphocyte repertoire. The adap-
tive IS is organized to fight both intracellular and extracellular pathogenic
attacks. The lymphocyte repertoire is consists of approximately 1010 clones,
with a variability of at least 3 × 107 different clones [Arstila et al., 1999].
B-cells are responsible for the recognition of antigens present in the extracel-
lular environment and constitute the main players of the humoral immune
response. B-cells produce antibodies, which are able to bind and destroy
pathogens. In order to mount an effective IR, B-cells need help from a sub-
set of T-cells which are called T-helper. The latter provides costimulatory
signals which allow the activation and proliferation of B-cells. On the other
hand, T-cells are involved in the recognition of intracellular peptides and are
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responsible for the cellular immune response. Intracellular antigens are pre-
sented by the antigen presenting cell (APC), which displays the MHC-peptide
complex (MHCp) on their surface. APCs can be simply infected cells or pro-
fessional soldiers like dendritic cells, which possess the unique capacity to
interact with cytotoxic T-cells and to stimulate their proliferation.
Cytotoxic T-cell activation is mediated by professional APCs. They pro-
liferate and differentiate into effector cells, which kill infected cells present-
ing the specific antigen on their surface via MHC-class I molecules. MHC
molecules can be envisaged as the identity-card of almost all cells of the or-
ganism. MHCs allow the IS to recognize the state and the origin of the cells
present in the organism preventing unwanted attacks from the IS against
healthy-self cells. T-cells, as well as B-cells, require two signals in order to be
activated and to proliferate: the antigen as a primary signal, and a secondary
more general costimulatory signal, which is typically provided by professional
APCs, like dendritic cells (DC) and macrophages. DCs are the most impor-
tant professional APCs that are seeded throughout peripheral tissues to act
as sentinels that process and present antigen to mount adequate immune
responses.
Depending on the type of antigen, and tissue localization, the IR is sup-
pressed or activated. Indeed, self-antigens can be derived from their in-
nocuous environment, such as necrotic and apoptotic cells that need to be
scavenged before they disintegrate. Alternatively, non self-antigens are for-
eign products from invading pathogens that need to be eliminated. The
main function of DCs is to capture antigen for processing and presentation
as antigenic fragments on major histocompatibility complex for naive T-cell
activation In a steady-state situation, prior to acute infection and inflam-
mation, DCs are in an immature state and are not fully differentiated to
carry out their known roles as inducers of immunity. They are not unre-
sponsive as they actively circulate through tissues and into lymphoid organs,
capturing self-antigens as well as innocuous environmental proteins. In a
state of alarm such as a microbial invasion, or massive cell death, immature
DCs receive simultaneous activation signals through the binding of conserved
molecular motifs by pattern recognition receptors, such as Toll-like receptors
or specific tumor necrosis factor (TNF) family members. This results in DC
maturation and migration to secondary lymphoid organs, where DCs present
the processed antigens to naive T-cells and induce antigen-specific immune
responses.
At the turn of the last century, Ehrlich and Metchnikoff debated pas-
sionately over the relative importance of humoral versus cellular immunity
in protecting hosts against pathogens and foreign substances. The delay
in appreciating the importance of cellular immunity was due to its greater
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complexity than humoral immunity. The role of the B-cell is to produce
high-affinity protective antibodies. To succeed in this function, it attempts
to increase the affinity of its receptors for the immunizing antigen by mutat-
ing its variable-region genes. Antigen recognition via T-cells, which is driven
by the T-cell receptor (TCR) present on the surface of T-cells, is not simply
based on TCR-antigen interaction as it occurs for the B-cell receptor (an-
tibody) with extracellular antigens. The variable regions of T-cells cannot
bind directly to antigen, and their genes do not mutate. Instead, an antigen-
activated T-cell forms clusters of receptors with high avidity for the antigen
presented on the cell surface via MHC class I or class II molecule [Janeway
et al., 2001].
The selection mechanisms which define the specific T-cell over hundreds
of different T-cell clones which receive a positive stimulus from the MHCp is
still largely unknown. Cytotoxic (or CD8+) T-cells, which recognize MHC
class I molecules, have a particularly important role in viral infections. MHC
class I peptide ligands are generated from intracellular proteins that are syn-
thesized by target cells, which can be any cell type in a vertebrate organism.
The proteasome, an abundant and ubiquitous multi-catalytic protease, is re-
sponsible for the generation of most of these peptides in the cytosol (see Fig.
1.1). The proteasome activity is of outstanding importance in the process
leading to the CD8+ T-cell response. After several decades we still don’t
have a clear picture. There are still many unanswered such as how specific
T-cell clones are selected from the whole repertoire during an IR, or how
their differentiation program from the naive to the memory state is estab-
lished. Nevertheless, we now know that both the humoral and the cellular
IR are fundamental weapons for the IS, and that they work conjointly, and
not against each other. It could be worth to conclude with an interesting
suggestion of a brilliant immunologist, Polly Matzinger (I was in one of her
talks), stating that tolerance and IR are different masks of the same actor. It
is just a matter of which face is displayed, and which has been kept covered
because undesired. Sometimes these mechanisms become dysfunctional, and
pathological conditions such as autoimmune disease rises.
1.2 The MHC class I processing pathway
The MHC-peptide complexes (MHCp) define the key for the IS to recognize
bad from good, danger from non-danger, or self from non-self. The MHC class
I presentation pathway opens up a window from the cell surface onto the en-
tire repertoire of intracellular peptides. The cellular pathways involved in the
generation of peptides, which are mounted on the MHC class I complexes,
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Figure 1.2: Antigen presentation pathway. Intracellular proteins are trans-
ported into the proteasome. Some of the peptides resulting from the degrada-
tion are transported via TAP (transport associated peptide) to the endoplas-
matic reticulum. Here peptides ranging between 8 and 10 amino acids long
are mounted into precursor of the MHC molecule. Successively MHC-peptide
complexes are stabilized in the Golgi Apparatus and finally transported on
the cell surface, where T-cell recognizes the peptide specificity of the MHC
complex. Picture taken from Yewdell et al., 2003 (see also www.nature.com).
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have been intensively studied, although still much has to be understood. As
many viruses can replicate rapidly (progeny can be released as early as four
hours after the entry of virus into cells), all cell types need a mechanism for
rapidly generating peptides from viral proteins that are synthesized during
infection. Moreover, there must be a way to transport peptides from the
sites of antigenic protein synthesis in the cytoplasm to the site of MHC class
I biogenesis in the endoplasmatic reticulum (ER). Finally, there must be a
mechanism for MHC class I molecules to select peptides and carry them to
the cell surface for perusal by cytotoxic T-cells. The generation of MHCp
class I results from a multi-step process Fig. 1.2. Almost all of the MHC
class-I-associated peptides are between eight and eleven residues in length,
typically nine residues [Rock et al., 2004]. As most peptides have a limited
capacity to diffuse across membranes, transport from the cytoplasm to the
ER requires a transporter for antigen processing (TAP) an ER-resident, het-
erodimeric peptide transporter. TAP binds cytosolic peptides and drives the
translocation of peptides into the ER lumen in the process (see Fig. 1.2).
Successful peptide binding releases the MHC class I molecule from the MHC
class-I-loading complex for delivery to the cell surface of the APC.
At the beginning of this new millennium, pathogens and cancer remain
the leading causes of death world-wide. The development of vaccines to pre-
vent diseases for which no vaccine currently exists, such as AIDS or malaria,
or to treat chronic infections or cancers, as well as the improvement of efficacy
and safety of existing vaccines, remains a high priority. In most cases, the
development of such vaccines requires strategies capable of stimulating cyto-
toxic T lymphocytes and thus, to deliver antigen to MHC class I molecules.
Several different pathways exist for loading viral or tumour antigenic pep-
tides onto MHC class I molecules in order to stimulate the cellular immune
response. We can summarize the antigen loading mechanisms in two fam-
ilies: the endogenous pathways and the cross-presentation pathways. The
first family delivers the peptides which are mounted on the MHC class I
complex. Endogenous pathway follow the phagocytosis of bacteria, or other
amino acids sequences which are then processed intracellularly. The second
family of pathways follow when immuno-complexes, chaperons or virus-like
proteins, all of them carrying exogenous proteins, are captured by endocytosis
inside the APC and pushed into the cytosolic classic pathway. This mecha-
nism allows the processing of non-synthesized proteins (discovered in 1976,
see Bevan [1976]). Significant redundancy exists between these two pathways
(for a review see Norbury and Sigal [2003]). The prevailing pathways may
depend on the localization, form and concentration of antigen itself. The
proteasome seems to play a major role within both families.
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1.3 The proteasome and the immune system
Two different forms of proteasome can be distinguished: the constitutive
(CP) and the immunoproteasome (IP). Antigen processing has evolved dedi-
cated mechanism to improve the presentation of antigenic peptides. Immune
regulatory cytokines, IFN-γ and TNF-α, control the expression of several
constituents of the proteasome system [Kloetzel, 2004a], suggesting a con-
nection between the IS and the proteasome system. IP is a proteasome
formed with replacement of the catalytic subunits by their IFN-γ-inducible
homologs, LMP2 (β1i), MECL1 (β2i), and LMP7 (β5i), respectively. His-
torically, the location of LMP2 and LMP7 genes in the MHC class II locus
was one of the first clues suggesting their involvement in antigen presenta-
tion [Glynne et al., 1991, Kelly et al., 1991, Martinez and Monaco, 1991]. In
vitro studies performed with viral epitopes also showed that the IP is more
efficient with respect to the CP in processing a number of antigenic peptides
[Cerundolo et al., 1995]. For this reason, it was called immunoproteasome,
as opposed to the constitutively expressed standard proteasome. Under non-
inflammatory conditions many cell types lack expression of immuno-subunits
or present them at low levels. This suggests that a continuous presence of
IP in all tissues is either not required or desired. A possible function of the
IP lies in the development of the CD8+ T-cell repertoire. In particular, the
observation that in some cases immuno-subunits may differently influence
the antigen processing of foreign and self-antigens appears indicative for this
assumption. The expression of immuno-subunits in thymic cells may play
an important role in the negative selection of T-cells reactive against pep-
tides derived from self antigens. The presence of both CP and IP may be
important in the shaping of the immune cell repertoire, Interestingly, Morel
et al. [2000] reported that IPs are unable to produce several T-cell specific
epitopes derived from self proteins. The authors suggest that APCs which
contain IP present a different peptide distribution in the thymus, and there-
fore, the selected T-cell repertoire may not see some self peptides which are
then highly presented in the peripheral tissue (maybe rich in CP expression).
This would be an interesting way to escape autoimmune disease generated
by ubiquitous self-proteins presented in the peripheral tissues. In Chapter 4
it will be discussed how the IP is involved in the peripheral maintenance of
T-cell repertoire, and how the IP may improve the IR against viral challenges.
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1.4 Homeostasis of the immune system
Homeostasis is the self-regulating process by which biological systems tend to
maintain stability while adjusting to conditions that are optimal for survival.
If homeostasis is successful, life continues; if unsuccessful, disaster or death
ensues. (Encyclopedia Britannica)
The concept of homeostasis
A seminal contribution to medical science was the the definition of the mean-
ing of the modern terms “stress" and “homeostasis". The physiologist Walter
Cannon describes stress as any force which changes the physiological param-
eters of the organism, and homeostasis as the intrinsic ability of the organism
to restore its original status [Cannon, 1939]. Improvements in the knowledge
of intracellular mechanisms such as degradation pathways and regulatory
gene networks allowed the extension of these concepts to the level of the cell.
Stress is now broadly defined as any stimulus, whether internal or exter-
nal, that disturbs the delicate but resilient cellular metabolism [Gleimer and
Parham, 2003]. Claude Bernard was the first to realize that the body has
control mechanisms able to maintain an internal equilibrium (like body tem-
perature and the levels of nutrients and waste products) in spite of changes
in the environment [Bernard, 1865]. This type of control was later called
homeostasis [Cannon, 1939]. Homeostatic controls also determine the size
and the number of cells in each organ of the body. The immune system is
no exception; it reacts to changes in the environment to maintain internal
balance; it tends to keep a steady constant number of its cells throughout
the adult life of an individual. The concept of homeostasis implies that the
introduction of a perturbation may modify the number of lymphocytes, but
once the perturbation is removed, the number of cells tends to return to the
previous level.
We can then ask: why do we need this complex homeostatic control
of the lymphocyte repertoire? First, homeostasis prevents non-controlled
lymphocyte accumulation. Moreover, it has a determinant role in shaping T-
cell repertoires. Indeed, as the number of lymphocytes is kept constant, any
newly produced cell can only survive if another resident cell dies. Because
each lymphocyte may have a different antigen binding receptor, it is crucial
which cell survives or which cell dies.
In conclusion, lymphocyte homeostasis is a highly dynamic process and
homeostatic equilibrium may be reached at different levels depending on both
T-cell properties and environmental clues. Two questions can be posed:
• What determines the number of peripheral lymphocytes?
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• Which mechanisms contribute to the maintenance of steady state cell
numbers?
In this thesis, these questions will be faced from different point of views
and show how specific mechanisms, like antigen presentation, and non specific
stimuli, such as chronic fluctuations of the environmental stimuli might both
play an important role, maybe on different timescales.
Homeostasis of lymphocytes
The peripheral lymphocyte pool is under homeostatic control. Despite de
novo production of lymphocytes in the bone marrow and the thymus, and
proliferation of peripheral lymphocytes upon antigenic stimulation, the to-
tal number of peripheral lymphocytes remains at a steady state. A mouse
transplanted with 10-20 ectopic thymuses may have a slightly increase in the
number of peripheral T-cells [Berzins et al., 1998]. In this case the homeo-
static equilibrium is set at a higher level due to increased T-cell generation.
Once the transplants are removed, the number of T-cells returns to the level
previous to transplant. In thymectomized mice the homeostatic number of
peripheral T-cells is kept stable at a new lower level [Miller, 1965]. In contrast
in Rag-deficient mice, which cannot produce any B- or T-cells, the homeo-
static control of lymphocyte numbers can be said to be set at zero [Shinkai
et al., 1992]. If a population of T-cells is introduced into this T-cell-deficient
host, the T-cells expand to reach steady state numbers (homeostatic prolif-
eration). Somehow, the homeostasis of T-cells is a complex system in which
sources (thymic emigrants), local environment, and external stimuli work in
concert to keep the repertoire at the right size.
A critical feature of lymphocyte homeostasis is that these cells compete
against each other for filling the biological space through a variety of mech-
anisms. A well defined notion of biological space per se remains an area
of intense investigation and debate, despite recent identification of several
potential molecular mediators.
An equally important conceptual advance has been the general acceptance
that these processes are intimately tied to the specificity-based selection and
persistence of antigen experienced and non-experienced lymphocytes (see also
Chapter 5 and 6). T-cells can sense the presence or the absence of sufficient
numbers of others T-cells and adjust their division rate and numbers accord-
ingly. In lymphopenic conditions massive proliferation of pre-existing T-cells
occurs [Jameson, 2005, Surh and Sprent, 2002]. Once the cell number reaches
a given level, the proliferation is likely terminated or strongly reduced.
The mechanisms behind immune homeostasis are not fully understood,
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but there is increasing evidence that competition between lymphocytes plays
an important role [Freitas et al., 1995, 1996]. Competition between (intra
clonal) and within (inter clonal) T-cell compartments is observed [Tanchot
and Rocha, 1995]. Typically T-cells compete for resources, such as space,
cytokines antigens and physiological substances required for survival. It is
accepted that T-cells require MHC-self peptide complexes to survive and to
functionally stay in the peripheral system. Competition plays a role also in
this case [Almeida et al., 2005]. How homeostatic processes react to perturba-
tions in lymphocyte numbers during disease, therapy, or ageing are problems
awaiting investigation.
T-cell homeostasis and ageing
Regardless of the exact molecular meaning of the void, changes in supply
and demand of naive T-cells set the stage for the most profound changes in
ageing. Thymic production declines at least 10-fold by the time of puberty;
This induces an increase in the proliferation of the remaining cells. Mean-
while, naive T-cells over a lifetime are depleted by encounters with chronic
persisting pathogens. This leads to a lifelong accumulation of memory cells
that appear to be well preserved in ageing [Nikolich-Zugich, 2005, Fagnoni
et al., 2000, Franceschi et al., 2000a], which could impare naive homeostasis.
Lymphocytes can divide many times in response to antigen and in response to
homeostatic stimuli, and although these cells are equipped with mechanisms
to allow for intense division, such as the induction of telomerase [Hodes,
1999], the capacity of which may not be infinite [Effros and Pawelec, 1997].
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Part I
The proteasome and the antigen
presentation
11

Chapter 2
The kinetics of proteasome
degradation
Introduction
The proteasome is a barrel-shaped multi-subunit protease involved in most
cytosolic proteolysis. The role of the proteasome is to degrade (partially)
unfolded and nonfunctional intracellular proteins. The 20S core particle is
characterized by an internal chamber equipped with catalytic sites at the β
subunits [Whitby et al., 2000, Groll et al., 1997, Forster and Hill, 2003, Lowe
et al., 1995]. The α subunits, organized in a ring shaped structure, function
as a gate by forming an axial channel that regulates the influx and efflux
of proteins via the opening and closing of the entrance of the proteolytic
chambers. The size of the axial channel can be controlled by regulatory par-
ticles like PA28 or its homologs, which can facilitate the substrate uptake
and the release of fragments [DeMartino and Slaughter, 1999, Rechsteiner
et al., 2000, Cascio et al., 2002, Dick et al., 1996, Groettrup et al., 1996,
Kloetzel, 2004b, Van Hall et al., 2000, Kohler et al., 2001] and 19S [Groll
et al., 2000, Cascio et al., 2001, Kisselev et al., 1999], which can bind sub-
strates, unfold them and translocate them in to the internal chamber [Groll
and Huber, 2003, Pickart and VanDemark, 2000]. The channel imposes con-
straints on the access of substrates into the proteolytic chamber and on the
efflux of partially digested polypeptides [Akopian et al., 1997, Kisselev et al.,
1998, Dorn et al., 1999, Groll et al., 1997, Groll and Huber, 2003]. Further-
more, the channel might favor the processive degradation of substrates by
restricting the release of degradation products. Using open-channel eukary-
otic proteasome mutants, Kohler et al. [2001] showed that the opening of the
channel strongly influences the kinetics and the length distribution of the
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fragments obtained in vitro. Opening the channel increases the degradation
rate and increases the median length of resulting fragments by 40%. These
results support the notion that the axial channel of the proteasome and its
regulation play a pivotal role in the degradation of endogenous proteins. We
develop a mathematical model of the proteasome degradation dynamics in
order to get more insight into the effects of the gate size on the kinetics of
degradation and products generation.
2.1 Mathematical models on the proteasome
degradation
Few theoretical models describing the kinetics of proteasome degradation
have been developed. Stein et al. [1996] report about experimental results
on in vitro degradation of short fluorogenic peptides by mammal 20S pro-
teasome. The reaction progress curves show a biphasic behaviour for high
substrate concentrations. The velocity of fragment production at the very
beginning of degradation is higher than at the steady state, and both veloc-
ities decrease with increasing substrate concentration. Fitting experimental
results to a pseudo first-order model derived from a standard kinetic scheme,
the authors show that this behavior can be explained by a slow conforma-
tional change of the proteasome due to substrate binding. Moreover, the
presence of a second, inhibiting binding site has been proposed. A standard
kinetic model has been proposed to fit experimental data on hydrolysis of
small fluorogenic peptides by mammal 20S constitutive and immunoprotea-
some [Stohwasser et al., 2000]. It is showed that the cap subunit PA28 reduces
the cooperative effect of the substrate binding, and increases the efficiency of
the substrate uptake and the fragment exit, without considerably changing
the cleavage specificity. Experiments conducted by Osmulski and Gaczynska
[2002] and Hutschenreiter et al. [2004] showed that both the apertures of the
20S serve as influx and efflux with a reduced access for longer substrates,
and that the rate limiting factor in the degradation kinetics is the substrate
threading and transport, and not its cleavage. The authors propose a theo-
retical scheme in which the substrate binding shifts the equilibrium from a
closed gate to an open gate conformation, which favors the uptake of sub-
strate and the release of fragments from the COP (core particle). Schmidtke
et al. [2000] relate to the fact that hydrolysis of short fluorogenic peptides by
mammal 20S proteasomes can be either activated or inhibited, in dependence
on the site specificity, by the presence of the protease inhibitor Ritonavir. Us-
ing rate equations derived from a kinetic scheme, they show that such kinetic
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data can be explained by the existence of a non-catalytic modifier site, to
which both the protease inhibitor and the substrate can bind, thus regulating
degradation rates.
To our knowledge, only two theoretical works refer to the digestion of
longer substrates. Both consider a length dependent transport rate of frag-
ments either into or out of the proteasome cavity. In the first work, -
Holzhutter and Kloetzel [2000] consider the digestion of 20 − 40 aa (amino
acids) long substrates by yeast 20S proteasome. Assuming an efflux rate de-
caying exponentially with the length, a maximum of two cleavages per sub-
strate molecule, and a cleavage rate depending on the sequence specificity,
the authors set up first-order differential equations describing the evolution
of the probability with which fragments are generated during degradation
process. By fitting the model parameters to experimental data on which frag-
ments were produced, they show that the double cleavage products, namely
fragments which are obtained by cutting twice the substrate, are generated
with an asymmetric cleavage mechanism. The proteasome is shown to cut
fragments of 7 − 13 aa length first at the C terminus of the substrate and
subsequently at the N terminus, while fragments of other lengths are cut pre-
dominantly first at the N, then at the C terminus. As in the present model,
they suggests an optimal distance of nine amino acids between two cleavages,
recalling the old molecular ruler hypothesis [Wenzel et al., 1994]. Upstream
fragments are found to be released from the proteasome with higher rates
then downstream fragments. In the second work, Peters et al. [2002] in-
vestigate quantitative kinetic data on the degradation of 25 and 27 aa long
substrates by human 20S constitutive and immunoproteasome, as well as
on fragment production. Here, a set of first-order differential equations de-
scribes the time evolution of fragment production probability assuming site
specific cleavage probabilities. The authors investigate the effect of re-entry,
which is shown to be responsible for changing the distribution of products
during the time course of the degradation. The re-entry rate is assumed to
be constant for long fragments but to decrease rapidly for fragments smaller
then 12 − 15 aa. Peters et al. [2002] suggest that the cleavage sites of the
immunoproteasome are not modified (as reported by others [Cascio et al.,
2001]), but instead that the kinetic rates and the amount of small fragments
are increased. Also Hadeler et al. [2004] illustrate the influence of re-entry
on the distribution of products with a toy model.
In the present work, we aim at investigating the influence of a length de-
pendent cleavage process and of length dependent in- and efflux rates on the
outcome of a digestion experiment. Unfortunately, these dependencies are
not known explicitly. Therefore, we choose ad hoc terms do describe them.
Moreover, we neglect any sequence specificity of the degradation process. As
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a consequence, in contrast to the theoretical works cited above, we do not
have the intent of fitting model parameters to data. Rather, we show how
fairly simple assumptions about the degradation process lead to good agree-
ment with experimental data. Thereby, the main focus of our investigation
lies on i) the product length distribution and ii) the dependence of substrate
degradation rates on its concentration.
The model describes the influx of the substrate, the cleavage process, and
the efflux of the fragments. The proteasomal degradation exhibits Michaelis-
Menten kinetics. The Michaelis-Menten constant Km and the maximum
velocity of degradation Vmax are both decreasing functions of the substrate
length, which is in agreement with experimental data Kisselev et al. [1998,
2000]. By tuning the parameters of the model, we can obtain a three-peak
length distribution of products as observed experimentally [Kohler et al.,
2001, Cascio et al., 2002, Saric et al., 2004, Wang et al., 1999]. The first
peak corresponds to 2 − 3 aa, the second to 8 − 10 aa and the third is a
wide peak around 20− 30 aa. The opening of the gate changes the residence
time of fragments inside the COP and thereby changes the ratio of small
over long fragments observed outside. Finally, we find that the re-entry of
intermediate products does not strongly influence the initial dynamics unless
the influx rate depends on the length of the peptides.
2.2 Model
The model describes the rates at which the concentrations of fragments of
length k change over time. The concentrations change by proteasomal cleav-
age, making two short fragments out of a long one, and by the influx and
efflux of fragments through the gates. A major characteristic of our model
is that the dynamics do not depend on the actual amino acid sequence and
orientation of the fragment. Influx, efflux, and cleavage only depend on the
length of the fragment. Let nk be the concentration of fragments of length
k inside the proteolytic chambers, and let Nk be the fragments of length k
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outside. The dynamics of nk and Nk are given as:
dNk
dt
= −a(k)
[
1− v
L∑
j=1
jnj
]
Nk + e(k)nk , (2.1)
dnk
dt
= a(k)
[
1− v
L∑
j=1
jnj
]
Nk − e(k)nk
−c
k−1∑
i=1
Fk,ink + c
L∑
j=k+1
(Fj,k + Fj,j−k)nj , (2.2)
for k = 1, 2, . . . , L. The substrate NL is an outside fragment of length k =
L. The first term of Eq. (2.1) describes the influx of fragments into the
proteasome. For the influx function a(k) we will first consider the case where
there is no re-entry of fragments other than the substrate, i.e., we set a(k) =
aˆ for k = L, and a(k) = 0 otherwise. Later (see Section 2.3.3) we also
allow other fragments to enter. The influx of substrate into the proteolytic
chambers is a rate limiting factor in protein degradation [Dorn et al., 1999,
Liu et al., 2003, Lee et al., 2002, Huffman et al., 2003, Akopian et al., 1997].
Experimental works have suggested that the influx is limited by the maximum
amount of amino acids that can be accommodated in the proteasome [Groll
et al., 1997, Whitby et al., 2000, Forster and Hill, 2003] (see also Section
2.3.3). In our model the influx rate therefore decreases when the total amount
of amino acids inside,
∑L
k=1 knk, increases. The maximum filling of the
proteasome is normalized to one by a scaling parameter v determining the
maximum number of amino acids that can be accommodated within the
COP.
Proteasomes degrade a wide range of different substrates, including non
protein substrates such as synthetic linear polymers, and a decreased degra-
dation is observed with the increasing of the substrate length [Hortin and
Murthy, 2002]. We assume that the influx does not strongly depend on the
amino acid composition of the substrate. During in vitro digestion very large
intermediate fragments can be observed [Cardozo and Michaud, 2002]. Based
on the fact that the gates impose physical constraints to the in-going sub-
strate, in this model we consider very long intermediate fragments (greater
than 200 aa) as a new effective substrate. Very little is known about the
efflux of fragments from the proteasome. Based on the intuition that each
peptide binds with a probability p to the gate subunits, hence impairing the
passage through the narrow pore, it has been proposed that the efflux rate
is a negative exponent of the length exp(−γn) where γ = 1
1−p and n is the
fragment’s length [Holzhutter and Kloetzel, 2000]. On the other hand, the
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Parameter Description Dimension Default value
L Length of the Substrate amino acids 100
NL(0) Initial substrate concentration mol 100
aˆ Rate of influx time−1 0.1
eˆ Rate of efflux time−1 1
c Cleavage rate time−1 1
θ Critical fragment length amino acids 25
µ Preferred cleavage position amino acids 9
σ Std of cleavage position amino acids 3
v Scaling factor - 1/200
Table 2.1: Parameters values
analysis of in vitro digestion of 25 and 27 aa long substrates performed with
the 20S proteasome suggests a length dependent reprocessing rate which de-
creases with the increase of the substrate length. These data suggest an
increasing Hill function with high exponent to describe the reduced cleavage
rate for short substrates [Peters et al., 2002]. Similar to the latter study,
we describe the efflux rate with a phenomenological Hill function with high
exponent and a critical length θ = 25 aa. This function simply accounts
for a high exit rate for short fragments which can be rescued from further
degradation, while longer fragments hardly escape from the proteasome and
are highly degraded. Although this assumption does not follow any mecha-
nistic process, a simple biological rationale for this assumption can be given.
Long fragments have, on average, a high probability to bend (or partially
fold), and therefore their exit rate might be strongly reduced with respect to
shorter fragments which can freely diffuse out (see also Section 2.4). Using
the decreasing Hill function
e(k) =
eˆ
1 + (k/θ)10
, (2.3)
the efflux rate switches at a fragment length of k ' θ from the maximal efflux
rate eˆ for short fragments to an efflux close to zero for long fragments. In
Fig. 2.1A we depict this function for θ = 25 and eˆ = 1.
The first two terms of Eq. (2.2) are the same influx and efflux terms as
discussed above. The last terms describe the cleavage machinery located in
the core of the proteasome. Fragments of length k are cut at a maximum
rate c and with probability 0 < Fk,i < 1 into two fragments of length i and
k − i. Two terms account for the loss and for the gain of each fragment of
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length k. The negative term corresponds to a loss for fragments of length k
which are cut in shorter fragments, and the positive term is a gain because
fragments of length j > k can be cleaved into a fragment of length k. The
standard parameters that are used in the simulations are given in Table 2.1,
and will be discussed in more detail in Section 2.3.
2.2.1 Cleavage mechanism
Our main assumption for the cleavage mechanism is that the proteasome
cleaves proteins starting around their N-termini or C-termini. To allow for
cleavages, the protein has to bind into a groove close to a catalytic site
[Lowe et al., 1995, Seemuller et al., 1995, Groll and Huber, 2003, Heinemeyer
et al., 1997], and the minimal size of a binding motif is about 3-4 aa [Lowe
et al., 1995, Seemuller et al., 1995, Groll and Huber, 2003, Heinemeyer et al.,
1997, Kesmir et al., 2003]. During the maturation of proteasome, in which
the catalytic sites are activated, intermediate fragments are cleaved inside
the COP. Studies with mutant proteasome showed that these intermediate
peptides possess a typical length of 7-9 aa [Heinemeyer et al., 1997]. It
has been suggested that there is a preferred length of 7-9 aa for an optimal
docking of the substrate with the binding grooves during the cleavage process
inside the COP [Groll and Huber, 2003]. We therefore assume that the
proteasome starts at a distance m ' 9 from one end of the protein/peptide,
and scans the substrate chain in both directions until a cleavage site is found.
Letting p be the probability to find a cleavage site, the chance to cut at
site i has its maximum p at m, and is given by Pi = p(1 − p)|i−m|. Since
possible cleavage sites are expected to be found on average once in 4 aa
[Kesmir et al., 2002, 2003], we choose p ' 0.25. This probability distribution
is depicted in Fig. 2.1B by the dashed lines. Using this cleavage function
we were able to reproduce degradation kinetics found experimentally, but the
fragment distribution had very sharp peaks (data not shown). Indeed it seems
unrealistic that the cleavage probability has the sharp peak atm = 9 depicted
in Fig. 2.1B. To round the peak one can model the cleavage probability with
a phenomenological Gaussian distribution
g(i) =
1√
2piσ
e−
(i−µ)2
2σ2 , (2.4)
where the mean µ provides the most likely cutting position, and the standard
deviation σ defines the range of likely cleavage positions. This distribution is
similar to the previous one but it has a rounder peak (see Fig. 2.1B, where
the solid line depicts Eq. (2.4) with µ = 9 and σ = 3). Thus, the probability
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of cutting a peptide of length k at position i is:
Fk,i = g(i) for i < k (2.5)
The cleavage probability should be very low for the first 3− 4 residues of
the protein due to the binding of the substrate prior to cleavage (see above).
Hence the standard deviation, σ, should be small. Choosing µ = 9 and
σ = 3 implies that we expect at least one cleavage site in every µ+ 2σ = 15
consecutive residues, which seems a fair assumption. Because σ < µ we
obtain that the proteasome has a low probability to cut in the very first
positions (see Fig. 2.1). Note that this model does not address the question
of the orientation of the sequence and thus the possibility to distinguish a
cut at the N or at the C terminus. We consider a simple example: suppose
the proteasome cuts with probability p1 and p2 at a distance d from the N
terminus and from the C terminus, respectively. The fragments generated
with this mechanism are the same of the case in which the proteasome cuts
with probability p1 + p2 at distance d from only one side of the sequence.
2.3 Results
The model has three rate parameters: the cleavage rate c, the maximum
influx rate aˆ, and the maximum efflux rate eˆ. A normal time scale of protea-
some experiments is minutes. However, experimental results on proteasome
degradation are typically compared for a certain level of substrate degrada-
tion, rather than at a specific point in time. Since time is not an important
issue, and because we have three rate parameters in our model one can al-
ways rescale the time such that c = 1 per time unit. Increasing the cleavage
rate will therefore be the same as decreasing the flux through the gates (i.e.,
as decreasing aˆ and eˆ). Where not otherwise stated, the results of the model
have been obtained numerically integrating Eqs. (2.1, 2.2) with a fourth
order Runge-Kutta integrator.
2.3.1 Kinetics
Experimental data suggest that the in vitro degradation rate of substrates
by the proteasome obeys Michaelis-Menten kinetics [Reidlinger et al., 1997,
Djaballah and Rivett, 1992, Hortin and Murthy, 2002, Realini et al., 1997,
Orlowski et al., 1991, Cardozo et al., 1999, 1994, Akopian et al., 1997, Kisselev
et al., 2002]. For long substrates the maximum degradation rate and the
Michaelis-Menten constant are known to decrease with the length of the
substrate [Kisselev et al., 1999, 2000, Akopian et al., 1997, Cascio et al.,
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Figure 2.1: A. The efflux rate as given in Eq. (2.3). B. Binomial (dashed
lines) and gaussian (solid lines) distributions for the cleavage probability. For
the binomial distribution p = 0.25,m = 9 and for the gaussian distribution
µ = 9, σ = 3. C. Schematic representation of the phenomenological cleavage
machinery given in Eq. (2.5) for different sequence lengths. The cleavage
probability is peaked at µ = 9 residues from one end of the substrate.
2002]. Our model also exhibits Michaelis-Menten kinetics (see Fig. 2.2). For
various initial substrate concentrations, Fig. 2.2 depicts the depletion of the
substrate (L = 100) in the solution (Panel A), and the corresponding filling
of the proteasome (Panel B). There is a rapid initial phase during which
the proteasome fills up by influx of the substrate. At the very early stage
of degradation, due to the filling of the proteasome, the substrate loss is
not linear. When the initial substrate concentration is low this initial phase
accounts for a significant depletion of the substrate concentration NL (see
Fig. 2.2A). Otherwise, the substrate concentration remains high and the
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filling of the proteasome approaches a quasi steady state corresponding to a
maximum degradation rate.
To study the Michaelis-Menten kinetics, we fix the substrate concentra-
tion by fixing N(t) = N(0) and let the model approach the corresponding
steady state. At the steady state we measure the degradation rate as the
number of substrate molecules in solution which are lost per unit time, and
depict that as a function of the substrate concentration and the length of the
substrate, L (see Fig. 2.2C). This reveals a family of Michaelis-Menten curves
for the various lengths of the substrate. The longer the substrate, the smaller
the maximum degradation rate, Vmax, and the smaller the Michaelis-Menten
constant, Km. The degradation rate at low substrate concentrations is fairly
independent on the length of the substrate (see Fig. 2.2C and Appendix).
More formally, one can illustrate the Michaelis-Menten kinetics by an approx-
imation employing the quasi steady state behavior observed with the model
Eqs. (2.1, 2.2). In the Appendix, we develop a simplified model of three dif-
ferential equations for the substrate concentration inside, n(t), and outside
N(t), and for the total concentration of fragments inside, p(t). By a quasi
steady state assumption for the internal dynamics, i.e., dn/dt = dp/dt = 0,
we arrive at the following equation
dN
dt
= − VmaxN
Vmax/aˆ+N
where Vmax =
ce¯
vL(c+ e¯)
, (2.6)
and aˆ is the influx rate of the substrate and e¯ is an “average efflux rate” of
the fragments (for details, see the Appendix). The latter should be taken as
an average of the length dependent efflux of the full model (see Eq. (2.3)
and the Appendix). The simplified model has a Michaelis-Menten constant
Km = Vmax/aˆ. This approximation is in good agreement with the kinetics
of the full model for long substrates (see Fig. 2.2D). For small substrate
concentrations, i.e., for N  Km, dN/dt ' aˆN , and the degradation rate is
indeed independent of the length of the substrate. The line aˆN is depicted by
the solid line in Fig. 2.2C and is in excellent agreement with the simulations
of the full model. For the current parameter settings, Vmax is approached
rapidly, e.g., within 10 time units (results not shown). The plateau level
in Fig. 2.2C depicted as dot-dashed line is the Vmax value obtained from
the simplified model for a substrate of length L = 100 and average efflux
e¯ = 0.2 per time unit. In this model, Vmax itself is a saturation function of
the cleavage rate c and the efflux rate e¯ (see Eq. (2.6)). This means that
the efflux and the cleavage play a similar role in limiting the maximum rate
of degradation. At high cleavage rates the degradation rate is limited by the
efflux, and at high efflux rates it is limited by the cleavage.
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Figure 2.2: Michaelis-Menten Kinetics. A. Substrate consumption, each
curve is the time course for a different initial concentration, NL(0). B.
Filling of the proteasome core particle (in amino acids) for each curve shown
in A. C. Michaelis-Menten log-log plot; each symbol-curve denotes a sub-
strate of a different length (see legend) obtained from the model presented
in Eqs. (2.1, 2.2) in conditions where the proteasome is in a bath of sub-
strate in order to prevent substrate limiting effects. Solid lines are non-linear
parameter fits with the Michaelis-Menten function. The solid line is given
by the initial slope aˆNL and the dashed-dot line is the Vmax, both predicted
with the simplified model (see Appendix) for the standard parameter values
(see Table 2.1) and an average efflux e¯ = 0.2 (see Eq. (2.6)). D. Vmax as
a function of the substrate length. It increases for substrate shorter than 10
aa and decreases for longer substrates. The initial substrate concentration is
NL(0) = 6000 to ensure that for each length the proteasome digests at the
saturation level.
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Fig. 2.2D shows the maximum degradation rate Vmax, calculated nu-
merically from the full model Eqs. (2.1, 2.2), as a non-linear function of
the substrate length. It increases for small substrates with a maximum at
ca. 10 aa and decreases with the inverse of the length for longer substrates.
Very small fragments are weakly degraded because of the low cleavage rate
for fragments shorter than 9 aa. This explains why the degradation rate
decreases for very short fragments. For longer fragments, Vmax was found
to decrease with the inverse of the length. This is due to the fact that the
COP volume is finite and thus the influx decreases with the increase of the
substrate length. Therefore, the degradation rate decreses accordingly. This
compares well with experimental results ([Dolenc et al., 1998, Kisselev et al.,
2000, Akopian et al., 1997, Kisselev et al., 1998, 1999]). Interestingly, the
ratio of Vmax/Km increases with the increase of the substrate length [Dolenc
et al., 1998] and saturates for long substrates reaching 50% of its maximum
for substrate of 23 aa which indicating that both constants decrease with the
length of the substrate in the same ratio.
2.3.2 Length distribution of the fragments
In vitro experiments generate cleavage products that range from 2 to 35 aa
with an average length of 7 − 8 aa [Nussbaum et al., 1998, Kisselev et al.,
1998, Kohler et al., 2001, Kisselev et al., 1999, Cascio et al., 2001]. Using size
exclusion chromatography and on-line fluorescence detection, Kohler et al.
[2001] showed that the products generated by the wild type (WT) proteasome
have a length distribution with three broad peaks corresponding to lengths
of 2−3, 8−10, and 20−30 aa, respectively. Other approaches, such as mass
spectrometry, are not quantitative and fail to detect short peptides. We have
searched the parameter space of our model to identify the regimes that result
in similar fragment length distributions.
Parameter Sweep. In Fig. 2.3 we show how the fragment length distri-
bution depends on the size of the gate, i.e., on the influx and efflux rates
aˆ and eˆ, as calculated with the model Eqs. (2.1, 2.2). In each panel, the
distribution is depicted for the time point at which 20% of the substrate
is degraded. The time at which this is achieved is indicated in each panel.
For an intermediate efflux rate, we obtain three-peaked distributions similar
to those observed in experiments [Kohler et al., 2001] for a wide range of
influx rates. Note that the first peak has its maximum at 1 aa but we call
this decreasing slope “peak" for simplicity. In our model, the three-peaked
distributions are the result of the cleavage machinery, which tends to cut
fragments of 8 − 10 aa, and the efflux of products, which favors the short
fragments. The distribution is insensitive to hundred fold variation of the
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Figure 2.3: Parameter sweep for the influx and efflux rates: length distribu-
tions of the fragments outside the proteasome. From left to right the efflux
rate eˆ increases, from up to bottom the influx rate aˆ increases. Each distri-
bution has been taken at 20 % of substrate degraded. The time at which the
20 % of substrate degradation is reached is shown in each panel. Parameter’s
sweep: aˆ = (0.01, 0.1, 1) and eˆ = (0.1, 1, 10). Panel E and Panel I could
represent the WT proteasome and an open-channel mutant respectively (see
also Fig. 2.4). Note that the distributions are insensitive to the variation in
the influx rate aˆ.
influx rate aˆ (see Fig. 2.3). From Eq. (2.2) it is clear that the influx rate
does not influence the distribution of produced fragments but only the rate
at which the proteasome fills up. Due to the linearity of the efflux and of the
cleavage rate with the density of internal fragments, the outside distribution
is independent on the rate at which the proteasome fills up.
In the first column of Fig. 2.3, Panels A, D and G, the efflux is slow
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compared to the cleavage (c/eˆ = 10). As a consequence, most substrate
molecules are fragmented extensively before they are exported, and one ob-
serves short fragments in the solution. Increasing the efflux rate 10-fold (see
the second column of Fig. 2.3, panels B, E and H) gives a similar time scale
to the efflux and to the cleavage, and allows for a three-peak distribution
(see below). Another 10-fold increase of the efflux rate (see Fig. 2.3, Panels
C, F, and I) makes cleavage the limiting factor. The ratio of long to short
fragments increases (which will later be interpreted as opening the gate, see
below). Because the residence time of fragments in the COP is short, there
is less fragmentation, and the first peak at 1-3 aa decreases.
Three-peaked distribution. When the efflux rate and the cleavage rate
have a similar time scale we observe three peaks in the distribution of frag-
ments (see Fig. 2.3 and the “WT” curves in Fig. 2.4). Similar to what is
observed experimentally [Kohler et al., 2001], the third peak is much smaller
than the other two, and the second peak is larger than the first peak. In
our model, the first peak corresponding to the small fragments reflects an
efficient cleavage mechanism where fragments are repeatedly cleaved before
they are released from the COP. These “rest” products do not collapse to
single amino acids because cleavage of very short fragments is improbable in
our model (see Fig. 2.1B). The second peak corresponding to fragments with
a length of 8 − 10 aa, is the result of the preference to cut at µ = 9 aa (see
Section 2.2.1). Fragments are found in a broad peak around 9 aa, because of
the variation in the cleavage (i.e., standard deviation of the Gaussian func-
tion). The third peak around 25 aa found in the WT distribution is due
to the efflux function. It results from the high probability of a fraction of
intermediate 25-35 aa fragments to exit the proteasome. As they would have
been a source for fragments of length 15-25 aa, the production of fragments
of this length drops. This intuitive explanation elucidates the presence of the
third peak.
Gate Opening. Comparing WT eukaryotic proteasomes with open-channel
mutants Kohler et al. [2001] showed that: i) mutants degrade substrates
faster, ii) the median length of resulting fragments is 40% longer than when
the same substrate is degraded with the WT proteasome, and iii) the main
effect of opening the gate is to increase the amount of long fragments and to
decrease the amount of short (2-3 aa long) fragments. In Fig. 2.4 we report
the effect of the gate size by increasing the influx and efflux rate 3-fold from
a WT with aˆ = 0.1 and eˆ = 1 to an “open-channel mutant” with aˆ = 0.3
and eˆ = 3. The fragment length distributions are compared at time points
where 20% (Panel A) or 80% (Panel B) of the substrate is degraded. For
these parameters the WT proteasome delivers the three-peaked distribution
discussed above (see Fig. 2.4).
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Figure 2.4: Fragment length distributions after opening the gate. Panel
A: The solid line corresponds to the WT proteasome at time t = 66 and
the dashed line to the open-channel mutant at time t = 56. At these time
points 20% of substrate is degraded. The stars depict the distribution of the
open-channel mutant at t = 66 (when 23% of substrate is degraded). This
illustrates that the degradation rate is higher for the open-channel mutant.
The average length of the products is 9.1 aa for the mutant and 7.3 aa for
the WT proteasome. Panel B: Same as Panel A but at a time point when
80% of the substrate is degraded. The average length are the same as in
Panel A and no evident shift of the peaks is observed. The stars depict the
distribution of the open-channel mutant at t = 279, when 92% of substrate
is degraded. Parameters: open-channel mutant aˆ = 0.3, eˆ = 3, and WT
aˆ = 0.1, eˆ = 1.
In the “open-channel” mutant the flux of fragments through the axial
channel is increased. As a consequence, the ratio of small over long frag-
ments decreases (see Fig. 2.4A, dashed lines). In terms of the three-peaked
distribution this results in a decrease in the first peak, and an increase in
the second and the third peak. The average length of the outside fragments
increases from 7.3 aa for the WT to 9.1 aa for the open-channel mutant.
With the mutant, 20% substrate degradation is achieved at t = 56, and with
WT this takes until t = 66. This corresponds to 18% increase in the degra-
dation rate. Fragments are produced with the same frequency during the
degradation process; the positions of the peaks remain similar between the
distribution at 20% and 80% substrate degradation. In this case the average
27
fragment lengths are 7.3 and 9.1 respectively with an increase of 24.6% of
the mutant with respect to the WT. The fraction of small fragments (1-5 aa)
is 36.5% (22% mutant), of intermediates (6-11) is 51% (58% mutant) and
of long fragments (> 11) is 12.5% (20% mutant) as reported experiemntally
[Kohler et al., 2001]. The third peak is centered at 23 aa and at 27 aa for
the WT and the mutant proteasome respectively.
2.3.3 Re-entry
In vivo the processed fragments of the proteasome degradation are exposed
to amino peptidases and other proteases in the cytosol [Reits et al., 2004].
This strongly reduces the possibility that fragments can enter the proteasome
and be further degraded. However, re-entry of fragments is possible in vitro,
and this is a controversial point regarding the validity of in vitro experiments
for the understanding of in vivo proteasomal activity. All results discussed
above were obtained in the absence of re-entry because only the substrate
had a non-zero influx rate a(L) = aˆ. To study the effect of re-entry of
processed fragments we first give all fragments the same influx rate a(k) = aˆ
for k = 1, 2, . . . , L. Fig. 2.5A and B show how re-entry affects the time
course and the length distribution of fragments. Re-entry slightly reduces
the degradation rate at late time points, e.g., after 50% of the substrate has
been degraded, when the concentration of some fragments in the solution
exceeds that of the substrate, see Fig. 2.5A. In open-channel mutants this
late effect of re-entry is even weaker (not shown). The effect of re-entry
increases when time proceeds, e.g., when the substrate is more than 80%
degraded, because the products start to dominate in the solution, see Fig.
2.5A. Comparing the number of fragments of length 8 − 10 aa illustrates
that the effect of re-entry on the degradation process is small. The length
distribution at 80% substrate degradation is shown in Fig. 2.5B. During the
course of the degradation the position of the peaks shift to smaller fragments
as a result of the reprocessing of products. The average fragment length
shifts from 7.3 aa to 6 aa.
Re-entry becomes more important if we allow small fragments to have a
faster influx than large fragments. For instance, this would be the case if the
fragments are actively transported through the axial channel. One would
then expect the transportation time to be proportional to the length of the
substrate, and the influx rate would be inversely related to the substrate
length, e.g. a(k) = Laˆ/k for k = 1, 2, . . . , L. Note that this function preserves
the influx rate aˆ for substrates of length L that was used above. With such a
length dependent influx rate, the re-entry of products markedly slows down
the degradation of the substrate (Fig. 2.5C). As a consequence of the re-
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Figure 2.5: Effect of the re-entry of fragments. A, B: Comparison of
the time course and fragment length distribution without re-entry and with
re-entry employing a constant influx rate for all the fragments: a(k) = aˆ.
Panel A: time course of the degradation process: the solid line is the sub-
strate depletion with re-entry (a(k) = aˆ for k = 1, 2, . . . , L), and dashed line
depicts the same without re-entry. The filled symbols depict the time courses
of fragments with re-entry, the empty symbols those of the same fragment
lengths without re-entry. B: length distribution of fragment with re-entry
(solid line) and without re-entry (dashed line). C, D: same as panels A,
B but with a length dependent influx rate a(k) = Laˆ/k for k = 1, 2, . . . , L.
Because short fragments rapidly re-enter the COP, there are less fragments
outside. D: The distribution shifts to the left increasing the first peak, 1− 3
aa, while the second (8− 10 aa) and the third (20− 30 aa) peak disappear.
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entry, the peak at a length of 8 − 10 residues vanishes, and more than 50%
of fragments outside are smaller than 4 aa (see Fig. 2.5D). Allowing for re-
entry, the average fragment length shifts from 7.3 to 4.7 aa. Summarizing,
these results suggest that for in vitro experiments, re-entry could indeed be
an issue: if the transport rate of substrates inside the COP is dependent on
the length, the experiments should be terminated when less than 10% of the
substrate is degraded to exclude the possibility of re-entry. At the moment
many groups use 20% as the typical stopping criteria [Cascio et al., 2001,
Kisselev et al., 1999]. An accurate analysis of the transport rates through
the proteasome channel is required to resolve this issue further.
2.4 Discussion and Conclusion
This work provides insights on the effect of the size of the axial channel on
proteasome degradation.
A realistic choice for the model parameters is hard to obtain. The model is
phenomenological and is designed to qualitatively capture the main features
of the kinetics of degradation. Furthermore, available experimental data are
not yet adequate for a mechanistic and more realistic description of the gate
functioning and the cleavage mechanism.
2.4.1 Length distribution
The main result of the model is that the residence time inside the COP, which
depends on the gate size of the axial channel, drastically affects the fragment
length distribution and the proteasome kinetics. We now understand how a
three-peaked fragment length distribution that is observed in the experiments
can be obtained. In the model the first peak is due to efficient fragmentation
to the minimal length before the fragment is released from the proteasome.
The second peak is due to the preference of the cleavage mechanism (see
Eq. (2.5)) to cut around position 9 from one terminus, delivering many frag-
ments of approximately that length from a single substrate molecule. The
third peak between 20 and 30 residues is the result of the size filter described
by the efflux function Eq. (2.3). Very little is known about the effects of
size, charge, and hydrophobicity on the transport of peptides through large
aqueous pores. We therefore prefer our simple phenomenological function
for the efflux (Eq. (2.3)) over complicated mechanistic functions. We sim-
ply assume that long fragments hardly leave the proteasome. An intuitive
phenomenological reason may be that a partial re-folding or the bending of
long fragments inside the COP (which are feasible for amino acid sequences
30
longer than 30 40 aa) may be responsible for the low rate of long fragments
to exit from the narrow proteasome pores. Moreover, secondary binding sites
that stabilize and increase the binding of long substrates are likely to exist
[Bogyo et al., 1998].
In order to check the robustness of the model’s results, we studied the
length distribution of fragments when the efflux parameters are varied. De-
creasing the value of the switching length θ, longer fragments have a very
low exit rate. Therefore, they are hardly generated and the third peak is lost
or becomes a shoulder of the second peak. The increase of θ results in an
accumulation of long fragments outside without strongly affecting the posi-
tion and height of the first two peaks. We obtain very similar results if the
increase of the θ values is accompanied with a decrease of the efflux rate eˆ (re-
sults not shown). This shows that the model is robust against perturbations
of the parameter θ. The robustness of the resulting product length distribu-
tion was also checked against changes of substrate length. Intuition leads to
the expectation that the proportion of fragments with a length around 8 aa
is diminished with respect to the number of produced fragments of length
around 23 to 27 aa, if the substrate length is shortened. This is due to the
fact that a long fragment will lead to a higher production of fragments of
lengths around 8 aa than a shorter one, before it can exit the COP with high
probability. Indeed, model results show exactly this behavior concerning the
frequencies of fragments, while retaining the three peaks: Shorter substrates
yield a smaller second peak than longer ones (results not shown). With that,
this model predicts that product length distribution changes with different
substrate lengths. Indeed, Ferrington et al. [2001] observe that degradation
of oxidized calmodulin by 20S proteasome produces a lower concentration of
fragments of length around 8 aa than of fragments of length around 25 aa,
for degradation of 10 % of substrate. Note that this substrate is almost
three times smaller than the substrate used by Kohler et al. [2001], whose
experimental data on length distribution is referred as comparison with our
length distribution results. A more thorough experimental investigation of
this effect could be used to confirm or falsify an efflux behavior like the one
assumed here (Eq. (2.3)).
2.4.2 The cleavage
The cleavage mechanism in our model is also phenomenological and basically
assumes that cleavage occurs, independently on the substrate orientation, at
some preferred distance from one end (see Eq. (2.5)), and requires a minimal
substrate length to efficiently cleave the sequence. This was inspired from
crystallographic structure [Lowe et al., 1995, Seemuller et al., 1995, Groll and
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Huber, 2003, Groll et al., 1997] describing a binding pocket nearby the active
site where the substrate docks before the cut takes place and from enzymatic
studies with inhibitors suggesting that a minimal length of 3-4 aa is required
to dock to the internal walls and efficiently cleave the substrate [Lowe et al.,
1995, Seemuller et al., 1995, Groll and Huber, 2003, Groll et al., 1997, Bogyo
et al., 1998]. Additionally, it has been recently shown that both in vitro and
in vivo initiation of proteolysis occurs close to the C-terminus of proteins
[Zhang et al., 2004]. This result supports our hypothesis of high cleavage
probability at the ends of the substrate although we do not address the ques-
tion of the orientation of the substrate and thus the distinction of the C- from
the N- terminus of the substrate. The low cleavage rate for fragments smaller
than 9 aa (see Fig. 2.1 C) and the size filter effect are both responsible for
the length dependent kinetics reported for the model. The rate characteriz-
ing the degradation of short fluorogenic peptides and decapeptide libraries
[Kisselev et al., 2000] increases with length while, for long substrate, a de-
creasing slope for both Vmax and Km is found, as was found in this model.
Random distributions for the cleavage probabilities have also been considered
(data not shown). For instance, let the proteasome cut with probability p
at a randomly chosen amino acid. The chance to cut a random amino acid
will be uniformly distributed, namely 1/L where L is substrate length. This
mechanism failed to generate a three-peaked distribution of the products un-
less specific “ad hoc” size filtering functions for the influx and/or the efflux
were considered. Moreover, even though the kinetics of the degradation is
not affected by this random mechanism, we would expect intuitively that the
length distribution will not show the peak at 8-10 aa. Simulations have con-
firmed that the loss of the length scale introduced by the cleavage mechanism
of Eq. (2.5) was responsible for the loss of the multi peaked distribution in
a wide range of parameter values. We also investigated a different random
cleavage in which each amino acid has equal probability to be cut, hence a
constant cut probability for each position is assigned. As for the previous
case, even if less short fragments are produced because long fragments have
higher cleavage rate with respect to the short ones, the distribution is not a
multi peaked curve. Other mechanisms have been also suggested in which
the fragments are generated with a double cleavage performed sequentially
on the same fragments [Wenzel et al., 1994, Holzhutter and Kloetzel, 2000].
We do not rule out this mechanism in our model since several consecutive
single cuts from the end of intermediate fragments are very probable.
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2.4.3 Kinetics of degradation
A major simplification of the model was to ignore the substrate specificity
of the proteasome. This allowed us to find an expression for the relationship
between the maximal degradation rate, Vmax, and the length of the substrate
(see Eq. (2.6)). Additionally, the Michaelis-Menten function, i.e., Eq. (2.6),
showed that the degradation rate can be either efflux limited or cleavage lim-
ited. Kinetically, one can therefore distinguish between the “efflux limited
case” where the cleavage is fast and the efflux is slow, and the “cleavage lim-
ited case” where the cleavage is slow and efflux is fast (see Fig. 2.3). When
efflux is limiting the residence time is long, and long fragments are cleaved
repeatedly into small products. When the cleavage is limiting long fragments
will be produced. Since open-channel mutants have an increased degradation
rate [Kohler et al., 2001], one can conclude that in the WT-proteasome the
efflux was the limiting factor. On the other hand, experiments with mu-
tant proteasomes, in which the catalytic site threonine was replaced with
serine [Kisselev et al., 2000], showed that the Vmax decreases strongly and
longer fragments are produced when compared to the WT. This suggests
that in this mutant proteasome cleavage is the rate limiting factor (see Eq.
(2.6) and Section 2.3). It has been suggested that the regulatory 19S cap,
which binds to the COP forming the 26S proteasome, increases the enzy-
matic activity [Hoffman and Rechsteiner, 1996], and facilitates the binding
of the substrates. The 26S proteasome exhibits a fragment length distribu-
tion similar to 20S proteasome but the average length of the fragments is
shorter [Kisselev et al., 1999, Emmerich et al., 2000]. These results are in
agreement with our model which predicts that an increased efficiency in the
cleavage activity limits the capacity of long fragments to go out, increasing
the frequency of shorter products. The 26S can be therefore described as a
proteasome with higher cleavage efficiency with respect to 20S and therefore
releases less longer fragments.
Recently a new model addressing the length dependent aspects of anti-
gen processing in vivo has been proposed [Kloetzel, 2004b]. Recent results
suggest that the proteasome may be one of the several proteases involved in
the production of peptides by a concerted multi-step mechanism. We do not
address the question of the proteasome kinetics in vivo. Our results point
on the proteasome digestion during in vitro experiment which might diverge
from in vivo substrate processing emerging from a more complex machinery
in which the fragment generated from a proteasome during one step could
serve as substrate for other proteases.
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2.4.4 Immunoproteasome
The relationship between proteasome activity and the IFN-γ induced sub-
unit PA28 [Cascio et al., 2002, Sijts et al., 2000, Van Hall et al., 2000, Kloet-
zel, 2004b] remains controversial. Different forms of the IP, i.e., 20S+PA28,
and 26S IP, cleave both short fluorogenic peptides and long substrates faster
than the constitutive forms of the proteasome [Eleuteri et al., 1997, Glick-
man, 2000, Cardozo and Michaud, 2002, Tenzer et al., 2004], and generate
longer products [Toes et al., 2001, Cascio et al., 2001, Dick et al., 1996, Kohler
et al., 2001]. Nevertheless, some experiments have shown that the substrate
turnover is very similar when compared between constitutive and immuno
forms [Cascio et al., 2001, Toes et al., 2001, Peters et al., 2002]. Although
experiments are still contradictory and the immunoproteasome not always
results in a faster substrate turnover and increased production of long frag-
ments, our model suggest that proteasomes equipped with the PA28, like the
20S IP +PA28, can be considered almost as being in an open gate config-
uration. Above we already discussed that the maximum degradation rate,
Vmax, saturates and can be limited by either the cleavage c or the efflux rate
e¯. In the cleavage limited case augmenting the efflux e¯ of the products in
Eq. (2.6) will hardly increase the degradation rate, and hence the average
fragment length will remain the same.
2.4.5 Improving the quantification of the antigen pro-
cessing pathways
Finally, our model can be used to achieve a more quantitative picture of
the MHC class I antigen processing and presentation pathway. Based on
estimates coming from the average turnover of proteins in a cell, Yewdell
and colleagues argue that the efficiency of antigen processing is low, meaning
that most of the potential MHC ligands are destroyed by the proteasome
[Yewdell, 2001, Yewdell et al., 2003]. We also find that at least 50% of the
fragments generated by the proteasome are shorter than eight amino acids
(see Fig. 2.4) and therefore can not be used for antigen presentation.
Modeling the proteasome by an opened gate, as can be 20S+PA28 (con-
stitutive and immuno), the average fragment length increases, and the steady
state level of fragments from 8 to 35 aa is elevated (see Fig. 2.4). Thus, an
open gate proteasome can markedly increase the amount of possible MHC
ligands. With open gate the average fragment length is at least three amino
acids longer and the steady state levels of fragments from 8 to 35 aa increases
by at least 25% (see Fig. 2.4). Thus, the immunoproteasomes can increase
the amount of possible MHC ligands by 25%. Adjusting the parameters of
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the model to the values used by Yewdell et al. [2003], i.e., the degradation
rate is 2.2 molecules degraded per time unit, Vmax = 11 molecules per unit,
8 · 105 proteasomes per cell and an average substrate length of L = 450
aa [Yewdell et al., 2003], we estimate the amount of fragments of different
lengths present in the cytosol during the steady state. Around 10% of frag-
ments are octa-mers, 9% nona-mers and 7% deca-mers. The production rate
αk of fragments of length k can be found from the model simulations once
the degradation rate is constant, e.g., α9 = 6 ·106. Assuming that nona-mers
have half life of 7 sec in the cytosol [Reits et al., 2003], the steady state con-
centration of nona-mers per cell becomes 106. This value is 16 times smaller
than the rough estimations of Yewdell et al. [2003], and comes very close
to the steady-state peptide concentrations measured in peptide competition
experiments (2 · 105, [Reits et al., 2003]). Similarly, summing over all k-
mers longer than 8 produced by our degradation dynamics, we calculate the
potential MHC ligands steady-state to be 7 · 106 circa.
Summary
It is evident that the proteasome degradation is a key-step in the processing
of antigenic peptides, which serve for the IS to check the state of cells and
to eventually recognize and destroy infected cells. This Chapter presents a
simple model able to capture important aspects of the proteasome degrada-
tion. The model shows that the fragment length distribution depends on the
substrate length and on the concentration with which proteins enter into the
proteolytic chamber. The gate opening is the main regulator of the substrate
degradation. Longer fragments, which have higher chance to reach the sur-
face of cells and be presented to the T-cells, have increased abundance as far
as an open gate proteasome is provided. It is worth to note that the size and
the amount of peptides longer than 8 amino acids, which are generated by the
proteasome, affect the antigen processing and therefore the IR. Longer pep-
tides have higher chance to not be destroyed by several intracellular amino
peptidases, which shorten the peptides during the transportation phase from
the cytosol to the ER, where they become part of the MHCp complex. The
open gate proteasome can be one of the factors which allow peptides to reach
the ER. In fact, most of the peptides generated by the proteasome are to-
tally destroyed or reduced to short length, losing immunological relevance.
The model proposed suggests that some forms of proteasomes, which are re-
placed during an IR, have an open gate configuration. This allows a better
degradation kinetics and longer fragments produced.
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Part II
The antigen presentation and the
clonal expansion
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Chapter 3
Competition for resources and the
shaping of the lymphocyte
repertoire
Introduction
In this Chapter we shall review published models regarding competition phe-
nomena for immunological resources between lymphocytes in the peripheral
tissue. We shall define what immunological resources are, and describe how
mathematical models are developed. In particular, we shall focus on com-
petition phenomena related to biological space and to antigens through the
description of three different mathematical approaches.
3.1 The concept of competition for resources
It has been accepted since decades that the IS is strongly regulated in size and
functionality by resources which shape and keep functional the immune cells
repertoire. We can define a “resource" for lymphocytes any antigen, MHC,
poly-clonal activators, cytokines (interleukins), chemokines which can lead
to increased cell survival or growth, at least in a certain availability range.
In ecology, the total requirements of a species for all resources and physical
conditions determine where it can live and how abundant it can be at any
one place within its range. These requirements are termed abstractly the
ecological niche. Lymphocytes can produce their own resources contributing
to generation of their niche. Their heterogeneity allows for the co-existence
of multiple niches. It is almost straightforward to imagine that these cells
compete against each other for the for mentioned resources. Therefore, the
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concept of competition between IS cells can be defined. We can take from
textbooks the following definition of competition: an interaction between
individuals brought about by a shared requirement for resources in limited
supply leading to a reduction in the survivorship, growth, and/or reproduc-
tion rates of the individuals concerned [Tilman, 1982].
Immunologists focused on the importance of the competition since a long
time [Mitchison, 1992, Rocha and Von Boehmer, 1991]. Several data point
to competition between lymphocytes for three main classes of resources
1. antigenic epitopes and self-peptides, which both influence the home-
ostasis and the survival of lymphocytes.
2. cytokines, which are mediator of activation, proliferation, death, and
survival signal pathways
3. the biological space
Criteria for the evidence of competition have been recently proposed by
[Gaudin et al., 2004]:
1. The competition between cells should modify the equilibrium size of
a population. It has been shown that the number of a certain clone
depends on the presence of other clones which share common resources.
2. The competition between cells should alter the dynamics of a popu-
lation. The half-life of lymphocytes is strongly dependent upon the
presence of other cells competing for resources.
3. The manipulation of the available resources should modify the equilib-
rium dynamics of two competing populations.
B-cell and T-cell dynamics fulfill these three criteria of competition [Gaudin
et al., 2004, Almeida et al., 2005]. Daily, our body generates a vast number
of immune cells with new specificities. Although pre-selection mechanism
(such as the thymus for T-cells) limits the influx of danger self-responding
cells in the periphery, the appearance of self-reactive cells in the periphery is
inescapable. Tolerance, therefore, must be determined not only at a single
cell level but also by global properties of the system. Competition is believed
to play a major role in shaping a diverse, as well as functional, cell repertoire.
3.1.1 Competition for space
Even though the mechanisms regulating the lymphocyte pools are very dif-
ferent, both T- and B-cells compete for space Fig. 3.1. Several examples
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Figure 3.1: Competition for space. This cartoon represent the basic idea
behind lymphocytes competition (B- and T-cells) for immunological space.
Although a precise definition of what immunological space means is still a
matter of debate, we can fairly imagine that during a proliferation phase,
caused by some antigenic stimulus, cells may eventually fill the local envi-
ronment. Unless a strong flux of cells makes again room, and cells occupy
the entire space available, the proliferation phase will be suppressed. Exper-
imental evidence suggests that a density dependent proliferation rate occurs
during the proliferation of T- and B-cells, and that in extreme lymphopenic
condition proliferation increases without antigenic stimuli in order to re-
establish the homeostatic size of the repertoire.
taken from literature suggest this common element between these mecha-
nisms. The death rate of lymphocytes depends on the cell density. Highly
proliferating cells undergo higher apoptosis rate, while slowly proliferating or
resting cells are characterized by a low death rate. As an indicative example
we can cite the Fas-FasL mechanism. This is induced during the expansion of
cytotoxic T-cells, which activate a programmed apoptosis leading to death.
Typically, this mechanism has been observed during the contraction phase of
a cellular immune response, where more than 90% of effector cells are elimi-
nated [Wherry et al., 2003]. Fas-FasL interaction has been found also during
the normal homeostatic maintenance of cells in the periphery (see also 5).
Experiments evidenced the importance of competition for the biological
space [Almeida et al., 2005, Gaudin et al., 2004]. For instance, parabiosis
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experiments, in which a series of mice are connected chirurgically to assess
a common circulation of blood and immune lymphatic system, show that
one mouse is able to fill the IS of a parabiotic system in which three mice
are connected each others. This clearly shows that biological constraint are
imposed on the pool of immune system cells, and that the pool size at the
steady state is a function of the biological space as well. Moreover, aged
individuals, despite the multiple antigenic experiences they underwent during
life, show a slightly reduced IS size with respect to young individuals. It is
worth to conclude that some general mechanisms must regulate the space
occupied by the IS cells [Franceschi et al., 2000a].
3.1.2 Competition for antigens
The phenomenon of antigenic competition, in which immune responses to
one determinant are inhibited by simultaneous exposure to another antigens
on the same or different molecules, has been known since at least the turn of
the century [Michaelis, 1902, 1904]. T-cell competition for antigen has been
suggested. During an IR, the average affinity for MHC-peptides of the T-cell
receptors on the responding T-cells increases [Busch and Pamer, 1999, Savage
et al., 1999]. This occurs in the absence of somatic mutation, the phenomenon
that drives the affinity maturation of B-cell responses. T-cell affinity selection
appears to be caused by a preferential outgrowth of the higher affinity T-cells
present within the pool of primary responders, suggesting that the higher
affinity cells have a competitive advantage for responding to antigen. In case
of chronic infections (HIV, mice LCMV) several response of cytotoxic T-
cell clones against multiple epitopes presented on the antigen presenting cell
(APC) are observed. This phenomenon can be considered as a competitive
coexistence of multiple clones for different epitopes.
An accepted but still controversial phenomenon is the immunodominance,
namely the selection of a restricted pool of epitopes from the wide spectrum
of antigenic peptides showed during an infection. Only few of these peptides
drive the clonal expansion. Mathematical models helped in the understand-
ing of such a mechanism (see later on and [Yewdell and Del Val, 2004]).
We also studied immunodominance and how this hierarchy can be changed
or reduced during an immune response (see Chapter 4). Many earlier re-
sults on immunodominance have been attributed to differential processing
of the peptide, which shapes the selection of T-cells. However, not all of
epitope dominance can be explained in terms of peptide loading and affinity
for MHC. There are data to suggest that T-cells responding to one antigen
can actively interfer with T-cells responding to another [Wolpert et al., 1998,
Kedl et al., 2003]. Moreover, experimental data demonstrated that some of
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these epitopes do not appear to have significant differences in their levels of
presentation [Chen et al., 2000]. Presumably, generation of a large number
of T-cells specific for the subdominant epitope allows them to compete more
effectively for access to APCs with cells specific for the traditionally more
dominant epitope.
In recent years, many of the mysteries of B-cell competition have been
elucidated and shown to be the consequence of somatic hypermutation and
affinity maturation [Cyster, 1997]. B-cells undergo affinity maturation in
the germinal center. They are the most well-characterized immune exam-
ple of competition for niches. Germinal centers play a critical role in the
maturation of the immune response by selecting B-cells with high avidity for
antigen. Affinity maturation is present only in species capable of germinal
center formation. Basically, a massive proliferation of few B-cells clones (on
average three) driven by antigen held by follicular dendritic cells occurs. The
B-cells expansion is accompanied by B-cell receptor hypermutation. Com-
petition among proliferating B-cells, based on their ability to interact with
antigen, leads to the preferential survival of the cells capable of high-affinity
recognition and to the death by apoptosis of other cells.
T-cell competition and its effect are observed in several experimental
model systems. The preponderance of data from diverse sources and models
systems indicates that epitope dominance, T-cell competition and affinity
maturation are part of a natural process of ongoing T-cell mediated immunity
(see also Fig. 3.2).
We will focus now on a short review of published models regarding com-
petition phenomena in B- and T-cell repertoire. Our main goal will be the
understanding of general mechanisms behind competition for resources.
3.2 Models: an overview
For both T- and B- cells, mathematical models based on competition for
resources have been proposed (e.g. for B-cells McLean et al. [1997], De Boer
et al. [2001a] and for T-cells De Boer and Perelson [1994, 1997]). Most of
them borrowed several concepts from theoretical ecology. Important concepts
which found application in modeling the IS are
1. The principle of competitive exclusion: namely one species exclude
another species with overlapped resources. Several examples are repre-
sentative of this phenomenon from both ecological and immunological
studies.
2. The principle of competitive coexistence: namely species coexist in the
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Figure 3.2: Sketch of the direct T-cell competition for antigen. Grey and
black T-cells represent two different clones. Intra-clonal competition is the
interaction between cells belonging to the same clone which compete for the
same resource (MHC-peptide molecule). Inter-clonal competition refers to
the impairment of some cells of a defined clone (light grey) to access resources
which are blocked by some other cells belonging to a different clone (dark
grey).
same environment even if they share resources. As an example, one
can imagine a situation in which the competition prevails between in-
dividuals of the same species, and is less expressed between individuals
belonging to different species.
At the equilibrium, an ecosystem characterized by N different resources can
maximally sustainN species [Macarthur and Levins, 1964]. Sharing resources
is an important feature for T-cell dynamics. In ecology the coexistence of
multiple species is possible only if a minimum number of resources are avail-
able. T-cells are characterized by cross-reactivity, which allow different T-
cells to recognize the same peptide. Coexistence and competitive exclusion
are therefore useful concepts to describe the kinetics of immune cells.
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Consider the following general representation of the standard predator-
prey model
dX
dt
= X(1−X)− αF (X, Y ) (3.1)
dY
dt
= αβF (X,Y )− δY (3.2)
where X is the prey and Y is the predator. The function F represents mathe-
matically the interaction between prey and predator and can assume different
forms. By purpose the term β has been introduced to describe the prolifer-
ation of predators to the capture of the prey. In theoretical immunology the
following expressions for the function F have been considered
F (X, Y ) = XY F (X,Y ) =
XY
K +X
(3.3)
The first function corresponds to what we shall call the Nowak’s model. This
approach has been used to explain general interaction between immune cell
clones competing against each other for resources (such as antigenic peptides)
[Nowak et al., 1995a,b]. The second case (known in ecology as Holling type
II function) leads to what we refer as the De Boer model. We discuss some
example for both cases, and show how simple mathematical models account
for competition mechanisms, and how strong is the effect of competition for
resources on the cell dynamics.
3.3 Nowak’s approach
We consider two application of the Nowak’s model. The first deals with the
immune response against multiple epitopes of the same virus, while the sec-
ond describes the competition between humoral and cellular IR. The first
example took inspiration from HIV infection [Nowak et al., 1995a,b]. This
chronic disease is characterized by a strong initial cytotoxic immune response.
Concomitantly to the AIDS development this IR vanishes, and rapid oscil-
lating immune responses are observed. Longitudinal studies evidenced a fast
change in epitopes presented on the APCs of infected individuals, which lead
to a rapid incoming of new specific T-cell clones.
It has been proposed that antigenic variations, due to virus mutant, or
dynamic change of the amount of epitopes presented on the APC, may un-
derlie these unexpected changes. The model offers an interesting mechanism
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to explain these phenomena, and suggests how competition between antivi-
ral clones for epitopes can be the leading element for the explanation of this
complicated dynamics.
The second example is based on competition between several predators
for one prey. In this case, the predators are the different adaptive immune
responses: the humoral (mediated by B-cells ) and the cellular (mediated by
T-cells) [Arnaout and Nowak, 2000]. The model clearly shows that the com-
petitive dynamics between different cells shapes a better immune response.
The coexistence of both responses may result in a better protection for the
host against infections while, in case of competitive exclusion, the virus may
persist at low concentration and re-expand later on, giving rise to danger
reinfections. The authors highlight an interesting analogy with free-market
economics: competition between companies results in a benefit for the con-
sumer. The coexistence of both humoral and cellular immune response results
in a benefit for the host, which can control much better the infection.
3.3.1 Immune responses against multiple epitopes
Suppose during an infection two different epitopes, say A and B, are presented
on the surface of APCs. Each epitope can be represented by a sequence of
8-10 aa, which is the result of the degradation of viral proteins. T-cells
recognize a spectrum of sequences with different affinity. Suppose several
variants of the epitope A and B-are possible due to the viral mutation or
simply to dynamic regulation of their abundance on the surface of APCs.
Suppose also that a mutant of the epitope A appears. This leads to a new
scenario for the antiviral response: the new IR can be very similar to the
previous one, or change toward a new clones distribution with new dominant
clones responding against the infections.
A simple way to show this is to write down the equations in the case of
two clones, x and y, recognizing epitopes A and B. Moreover, n1 possible
amino acid sequences for epitope A, and n2 possible amino acid sequences
for epitope B-are considered. We can write down the equations for the clone
xi recognizing sequence i, and for the clone yj specific for the sequence j of
the epitope B
dvi,j
dt
= vi,j(r − pxi − qyj) (3.4)
dxi
dt
= xi(cvi,∗ − b) i = 1, .., n1 (3.5)
dyj
dt
= yj(kv∗,j − b) j = 1, .., n2 (3.6)
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The parameters c, k are the immunogenicity of the sequence i of the epitope
A and the immunogenicity of the sequence j of the epitope B-respectively.
There are a total number of n1 × n2 clones responding to the virus. Clones
proliferate at rate proportional to the epitope immunogenicity and die at
rate b. The virus is killed at rate p in case the sequence of epitope A is
recognized, and at rate q in case sequence of epitope B. vi,∗ is the sum of all
viruses which possess the sequence i. The same for v∗,j.
It is worth to note that the competition between clones x and y is gov-
erned by two factors: the immunogenicity of the epitope, namely the more
immunogenic the better the IR, and the antigenic variability, which means
the less variability the better the IR. Antigenic variability does not neces-
sarily means that mutants of the virus arise over time. Oscillations between
different immune responses can be observed also with a fixed number of epi-
topes present since the beginning. The immune response can reduce the viral
peptide to very low level, and the number of clone cells diminishes. But later
on, the epitope abundance can rise again leading to a new peak of the same
clone. Competition between the IRs is decided by the ratios c/n1 and c/n2.
Consider a steady state characterized by x˙i = 0. It is trivial to see that the
solution is vi,∗ = b/c, and the total virus abundance is v¯ = bn1/c. On the
other hand, suppose y˙j = 0. It follows that v¯ = bn2/k. The competitive ex-
clusion is evident: in general these two solutions for the total virus v¯ cannot
be simultaneously fulfilled (unless n1/c = n2/k). Trivially, (simple steady
state analysis) one can show that a clone (x or y) will disappear and the
other survive according to the magnitude of the ratios c/n1 and k/n2. If all
the clones yj vanish, we are left with the following equations
dvi,∗
dt
= vi,j(r − pxi) (3.7)
dxi
dt
= xi(cvi,∗ − b) (3.8)
The clones xi oscillate, and the replication rate of the virus and the death
rate of clones define the oscillation period. In fact, this is a system of n1
uncoupled oscillators with an approximative period of T ' 2pi√
rb
.
Let consider a more general situation in which each immune response face
an epitope sequence with immunogenicity ci and ki.
We could than rise the question: which factors determine the immun-
odominance? This model suggests that the exclusion of the immune response
against the epitope B, yj is possible if the epitope A have immunogenicities
such that
∑
i
1
ci
>
∑
j
1
kj
. The epitope A will then be the immuno-dominant.
A same argument can be given for epitope B. If there is only a homoge-
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neous virus population then the generic situation is that there is exactly one
immuno-dominant epitope. But as we have already observed, immunodom-
inance is a function both of the immunogenicity and of the diversity of the
epitopes, and also of the replication rate of the various mutants. Antivi-
ral clones can compete for epitopes because of their cross reactivity. The
virus itself can replicate at different rates in dependence on the particular
sequence. These conditions can indeed generate both x and y responses with-
out competitive exclusion. We may expect coexistence of immune responses
against several epitopes. Basically, if the various epitopes have comparable
immunogenicity and eventually the virus mutants differ in their overall repli-
cation rates, we would aspect none of the immune response prevailing (at
least for an arbitrary choice of the parameters). The model suggests that
the virus heterogeneity will keep the resources diverse enough to stimulate a
wide spectra of different clones.
For slowly replicating viruses with low heterogeneity a restrict repertoire
of antiviral clones is expected and eventually a complete competitive exclu-
sion may leads to a monoclonal response. In cases where the virus replicates
fast and is very heterogeneously represented, than competitive coexistence
of several immune responses is expected. Intuitively the clones xi oscillate,
and the replication rate of the virus and the death rate of clones define the
oscillation period. In fact this is a system of n1 uncoupled oscillators with
an approximative period of T ' 2pi√
rb
.
3.3.2 Competition between humoral and cellular response
The second model is based on similar assumptions [Arnaout and Nowak,
2000]. Consider the humoral (B), and the cellular, (T cytotoxic) responses.
The former recognizes extracellular pathogens present in the body, while the
latter is driven by intracellular infections. Therefore, the viral infection is
modeled in terms of free virions v, which stimulate the humoral response,
and of infected cells I which are responsible for the T-cell activation
dI
dt
= βv − αI − pTI (3.9)
dv
dt
= kI − uv − hvB (3.10)
dT
dt
= cIT − bT (3.11)
dB
dt
= fvB − gB (3.12)
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Figure 3.3: Competition between humoral and cellular immune response.
This table is a summary of the steady states of the model presented in 3.3.
On the x-axes the ratio gc/bf is reported. The values α/β and k/u represent
the boundary values of the above defined ratio, which leads to the coexistence
of both humoral and cellular immune response (see also Eq. (3.13)). The
left and the right side of the figure represent the parameter region for which
competitive exclusion for one of the IR is observed. This picture is taken
from Arnaout and Nowak [2000]
Infected cells grow proportional to the virus at rate β, and die at rate α.
Infected cells produce virions at rate k, u is the per virion decay rate of free
virus. The cellular response limits the size of the infected cell pool by cell-
mediated lysis (by perforin, Fas-Fas ligand interaction). This is captured in
the pIT term, where p is the rate of killing. Similarly, the humoral response
limits viral load by antibody-mediated neutralization, captured in the hvB
term; h is the rate of antibody-mediated clearance. The constants c and f ,
respectively, denote cellular and humoral responsiveness, which are roughly
measures of the quickness with which the host elaborates these responses.
The constants b and g are the respective per capita natural decay rates of
the cellular and humoral responses.
The system has four stable equilibria. It is possible to show that the
following condition defines the steady state
k
u
>
cg
bf
>
α
β
(3.13)
Three qualitatively outcomes are possible (see Fig. 3.3): viral clearance
independent of the immune response (all of the above conditions do not
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hold) persistence controlled by a single response (only one of the two side of
the condition Eq. (3.13) hold: competitive exclusion) persistence controlled
by both responses (Eq. (3.13) holds: coexistence). The Fig. 3.3 shows
a schematic representation of the model outcome. Humoral and cellular
immune responses can out-compete or coexist in dependence of the kinetics
of the viral load and of the immune response. To better understand how
the competitive exclusion and the coexistence between humoral and cellular
immune response rises we consider two examples.
The competitive exclusion: suppose the virus is very cytopatic, namely
k/u ≤ cg/bf . In this case (see right side of Fig. 3.3 either the virion produc-
tion rate k is too low (or its clearance u too high), or the humoral response
has very low responsiveness f . This condition leads to a very high cellular
immune response, which result in the clearance of the infected cells and to a
very low viral load v. At equilibrium a strong impairment for the humoral
immune response to persist is observed: the number of infected cells reaches
very low level and viral load in not sufficient to keep a long term humoral
immune response. On the other hand, if the infectivity or cellular respon-
siveness is reduced, the humoral response persists and keep the virus under
control.
The competitive coexistence: suppose all the conditions in Eq. (3.13)
hold. The two responses never out-compete (see Fig. 3.3). These relation
results in a stable equilibrium for the system in which both humoral B and
cellular T are non zero. Unless the virus is completely cleared it would be
beneficial for the body to keep track of the virus from both humoral and
cellular immune responses. Viruses present very different replication rates
and present several degree of cytotoxicity. they can spread as free moving
particle or intra-cellularly and most important these parameters can change
during the course of the infection.
The message of this model is that competitive immune responses can
control better the very diverse spectra of action that viruses possess.
3.4 De Boer’s approach
The main feature of the model is the competition for binding of T- or B- cells
to ligands expressed on MHC molecules. Cells recognizing these molecules
according to some specificity rule are able to proliferate in the system. The
model describes the homeostasis of the system, the total number of cells is
kept almost constant with and is regulated by the cross-reactivity and th
diversity of the repertoire as far as the peptides presented to the surface of
APC are concerned. This approach will be used in the next Chapter as a
50
Figure 3.4: Protein sequences containing antigenic peptides are taken up and
degraded by intracellular proteolytic pathways, such as the proteasome degra-
dation. In the De Boer model a T-cell binds to the MHC-peptide molecule
presented on the APC. Th binding is regulated by the affinity between T-cell
receptor and the MHC-peptide complex. Each MHC molecule presents a
peptide, and its abundance limits the size of the T-cell repertoire.
template for our model, and it has been widely used in T- as well as B-cells
kinetics models [De Boer and Perelson, 1994, Borghans et al., 1999, De Boer
et al., 2001a].
The model can be obtained by the following reaction scheme
Ti + Fj 
 Ci,j → 2Ti + Fj (3.14)
The cell Ti binds to a free MHC-peptide molecule Fj forming a complex Cij.
The binding affinity is given by the kinetics rates of the complex formation
(see appendix B). Cells proliferate if the binding between the T-cell receptor
and the MHC molecule on the APC is strong enough. With this scheme,
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supposing a death rate δ for T-cells, one can write the following equations
dTi
dt
=
Pep∑
j=1
kpijKijSjTi − δTi (3.15)
Sj =
Pj
1 +
∑N
i=1KijTj
(3.16)
We consider N clones competing for M peptides (for more explicit calcula-
tions see Chapter 4 and De Boer and Perelson [1994, 1997]). Sj defines the
number of free MHC-peptide complexes available on the APCs. Suppose the
number of different clones is greater than the number of different peptides.
For at least N−M clones the equilibrium is given by Ti = 0. Therefore, only
M clones, which correspond to the number of antigens, can survive. This
result corresponds to the standard ecological concept known as principle of
competitive exclusion. At the equilibrium
Pep∑
j=1
kpijKijSj = δ (3.17)
For instance, suppose we have N clones and that the first i = 1 is the one that
has maximum β =
∑Pep
j=1 k
p
ijKijSj. At the equilibrium β = δ and T1 6= 0.
This implies that all other clones 2, 3, ....N necessarily have to die (T˙i < 0).
Competitive exclusion is presented in the context of affinity selection:
T-cells undergo a selection process during the clonal expansion without mu-
tation of their receptor as commonly happens for B-cells. In this scenario,
the principle of competitive exclusion state that given a peptide and the set
of clones which has a defined affinity for it, the clone with the highest affinity
will survive.
This model shows that the diversity of the T-cell repertoire is shaped by
the diversity of self-peptides presented on the MHC molecules. The com-
petitive coexistence of a diverse T-cell repertoire can be maintained by a
sufficient diverse peptide repertoire. One should also keep in mind that in
case the selection mechanism lasts for a very long timescale, such as the indi-
vidual lifespan, the exclusion of some clones might never be observed. Studies
on aged mice and cross-sectional human data evidence a reduced diversity
in the naive T-cell pool. Probably competitive exclusion can be one of the
mechanism influencing this phenomenon. Today we know that the affinity of
an epitope specific immune response tends to increase with the duration of
the antigen exposure, confirming the main result of this model [Busch and
Pamer, 1999, Slifka and Whitton, 2001, Yewdell and Bennink, 1999].
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3.4.1 T-cell competition for peptides presented on the
same cell
A recent application of the De Boer’s approach has been the competition be-
tween different T-cell clones when their specific epitopes are presented on the
same antigen presenting cell [Scherer and Bonhoeffer, 2005]. Experimental
data suggests another interesting way of competition between T-cells, and
confirms the importance of competition mechanisms [Kedl et al., 2003].
T-cells compete for antigen at several levels. For instance, T-cells can
directly inhibit the response of other clones by down regulating the epitope
expression on the APC or inhibiting the contact between APC and other
clones (Fig. 3.2). This is known as inter clonal competition. Intra clonal
competition, namely competition between cells of the same specificity is also
observed. T-cells can indirectly out-compete other cells by killing the APCs
or by reducing general resources like cytokines, inducing proliferation and
survival signaling.
The model proposed by Scherer et al. is based on the down-regulation of
different epitopes presented on the same APC, and shows that T-cell compe-
tition occurs at the level of access to the limited number of antigen-bearing
APCs.
dV
dt
= rV (1− cV )−KkillV (E1 + E2) (3.18)
dA1,1
dt
= σV − δAA1,1 (3.19)
dE1
dt
= r1A1,1F1(E1, E2)− δEE1 (3.20)
dE2
dt
= r2A1,1F2(E1, E2)− δEE2 (3.21)
A population of virus infected cells, V grows with a maximal rate r in a
density dependent manner, and has a carrying capacity of c. It is assumed
that APCs present two epitopes on their surface. Virus infected cells are
cleared with clearance rate Kkill by effector T-cells E1 and E2, that have
respective avidities r1 and r2 for antigen presenting sites on APCs that
express both epitopes. The influx of new epitope expressing APC sites
is proportional to the number of infected cells with a proportionality con-
stant σ. APCs and effector T-cells have death rate δA and δE respectively.
The saturated proliferation functions F1(E1, E2) = E1/(1/K +E1 +E2) and
F2(E1, E2) = E2/(1/K + E1 + E2) account for the competition between T-
cells for the binding with the two epitopes on the same APC (see also Eq.
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(3.3)). The main idea is that competition between the two effector cell clones
responding to the epitopes exists. The number of APCs A1,1, presenting both
epitopes, decreases if there is epitope down-regulation. This pushes the sys-
tem to differentiate and have more APCs which show independently the two
epitopes. Namely we get A1,0 and A0,1. The equations for this APCs and the
epitope down-regulation kinetics are not shown for the sake of simplicity (see
Scherer and Bonhoeffer [2005] for a complete description). The inter-clonal
competition decreases. Epitope down-regulation leads to differentiation of
epitope presentation on antigen presenting sites. Different T-cell clones will
not compete for their resources because they will be presented on different
cells.
The conclusion is that APC differentiation promotes the coexistence of
multiple epitope specific responses. The functional relevance of epitope down-
modulation seems to enable the persistence of a broad immune response,
despite competition for antigenic stimulation. We shall discuss a similar
problem in the next Chapter. We consider the IR in the context of replace-
ment of constitutive with immunoproteasome. The consequences on antigen
presentation and the clonal selection of cytotoxic T-cells during the immune
response will be discussed.
3.5 The fratricide mechanism
It is well accepted but still largely unknown that T-cells can kill each oth-
ers. The reasons can be very disparate, going from space competition to
overexpression of substances inducing death (perforin, or cytokines inducing
apoptotic intracellular pathways). These phenomenon is generically named
fratricide killing mechanism. In literature the concept of fratricide is not fully
defined and the mechanisms behind are still largely unknown. Two possible
mechanisms have been proposed. The first is an antigen dependent fratri-
cide, where T-cell are recognized via their MHC class-I molecules by other
T-cells, and committed to die (via perforin) [Su et al., 2004]. The second, is
an antigen independent fratricide characterized by a generic competition for
space. Highly proliferating T-cells fill fast the space available, and undergo
a mechanism of apoptosis driven by Fas-FasL contact [Callard et al., 2003].
Antigen independent mechanisms are known to regulate T-cell prolifera-
tion and survival [Allan et al., 2004, Callard et al., 2003]. The next model
introduces a nonlinear death term (fratricide) in the population of antigen
activated cells, A, and memory, M , T-cells. Moreover, a certain amount of
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Figure 3.5: Scheme of the fratricide model. The fratricide killing mechanism
acts only in the cycling and activated T-cell pools, which are capable to
proliferate actively after antigenic stimuli. The resting pool has a very low
apoptosis rate and is capable to stay in the system for a long period of time.
memory cells is supposed to cycle (self renewal process), C (see Fig. 3.5).
dMi
dt
= rCi − (a+ d+ s)Mi + p(s)Ai (3.22)
dCi
dt
= 2aMi + cCi − fC
∑
j
Cj − (r + s)Ci (3.23)
dAi
dt
= s(Mi + Ci ∗N) + cAi − kAi
∑
j
Aj − p(s)Ai (3.24)
Proliferation within compartments C and A occurs at a rate c. Fratricide
is related to the proliferating pool: in the memory cells it occurs at rate f ,
and in the activated T-cell pool at rate k. During an infection, pre-existing
memory cells of specificity i are recruited into the activated pool A at rate s.
Recruitment also occurs from naive cells v. Activated cells are flowing back
into memory pool at a constant per capita rate p, which is zero during the
infection (proliferation happens only in the presence of the antigenic stimulus,
p(s = 0) = 0). A flux of cells between the cycling and the resting pool is
considered with the rates r and a. The quadratic terms have been introduced
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by phenomenological considerations. Basically, if two different clones are
proliferating, well mixed, and meet at random , the probability that their
daughter cells will encounter and induce fratricide killing is proportional to
the clone sizes. Because both clones are proliferating, we would expect a
death rate proportional to the product of the proliferating cells numbers.
Therefore, on a first approximation, fratricide should be a quadratic term of
the clone size.
This model predicts that long-term clonal memory does not have to de-
pend on antigen stimulation, but competition for space or for general re-
sources could be crucially related to fratricide through Fas or Fas-like mech-
anisms of apoptosis. The size of the total repertoire is inversely proportional
to the fratricide rate and independent on antigen (for more calculation see
Yates and Callard [2001]).
A similar result is obtained with the De Boer’s approach. The main
difference is that in the fratricide model a separate cycling population of
memory cells is considered. T-cell fratricide killing provides a T-cell density-
dependent death mechanism, which defines the homeostatic level of the total
T-cell repertoire and does not depend on antigen specific regulatory mecha-
nisms.
3.6 Conclusion
This short review of mathematical models of T- and B-cell competition dy-
namics should help the reader to understand the importance of including
such a phenomena in the quantification of the adaptive immune response.
It is important to summarize the main differences between these models.
Comparing the Nowak’s approach with the De Boer’s, we conclude that the
competitive exclusion can be obtained from different hypotheses. The for-
mer is based on the fact that high affinity clones kill infectious agents very
fast, and reduce the antigen to minimal concentration, that other cells can
no longer be stimulated. This is what is usually called an indirect competi-
tion. The latter approach offers a more explicit mechanism of competition.
Cells compete directly each other, even if the antigen is present at very low
concentrations or is kept constant. The maintenance of the T-cells is due
to the diversity of the MHC-peptide complexes, and not much dependent on
antigen concentration. Regarding the model of T-cell fratricide, we conclude
that competition for space during the proliferation phase is an interesting
and general mechanism to control the immune repertoires in an antigen in-
dependent fashion. Chronic unspecific stimuli or fluctuating environment
can affect the proliferation of clones. Fratricide via Fas-FasL interaction is a
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possible mechanism which can cope such a perturbation and reestablish the
homeostasis. In Chapter 5 we shall discuss how mechanism like Fas-FasL
can set the equilibrium size of clones. Under specific hypotheses, a possible
scenario for the maintenance and for the expansion of T-cell clones over long
timescales is proposed. Moreover, a fluctuating environment disturbing the
size of clones is described. The De Boer’s approach suggests a mechanistic in-
terpretation for the antigen recognition pathway, which is also missing in the
fratricide model. One can therefore consider also a more detailed analysis of
the peptide kinetics, and eventually a description of the intracellular path-
ways, which are responsible for the generation of MHC-peptide molecules.
Recently, experimental data pointed on mechanisms of the antigen process-
ing and on their quantification. The De Boer’s approach offers a natural
background where a more detailed theory of antigen presentation can seat
and develop. In the next Chapter we shall face this problem.
In Chapter 4 the clonal expansion of T-cells in a competitive environment
is considered. We show how competition for resources affects the homeosta-
sis of the naive pool and the efficiency of the IR. The peptide distributions,
which are the result of intracellular degradation, affect the clone size, the
immunodominance, and the quality of the IR. Some experimental data are
explained, and predictions regarding how vaccination strategy can be im-
proved are proposed. For instance, we shall show that the clearance of a
pathogen is improved when a re-shaping of the T-cell clones by the replace-
ment of constitutive proteasomes with his immuno-forms is considered.
Summary
It is now accepted that the homeostasis and the functionality of lymphocytes
are strongly affected by competition phenomena. The IS resources can be the
cytokines, which are responsible for a high number of functions, the antigens,
which constitute the main information source for the IS to get activated if
infection factors come over, and finally the biological space, which somehow
provides the physical conditions to allow proliferation and movement. We re-
viewed published mathematical models to describe the competition between
T- and B-cells for resources. In the next Chapter we shall discuss a model
based on some idea presented here.
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Chapter 4
The clonal expansion of cytotoxic
T-cells and the
immunoproteasome
Introduction
How many naive T-cells in the peripheral repertoire belong to the same clone?
Do large differences exist in the frequency of two distinct naive clones? Sev-
eral factors may generate differences in the size of various pre-immune clones.
Both the recombination machinery and thymic and peripheral selection pro-
cesses can favor the accumulation of certain clonotypes. Alternatively, par-
ticular T-cell clones may have already undergone some rounds of cell divi-
sion in the periphery, for example after cross-reaction with environmental or
food antigens. Obviously, if large differences exist, the largest clones could
dominate the immune repertoire by giving rise to a much more abundant
progeny than that derived from a single precursor. In this chapter we pro-
pose a mathematical description of the peripheral T-cell repertoire and its
dynamics. We show how low precursor frequency clones can efficiently kill
intracellular pathogens with the help of a clever way to distribute resources.
4.1 The biology of the problem
As already explained in Chapter 1, the thymic selection is the first and
fundamental selection phase that T-cell repertoire suffers. The repertoire
selection is made by a positive and negative discrimination, which is based
on the affinity between T cell receptor (TCR) and MHC- peptide complexes
(MHCp). In the thymus, APCs present peptides generated with both the
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Figure 4.1: Upper panel: T-cells competing for peptides presented on the sur-
face of APC. T-cell clones survive and keep their functionality in the periph-
eral tissues requiring contact with MHC molecules presenting self-peptides.
Moreover, the peptide abundance is a major factor in shaping the T-cell clone
abundance. Bottom panel: intracellular processing of peptides. The replace-
ment of CP (light grey cylinder) with the IP (dark grey cylinder) induces a
new peptide distribution on the surface of the APC. This is the base for a
re-shaping of the T-cell repertoire.
constitutive (CP) and immunoproteasome (IP). IP and CP shape the peptide
repertoire which selects the candidate T-cells for the emigration through
peripheral tissues. During our lifespan the thymus reduces in activity, but
still an efficient repertoire of peripheral T-cells is maintained. How can this
happen? It has been shown that peripheral mechanisms maintain an efficient
immune repertoire. Efficient means diverse enough to fight challenges, and
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tolerant at the right point to not destroy non dangerous factors that immune
cells meet during the continuous rendezvous with parts of our body.
In order to understand these selection mechanisms, it is very important to
know the diversity and the abundance of the peptide distribution presented
on the MHC molecules. In the periphery, T-cell homeostasis depends upon
MHCp T-cell receptor contact (for a review see Almeida et al. [2005]). Several
experiments highlight the importance for the peripheral mature T-cell pool
to recognize self-peptides with low or medium affinity [Holler and Kranz,
2004, Jameson, 2005]. Before an IR starts, there is a very heterogeneous
distribution of clone sizes, and very often small clones are capable to out-
compete huge clones.
Quantification of T-cell and MHCs diversity suggests that the clone dis-
tribution responding to a given antigen is heterogeneous and time dependent
[Zhong and Reinherz, 2004]. It has been estimated that up to thousand dif-
ferent clones can be stimulated with a given antigen [Naumov et al., 2003,
Pewe et al., 2004]. The majority of these cells belongs to few big clones,
while the other part make up a very large repertoire of small clones, and all
with a potential capability to rise an IR. Several statistical models have been
applied to fit these data. Basically, the distribution of clone frequencies looks
like a power law distribution or like a log-normal distribution [Naumov et al.,
2003, Pewe et al., 2004]. These functions are characterized by a long-tail in
which few clones represent the majority of cells, and a very high number of
low-frequency clones defines an evident and non-excludable tail which play
a major role for shaping the diversity of the responding T-cell repertoire.
During an IR some of the APCs, the most important being dendritic
cells, become professional, and show on the surface a fairly different MHCp
repertoire. Within these cells, the IP content is increased and the CP abun-
dance reduced. Professional APCs initiate the differentiation program, and
during an IR naive T-cells are activated by the APC and differentiate to
experienced T-cells which are capable to fight pathogens. Only few of the
activated T-cells will respond to the antigenic peptide, and the selection is
performed during the expansion phase [Blattman et al., 2000]. T-cells are
characterized by cross-reactivity, namely are sensitive to a diverse ensemble
of MHCp.
The timescale of an IR is of the order of weeks for acute infections, and can
last for years in case of chronic infections (HIV, Hepatitis C, Coriomeningitis,
etc.).
During an infection, many different viral peptides are presented on the
surface of APCs, but only some will elicit an IR. It is a matter of debate why
only few of these peptides drive the immune repertoire and a hierarchical
distributions of IRs are observed. This phenomenon is commonly called
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peptide immunodominance [Yewdell and Del Val, 2004]. Several factors are
involved in shaping the immunodominance. The intracellular viral kinetics
and the antigen processing machinery are the most known and important
factors. Notably, the IP affects the immunodominance. Mice deficient in
IP (such as IFN-γ and immunoproteasome-subunit deficient mice) present
alterations in the immunodominance hierarchy of peptides presented on their
APCs.
We investigate the hypothesis that the IS has a clever way to allow few
cells to become the best weapon against pathogenic challenges.
4.2 Purpose of the model
We investigate how competition for peptides shapes the cytotoxic T-cell
repertoire during an IR. The model is based on the assumption that the
amount of CP and of IP in the APC influences the peptide distribution pre-
sented on the MHC molecules, and with that influences the T-cell repertoire.
Our goal is to show a possible role of the production of IP during an IR.
We investigate the IP-effect, namely the effect of a change of the MHCp
distribution presented by APCs, induced by an increased intracellular IP
content. In Fig. 4.1 a cartoon which present this idea is shown. We show
how the clearance of the pathogen can be improved without any change of
the parameter values, besides a change in the IP concentration in APCs.
The model is based on De Boer’s approach (see Chapter 3 and De Boer
and Perelson [1994]). Due to the very high diversity and size of the T-
cell clone repertoire, a caricature model which takes into consideration only
families of clones is proposed. Clones are grouped according to their pattern
recognition of MHCp (see Tab. 4.3). The model first describes the steady
state condition in a given peripheral tissue, namely the homeostasis of the
T-cell repertoire without the pathogenic insult. It takes into account the
thymic output, and competition between T-cells for MHCp. Starting from
this steady state condition, we describe the following IR against pathogenic
peptides for two cases. First, no MHCp redistribution, second we suppose
an MHCp redistribution due to IP induction in APCs at the onset of the IR.
4.3 The model
This model describes the dynamics of naive N and the experienced E cyto-
toxic T-cell pools (see also Fig. 4.2 and Chapter 3 for a review of the the
general approach). Our ansatz is that both naive and experienced T-cell
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pools require MHCp-TCR contact to maintain their homeostatic size (see
Fig. 4.1). Naive cells are activated and proliferate. Some of them become
antigen experienced cells and move towards the infection sites and kill the
infected cells which present the antigenic peptides. The following scheme is
proposed:
Ni + Fj
ka


kd
CNij
kp
N
→ T ∗i + Fj (4.1)
Ei + Fj
ka


kd
CEij
kp
E
→ 2Ei + Fj (4.2)
T ∗
k∗→2φNi + 2(1− φ)Ei (4.3)
This reactions describe the proliferation and differentiation rates for both
T-cell pools considered. The indexes i, j denote T-cell clone i, i = 1 · · ·Nclone
and MHCp of specificity j, j = 1 · · ·Npep, respectively. Fj is the amount
of free MHCp sites on the APCs with specificity j. CNij and CEij are the
complexes formed between TCR and MHCp of the naive and experienced
pool respectively. The kinetics of complex formation are described by the
classical enzyme reaction kinetics with association and dissociation constant
ka and kd respectively. For the sake of simplicity, we consider the same
complex formation kinetics for both the naive and the experienced pool.
Naive cells are activated after MHCp contact with rate kpN . They become T ∗.
These cells proliferate with rate k∗, and stay in the naive pool with probability
0 ≤ φ ≤ 1, or differentiate to experienced cell with probability 1 − φ. The
probability φ can be considered a function of the APC state (professional or
non-professional APC), and/or of the γ-chain cytokines amount (IL-7, IL-15
and IL-2). If the APC presents co-stimulatory signals, a naive cell tends to
differentiate, while in case the APC is non professional, naive undergoes a
self-renewal process. Experienced cells Ei are characterized by a proliferation
rate kpE and constant death rate δE. We suppose that the experienced cells
proliferate faster than naive cells, namely kpE > kpN . During the presence
of foreign pathogenic peptides, both the naive and experienced cells may
proliferate. The latter can kill infected cells reducing concomitantly the
expression of foreign peptides on the surface of infected cells. The phase
characterized by the establishment of memory T-cells is not considered in the
model. We consider the thymic output, Hi, per clone defined as a constant
number of cells coming from the thymus for each specificity i. Moreover, a
death rate for naive, δN , and for experienced cells, δE, has been considered.
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Figure 4.2: Scheme of the model presented in Eqs. (4.1 - 4.3). Thymic output
is considered as a constant flux which uniformly fills the naive compartment.
Naive cells share resources with the pool of experienced cells. They compete
for MHCp. Naive cells can be activated and proliferate. Once activated they
can differentiate into the pool of experienced cells or stay in the naive pool
according to the rate φ. Death is considered for both pools. Experienced
cells proliferate and die faster than naive.
We define the following constants
KNij =
kaij
kp
N + kdij
KEij =
kaij
kp
E + kdij
(4.4)
The equations for the complete dynamics are
dNi
dt
= Hi + (2φ− 1) kpN
Npep∑
j=1
KNij FjNi − δNNi (4.5)
dEi
dt
= 2(1− φ) kpN
Npep∑
j=1
KNij FjNi +
Npep∑
j=1
kp
E KEij FjEi − δEEi (4.6)
The equations are obtained under a quasi-steady state approximation (QSS)
on the kinetics of T-cell clones. Basically, we supposed that T-cell differ-
entiation after complex formation is supposed to happen with a rate much
faster than the rates characterizing complex formation and T-cell prolifera-
tion. This allows us to consider an instantaneous reaction (Eq. (4.3)). More-
over, we suppose that the dynamics of the complexes CNij and CEij are at
the steady state, namely dCN
dt
= dC
E
dt
= 0 (we skip the index for simplicity).
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In order to model the MHCp concentration available on the surface of
APC we have followed De Boer and Perelson [1995]. In this paper the peptide
concentration is at the equilibrium, and is limited by the MHC availability ,
which is defined by the maximum abundance MT , and by the T-cell, which
binds to MHCp. In Appendix B the explicit calculations are shown. Peptides
are generated intra-cellularly by the proteasome degradation of cells (see also
the cartoons in Fig. 4.1 and Fig. 4.2). Given the following scheme
Pi + E
k+


k−
Si (4.7)
Z = MT −
Npep∑
j=1
Sj (4.8)
with k = k−
k+
, where Z is total amount of MHC molecules available intracellu-
larly. Peptides of specificity Pj meet a free MHC molecule forming a MHCp
named Sj. Peptides are mounted on the MHC molecule at faster kinetics
with respect of T-cell - MHCp contact.
Writing the explicit equations for Pj, and considering the steady state
approximation dSj/dt = 0 we get an explicit formula for Fj
Fj =
Sj
1 +
∑Nclone
l=1 (K
N
ijNl +KEijEl)
(4.9)
Clearly, increasing the total T-cell pool, the number of free complexes dimin-
ishes. Competition for MHCp, which are considered resources for survival
i.e. free sites (see Chapter 3), limits the clonal size [De Boer and Perelson,
1997]. It should be emphasized that a normalized distribution of peptides on
the surface of APC is considered
Npep∑
l=1
Pl = 1 (4.10)
In this way it is possible to consider only the frequency of each peptide.
The pathogen dynamics and the definition of a foreign
peptide
Suppose that a pathogen infects cells. Foreign peptides will be processed and
presented on the surface of infected cells. For instance, a virus like Lympho-
cyte Coriomeningitis virus (LCMV) infects mice intracellularly. APCs, which
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Parameter Description Dimension Default value
δN death rate naive day−1 0.005
δE death rate effector day−1 0.4
φ naive renewal 0.99
Kij affinity T-cell-MHCp day−1 site−1 [10−7-10−2]
ki affinity MHCp day−1 site−1 1
ρE prol. rate per complex day−1 100
ρN prol. rate per complex day−1 10
Hi thymic output day−1clone−1 1
MT MHC complexes 105
θ sensitivity of pathogen presentation 1
P0 max. foreign peptide frequency 0.07
r pathogen replication day−1 10
c pathogen capacity cell−1 10−7
∆I Clearance of infected cells day−1 cell−1 1.2 ·10−4
Table 4.1: Parameter values chosen for the model Eq. (4.5) and Eq. (4.6).
If not specified, simulations are made according to these values. The value
of δE is from De Boer et al. [2003], while δN and Hi are taken from Chao
et al. [2004]. ρN has been chosen in order to have a proliferation rate similar
to the experimental data of Veiga-Fernandes et al. [2000]. The infection
parameters, r, ∆I , c have been chosen ad hoc to simulate an infection which
is comparable to the time scales found in experiments with mouse LCMV or
LM infections (see also De Boer and Perelson [1995]). The peptide kinetics
parameters Kij, ki, and MT are also chosen to simulate kinetics fairly similar
to experimental data.
take up infected proteins, home into secondary lymphoid tissues, activating
naive T-cells which recognize the viral peptides together with other self pep-
tides presented. A distribution of different foreign peptides derived from viral
proteins are presented on the surface of APCs (see also Section 4.5.2). In the
first model, for simplicity, we suppose that there is only one foreign peptide
which we call Pv. Antigen experienced cells which show specific affinity with
this peptide are able to kill infected cells. The dynamics of the infected cells
I is described with a standard model [De Boer and Perelson, 1995, Scherer
and Bonhoeffer, 2005]. The amount of foreign peptide Pv is supposed to be
a non linear function of the number of infected cells. This assumption has
been made in order to have a linear dependency with the amount of infected
cells and a saturation for high values of I, which is based on experimental
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Peptide Class Definition
P1, CP-self Self-peptides mainly generated by CP
P2, IP-self Self-peptides mainly generated by IP
P3 Foreign peptide during an IR
Table 4.2: Peptide classes
data showing a saturation threshold in the amount of peptide presented on
the surface of APCs. The equations for I and for Pv are
dI
dt
= r(1− cI)I −∆I(
Nclone∑
i=1
KEivEi)I (4.11)
Pv(t) =
P0
1 + θ
I(t)
(4.12)
Infected cells replicate with maximum rate r, which is controlled by a max-
imum capacity of the system to contain infected cells. This is accounted
with the parameter c. 1/c is the maximum number of infected cells in the
organism. Infected cells die proportionally to the amount of antigen specific
T-cells which are stimulated during the IR. This is accounted with the sec-
ond term in the equation given for I. The Eq. (4.12) represents the amount
of foreign peptide Pv. The parameter θ describes the sensitivity of the anti-
gen presentation. It is the amount of infected cells needed to mount 50% of
the maximum viral peptide, P0 ≤ 1, presented on the surface. The peptide
concentration increases with the increase of the number of infected cells, and
saturates when P0 is reached. The homing mechanism of APC from the site
of the infection to the secondary lymphoid tissue, where typically the con-
tact with T-cells occurs, is considered to evolve fast and therefore we consider
only a single type of APC, which presents all peptides. The parameter values
used in this chapter are summarized in Table 4.1.
4.4 Caricature of the cytotoxic T-cell reper-
toire
We assess the following questions: does the dynamics of the IR change when
the relative frequency of presented peptides varies at the onset of the IR?
If this is the case, how? As already explained in the introduction of this
Chapter, we assume that the expression of IP during an IR elicits a change
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Clone Class Definition Pept. Class Thymic output
N1, E1 Recognizes CP-self P1 H1=1000
N2, E2 Recognizes IP-self P2 H2=1000
N3, E3 Recognizes CP-self and foreign pep. P1, P3 H3=1
N4, E4 Recognizes IP-self and foreign pep. P2, P3 H4=1
Table 4.3: T-cell clone classes
in the peptide frequencies. We shall call IP-effect the redistribution of MHCp
on the surface of APCs during an IR. The high diversity and enormous size
of the cytotoxic T-cell repertoire make the quantitative description of the
dynamics of the IR very difficult. Therefore, in order to capture the main
feature of the problem, we have chosen a simple caricature representation of
the T-cell repertoire.
We divide clones, as well as peptides and affinities, in few classes. Ba-
sically we classify peptides according to their proteolytic origin (see Table
4.2). We define CP-self as the set of self-peptides which are mostly gener-
ated by intracellular degradation performed with the CP. Similarly, IP-self is
the set of self-peptides which are mostly generated by intracellular degrada-
tion performed with IP. Before the IR starts, we suppose that CP-self class
is characterized by high frequency, while the IP-self has a low value. We also
consider the class of foreign peptides, which is zero before the infection. We
named peptide classes as in the general model with P1, P2, P3 = Pv (see
Table 4.2). Each of this peptide classes give rise to the corresponding MHCp
class. T-cell clones are classified by the affinity between TCR and MHCp
class, and by the thymic input (see Table 4.3). We define the class of T-cell
clones recognizing CP-self, and the class recognizing IP-self. We further con-
sider other two classes of T-cell clones: the first recognizing, together with
self-peptides, the foreign pathogenic peptide, namely the clone recognizing
P1 and P3, and the second class recognizing the peptide classes P2 and P3.
Finally, we define the thymic input for the T-cell classes recognizing self-CP
and self-IP asH1 = H2 = 1000, while for the clone classes recognizing specific
foreign peptide we chose H3 = H4 = 1. These values represent a situation in
which the majority of clones does not recognize foreign peptides and there-
fore, for the first two classes of our caricature repertoire, a high value for the
thymic input H has been defined. In contrast, few clones with respect to
the whole repertoire will recognize with high affinity a foreign peptide. For
these classes the thymic input of 1 cell per day per clone has been chosen
according to published data (for a review see [Almeida et al., 2005].
Further, we will refer to a change in the proteasome content by a change
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Phase Definition P1/P2 P3
I Before IR starts 10 0
II-a IR, low IP 10 Pv
II-b IR, high IP (IP-effect) 0.1 Pv
Table 4.4: Relative peptide distributions used. In phase I there is no foreign
peptide P3 (no infection), and the peptide resources are rich in CP peptide,
namely P1/P2 = 10. Phase II is the infection phase. This phase can be II-a
(no IP rich peptide), or II-b (IP rich peptide). Phase II-b is characterized by
the IP-effect.
in the peptide ratio P1/P2. We used P1/P2 = 10, which has been extrap-
olated from Skoberne and Geginat [2002]. Table 4.4 represents the peptide
distribution that we used in the simulations to describe different phases of
the T-cell dynamics. Phase I is the condition without pathogen in which only
self peptides are presented. Phase II is the IR which can be of two types:
the first with low content of IP, and the second with high production of IP.
In the next sections we will refer to IP-effect or to phase II-b indistinctly.
We suppose that T-cells bind to MHCp either with low, ks, or with high,
kh, affinity. We choose the following values for the affinities: ks = 5 · 10−2
day−1 site−1 and kh = 5 · 10−5 day−1 site−1. The affinity matrix will then
read (see Eq. (4.5) and Eq. (4.6))
KE = KN =

ks 0 0
0 ks 0
ks 0 kh
0 ks kh

4.5 Results
With the proposed mathematical model we test several hypothesis. Based on
experimental evidence we suppose that during an IR the MHCp abundance
increases, the IP also rises and, consequently, the IP-self epitopes are more
expressed as well. We investigate the role of these phenomena during an
infection mediated by cellular IR. We recall that we define IP-effect as the
change in the relative abundance of CP- and IP-self peptides when a foreign
peptide is shown (see Phase II-b in Table 4.4 and Section 4.4). The measure
of this effect will be the ratio P1/P2.
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4.5.1 Simulations
We perform simulations of the caricature of the T-cell repertoire with the
equations given in Eq. (4.5) and Eq. (4.6). The parameter values used are
given in Table 4.1, while we refer to Table 4.4 for the values of the peptide
frequency distributions used to simulate the IR dynamics.
The system is considered at t = 0 at the steady state of phase I, in which
foreign peptide is absent. The introduction of the foreign peptide Pv perturbs
the system, which evolves towards a new steady state. In the simulation the
number of infected cells I can assume non integer numbers. Therefore, we
introduce a cut off: I was set to zero for I < 1. Infection results in the
expression of the foreign peptide (Pv), causing the activation of highly specific
T-cell clones (E3 and E4). Both clones, E3 and E4 proliferate proportionally
to the peptide amount, but with different rates. This is due to the different
self-peptide repertoire they recognize (CP-self and IP-self, i.e. P1 and P2).
Therefore, during the proliferation phase the amount of proliferating T-cells
depends on the overall peptide distribution. In the model we envisage
two possible scenarios: the experienced pool is already present in the pre-
immune system and does not expand because of the low affinity for self
peptides. This condition corresponds to φ < 1. The second scenario regards
the experienced pool present only if the viral peptide is introduced. In this
case the differentiation from naive to experienced is present only with the
antigenic load. This condition corresponds to φ < 1 only when I 6= 0. We
show simulations for the first scenario, although we did not observe strong
differences when results coming form both cases are compared.
In Fig. 4.3 the dynamics for the naive and the experienced pool, and for
the infected cells are shown. Panel A shows the time course of the IR, namely
E3 +E4, and of the number of infected cells, I, for both phases II-a and II-b
(see Table 4.4), which correspond to the IR with low and high IP content
respectively. In both cases a 2-fold increase in the value of MT during the
time course of the infection has been chosen. Infected cells (dashed lines) are
deleted only in case of high IP content (IP-effect, Phase II-b). The peak of
the IR for the phase II-b is at day 8 as suggested from experimental data of
in vivo mice infections (see also the next section). The IP-effect results in
the viral clearance because of a higher proliferation rate of the E4 clone (see
Fig. 4.3B), which takes advantage of the increased resources given by the
increased IP content, and of the presence of foreign peptide. In the case II-a,
both specific clone classes E3 and E4 proliferate with the same rate. The
proliferation rate returns to the steady state value as soon as the infection
vanishes, namely I = 0 and MT is set to the original value. The phase II-a is
characterized by a chronic presence of infected cells. We also found that the
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Figure 4.3: Comparison of the dynamics of the IR with (phase II-b) and
without (phase II-a) the IP-effect. The parameters of the model are the same
for both cases (see Tables 4.1 and 4.4). In all panels, heavy lines represent
the IR with the IP-effect. Panel A: the sum of the clone classes E3 and E4,
and the number of infected cells, I are shown. Panel B: the proliferation rate
for E3 and E4 are shown for both cases. A fast proliferation phase is observed
soon after the onset of the IR. This phase terminates with the deletion of
infected cells (see also the text). Panel C: the time course of the naive clone
classes. This pool is not strongly affected by the infection dynamics due
to their slower proliferation and death rate with respect to the experienced
pool. Panel D: the time course of the experienced clone classes.
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Figure 4.4: MHC-peptide abundance on the antigen presenting cells during
the IR. The parameters of the model are the same as in Fig. 4.3. The dif-
ference between the two cases (light line phase II-a, heavy line phase II-b)
shown is the different ratio of peptides produced by constitutive vs. im-
munoproteasome (see also Table 4.4). During the IR, the total amount of
MHCp increases 2-fold. For the IP-effect case, the infected cells are deleted
and therefore the number of MHCp returns to the steady state value. In the
other case (phase II-a) the infection persist in the system and therefore the
number of MHCp remains at high values (see light curves).
size and the diversity of the naive pool is not strongly influenced during the
IR (see Fig. 4.3 C). This is due to the slow proliferation and death rate char-
acterizing naive cells with respect to antigen activated cells. As can be seen
in Fig. 4.3D, the IP-effect, together with the injection of foreign challenge,
influences the proliferation phase and the size of experienced cells responding
to the pathogen. The E4 clone recognizing IP-self peptides undergoes a fast
expansion ranging from 10 to 107 cells circa. The size of self-CP specific clone
E1 is reduced during the IP-effect as result of the MHCp redistribution. The
proliferation rate, the clone abundance at the peak of the IR, and the size of
clones shown are in accordance with the experimental values [De Boer et al.,
2003, Murali-Krishna et al., 1998, Badovinac et al., 2000]. If the infection is
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cleared the foreign peptide reduces, and the clones stop the expansion and
return to a steady state situation. In Fig. 4.4 the time course of the MHCp,
S1, S2, S3, corresponding to each peptide class are shown. The figure corre-
sponds to the same parameter values of Fig. 4.3. As expected, the MHCp
mounting the foreign peptide, S3, for the phase II-b lasts in the system for
t = 7 − 8 days, which is the time at which infected cells are present in the
system. The IP-effect is responsible for the increase in the abundance of S2
with respect of S1 during the course of the IR (see the dashed S1, and the
point-lines, S2, in Fig. 4.4). After infection, the total amount of MHCp, MT ,
reduces. In the no IP-effect phase, II-a, the foreign peptide stays at high
level, as well as the total amount of resources.
We tested if the increase of the total amount of resources, MT , during the
IR might be sufficient to mount an IR resulting in the deletion of infected
cells. In Fig. 4.6 we show that the IR efficiently eliminates the pathogen
only if a 4-fold increase in the MHC molecules abundance is considered.
A 2-fold increase will not lead to the deletion of infections. On the con-
trary, the IP-effect, together with a moderate increase in the total number of
MHCp (2-fold), eliminates infected cells as good as the no-IP case in which
a more pronounced increase of resources is considered. The IP-effect can be
a clever and less expensive way (from an energetic point of view) to defeat
the pathogen.
In order to better understand the IP-effect we consider a simpler scenario.
The dynamics of infected cells is not taken into account. Instead, constant
peptide distributions were considered. This allows us to compare steady
states before and during the IR.
Phase I (Table 4.4), where P1/P2 = 10 and no foreign peptide is present,
represents the healthy state. The steady state of Eq. (4.5) and Eq. (4.6), in
this case, is denoted by I in the phase space projections shown in Fig. 4.5.
In phase II-a, P1/P2 = 10 still holds and the foreign peptide is introduced
with Pv = P0 = 0.07. This phase represents a chronic diseased state. Phase
II-b represents a diseased state as well, but the frequencies of P1 and P2 are
interchanged. In Fig. 4.5 the steady states of these two phases are denoted
by a and b. These two steady states are identical but for the interchange of
the indices 1 and 2 respectively 3 and 4. Therefore, they are symmetric with
respect to the bisectrix. The sums of the foreign peptide specific T-cells,
E3+E4 and N3+N4, are the same in both cases. The IP-effect, hence, does
not influence the effectiveness of the IR at the steady state.
The fact that the IP-effect results in the pathogen clearance, as shown
in Fig. 4.3A, thus has to stem from transient behavior. We simulated the
trajectories into the steady state of both phases II-a and II-b. The initial
condition was given by the steady state of phase I. These trajectories, shown
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Figure 4.5: Trajectories in the phase space projections. Peptide distributions
are considered to be constant. Trajectories relax into the steady states of
the infected phases, II-a and II-b (see Table 4.4. Other parameters from
Table 4.1 with P3 = 0.07), denoted by a and b respectively. The initial
condition, denoted by I, corresponds to the steady state values with peptide
distributions of phase I.
in Fig. 4.5, represent the transition from the healthy to the chronic diseased
state.
When approaching the new steady states, a and b, the trajectories are
symmetric with respect to the bisectrix. But soon after the introduction of
the foreign peptide, the IP-effect (phase II-b) leads to a more efficient IR, as
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can be clearly seen in Fig. 4.5D. Simulations performed for a vast parameter
set never evidenced the IP-effect to be less effective than the case in which
the self peptide distribution does not change. Thus, this phenomenon seems
to be robust although further investigations have to be performed.
Intuitively, it is reasonable to imagine that a small perturbation, such
as a small increase in the foreign peptide frequency, does not lead to a new
steady state which is very distant from the initial state. Therefore, we would
not expect a big change in the proliferation rates. In this model proliferation
rates are small close to the steady state, since they only outbalance the death
rates. On the other hand, a strong re-shaping of the peptide distribution,
such as the IP-effect or a significant increase in the total amount of resources
MT , may push the system far away from the actual steady state. This requires
a transitory fast proliferation rate for at least some clones.
In this model, the changing in performance due to the IP-effect is a feature
of the onset of the IR. It suggests that during a chronic disease, in which
the foreign peptide never disappears, the IP-effect does not influence the
performance of the IS.
4.5.2 Comparison with experimental data
In this section we compare our simulations with some experimental results.
We focus on two experimental data sets: mice infected with Lymphocytes
Coriomeningitis virus (LCMV) and mice infected with a bacteria, Liste-
ria Monocytogenes (LM). Depending on the viral strain, LCMV can affect
acutely or chronically the organism, resulting in a clearance or in a chronic
pathogenic state respectively. LCMV infection is characterized by a peak of
the IR at day 8 in wilde type, and at day 12 in IFN-γ deficient mice (GKO
mice). IP is strongly regulated by IFN-γ. IFN-γ is produced by T-cells and
NK-cells, and it enhances the antigen presentation by up-regulating MHC
expression as well as TAP. IFN-γ induces the synthesis of the proteasome
immuno subunits and PA28, which are then responsible for changing the
cleavage activity of the proteasome. IP deficient mice (LMP2-/-, LMP7-/-
, MECL-/-) and IFN-γ deficient mice possess an altered T-cell repertoire,
which emphasize the crucial role of IP for T-cell selection [Toes et al., 2001,
Chen et al., 2001b, Basler et al., 2004]. We therefore are interested in the
GKO mice model because of their impaired capability to form IP. They can
be a reliable experimental evidence for the importance of the IP-effect during
an IR. This gives the opportunity to compare the IR in both cases, as has
been done in the simulations. It should be emphasized that IFN-γ deficiency
has also other effects, such as an impaired apoptosis phase and a different
homeostatic level of cytotoxic T-cells [Harty and Badovinac, 2002]. Khan
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Figure 4.6: Increase in the total amount of resources, MT , also results in a
better IR. Left-side panel: same as in Panel A in Fig. 4.3. The comparison
between the immune responses correspondent to a different increase in the
amount of MHC-peptide molecules MT are shown. In the absence of the IP-
effect, phase II-a, the pathogen can also be cleared, but with an increase of
resources, MT . Right-side panel: comparison between the clonal expansion
of all clone classes (same condition as the left-side panel). Symbols represent
self-specific clone classes: squares E1, circles E2. Pathogen specific clone
classes, E3 and E4 (dashed and solid lines), expand faster than the clones
recognizing only the self-peptides (see Table 4.3). Parameter values are as
given in Table 4.1, the variation in the MHCp abundance is 4-fold (heavy
lines), and 2-fold (light lines)
et al. [2001] have shown a total replacement within 7 days of CP with IP in
wilde type mice infected with LCMV or LM. This suggests that IP deficiency
plays a role in shaping the antigenic peptide repertoire presented on the sur-
face of APCs. Moreover, GKO mice do not always clear the virus and in case
they succeed, the peak in the number of cytotoxic T-cells is shifted by few
days (from day 8 to day 10 after immunization with LCMV) and the num-
ber of infected cells in the organism is increased. Interestingly, a change in
immunodominance hierarchy of antigenic epitopes is observed in GKO mice
in both infections [Badovinac et al., 2000, Bartholdy et al., 2000].
LM infected GKO mice show a higher peak in the number of cytotoxic
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Figure 4.7: LM infection in IFN-γ deficient mice. Immune response against
LM with and without IP-effect, and with different apoptosis rates. Left panel:
The immune response, E3 + E4 (solid curves), and the number of infected
cells, I (dashed curves), are shown. Heavy lines represent the case of GKO
mice, while light lines represent the wilde type case. Right panel: Antigen
specific clone classes, E3 (dashed lines), and E4 (solid lines), are shown for
both GKO and wilde type. Experimental data of cytotoxic T-cells specific
for one immuno-dominant (wilde type filled circles, GKO empty circles) and
one subdominant (wilde type filled squares, GKO empty squares) peptides
for LM infection are shown. The IP-effect in the wild-type mice is shown
(comparison between light and heavy lines). Parameters: the same as in
table 4.1 but δE = 0.1, ∆I = 0.8 · 10−4 for the GKO mice, and P0 = 0.03,
∆I = 0.8 · 10−3 for the wilde type mice. The ratio P1/P2 is 2 for the GKO
and 6 for the wilde type mice.
T-cells with respect to wilde type. The peak is shifted from day 7 to day 10.
Moreover, in LM infected mice the experimental ratio between two dominant
peptides is found to be 5:1 in wilde type and 1:2 in IFN-γ deficient mice
[Skoberne and Geginat, 2002], suggesting that IP affects the hierarchy of
immunodominant peptides. It is interesting to note that, in contrast to the
LCMV infection case, GKO mice infected with LM show a higher peak in
the total amount of antigen experienced cytotoxic T-cells when compared to
wilde type response.
77
Clone Class Definition Peptide Class
N1, E1 Recognizes CP-self P1
N2, E2 Recognizes IP-self P2
N3, E3 Recognizes CP-self and CP-foreign peptide P1, P3
N4, E4 Recognizes IP-self and IP-foreign peptide P2, P4
N5, E5 Recognizes CP-self and IP-foreign peptide P1, P4
N6, E6 Recognizes IP-self and CP-foreign peptide P2, P3
Table 4.5: T-cell clone classes for the extended caricature representation of
cytotoxic T-cell clones with two foreign peptides.
We try to explain these experimental data according to the IP-effect. We
identify the wilde type IR as the IR with IP-effect (phase II-b), and the GKO
mice as the no IP-effect case (phase II-a, see also Table 4.4).
The Listeria Monocytogenes infection in mice In Fig. 4.7 the case
of LM infection is considered. Again, simulations for the wilde type show a
clearance of the infection with a peak of the IR at day 8, while the simulations
for GKO mice (no IP-effect) show a peak at day 11. We were not able to
fit the data only with the IP-effect. In order to compare our simulations
with experiments a lower apoptosis rate for the experienced pool (δE = 0.1)
and a lower killing efficiency, δI , was introduced for the GKO mice (see Fig.
4.7). These changes in the parameter values have also been suggested by the
authors of the experimental work, Badovinac et al. [2000]. They suggested
that IFN-γ deficient mice suffer a reduced capacity to undergo apoptosis.
They observed a delay of the peak of the IR and an increased number of
antigen specific T-cells against the dominant epitopes. It has to be noted that
the role of IFN-γ during an IR is still controversial [Wodarz and Thomsen,
2005], and the IP-effect may clarify some aspects of this complex scenario.
The LCMV infection in mice In Fig. 4.8 a semi-quantitative fit of
LCMV infection data is shown. For this purpose we chose a modified carica-
ture model in which we consider four peptide classes and six clone classes (see
Table 4.5). This has been made because experimental data show at least
two main dominant peptides shaping the IR, which are hierarchically orga-
nized and differentially produced by CP and IP. We describe therefore two
foreign peptides: the first as CP-dependent and the second as IP-dependent
peptide; their abundance is proportional to the concentration of CP and IP
respectively. This leads to six different T-cell clone classes: two classes rec-
ognizing only self-peptide, and four classes recognizing self-peptide and one
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Figure 4.8: Comparison between LCMV infection and the numerical results
of Eq.4.5 and 4.6 with the caricature of the cytotoxic T-cell clones extended
to six classes (see also Table 4.5). Upper panels: Sum of the clone class
E3 +E6, correspondent to P3 specific clones, and E4 +E5, correspondent to
P4 specific clones, and the number of infected cells, I are shown. Left side
with IP-effect (wilde type), and right side without IP-effect (GKO). Bottom
panels: Dynamics of the LCMV specific T-cell clones. The IP-effect (left
panels) characterized by a different peptide distribution (see text), changes
the immunodominance hierarchy and allows a faster and more effective clonal
expansion. Symbols represent experimental data of LCMV specific T-cell
clones. Dominant epitopes for BALB/C and C57BL6 mice infected with the
same amount of LCMV infection are shown (data from Murali-Krishna et al.
[1998], De Boer et al. [2003]). Parameter values: as in Table 4.1 except for
∆T = 2.7 days, P0 = 0.06, r = 50 and ∆I = 3 · 10−6. In both cases the total
amount of MHCp, MT , is increased of 7-fold.
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of the two viral peptides (see Table 4.5). On the top of that, in order to
show a more clear fit of the experimental data, a delay in the activation of
the experienced pool with respect to the time at which the infection starts
has been introduced. We choose a delay ∆T = 2.7, as suggested from a pub-
lished model in which a precise quantitative fit of LCMV infection has been
performed [De Boer et al., 2001b]. The IP-effect is now defined as a change
in the proteasome content which affects all four peptide classes. The ratio
P1/P2 and P3/P4 are both influenced by the IP-effect, and have been taken
equal, P1/P2 = P3/P4 = 10 as given in Table 4.4 for the previous caricature
repertoire.
Simulations were performed with an increase of 7-fold of the total amount
of MHCp, MT , during phase II. Our simulations show a peak of the IR at
day 8 for wilde type, and a chronic infection (infected cells are not deleted)
for GKO mice (see upper panels in Fig. 4.8). For a small change in the
parameter values of the infection variable (killing efficiency of T-cell ∆I and
pathogen capacity c), the model accounts also for viral strains which do not
cause chronic disease but only a delay in the peak of the IR. This has been also
observed experimentally with weakened viral strains [Bartholdy et al., 2000,
Harty and Badovinac, 2002]. As expected, a reverse order of the hierarchy
of pathogen specific clone sizes, E3, E4, E5, E6, is found when the IP-effect
(bottom panels, left side) and the NO-IP-effect (bottom panels, right side)
are compared. We show that the increase of IP, and therefore the augment of
the IP viral epitope, results in a change of the hierarchy of clones responding
to viral epitopes.
Our results confirm that the absence of IFN-γ results in a delay of the
clearance, or in a chronic infection. We explain the change in immunodom-
inance with the IP-effect, which is responsible for the change of the clonal
size of T-cell clones. In support of our results, experiments showed a sup-
pression of clones specific for epitopes which were produced at lower rates as
effect of IFN-γ treatment [Basler et al., 2004]. IP-deficient mice presented
an opposite scenario: T-cell clones recognizing IP-dependent peptides were
drastically reduced in size or disappeared. In this model, an increase in the
IP content would result in a higher peak of the IP-dependent clone classes
and a reduction of the size of CP-dependent clones.
4.6 Discussion
We investigate how the immune system can take advantage of the double
population of proteasomes, the CP and IP, and with it to select the appro-
priate cytotoxic T-cell pool responding against a foreign epitope which is
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presented on the APCs. Competition between T-cells for MHCp influences
the immune response. The idea behind this model is that the same pathogen
can potentially activate a very different T-cell specific repertoire. Its diver-
sity and size are shaped by the particular distribution of MHCp. We show
how the simple change of self-peptide abundance on the surface of APC can
have a remarkable effect on the T-cell selection.
One problem the immune system faces is how to use a finite TCR reper-
toire, distributed on a finite number of T-cells, to deal with a very large num-
ber of epitopes. It is essential for immune defense that sufficient numbers of
cells are deployed to combat infection. Simultaneously, specificity of recogni-
tion must be high enough for the repertoire to respond to foreign, but not to
self, peptides. Our model in fact suggest that, during an IR, the reshaping of
the MHCp distribution on the surface of APC might be a smart way to adjust
the immune cell repertoire to combat pathogens. When the fight is over the
re-establishment of the steady state distribution will guarantee the normal
conditions without that the IR would strongly influence the homeostasis of
the system. Nevertheless, this re-shaping of the antigen presentation could
be detrimental in case undesired peptides are over-expressed for a short time
period. This would lead to a clonal expansion of self-responding clones.
The relative abundance of peptides and not their diversity seems to be
influenced by the IP induction. Nevertheless, significant differences in the
amount of some epitopes with the immunoproteasome induction resulted in a
different selection of the T-cell repertoire during an immune response [Basler
et al., 2004] It has been recently shown (Groettrup M., personal communi-
cation) that intra-cerebral LCMV infected mice get ill. The brain presents
a significant reduction of IP content, and probably the antigen presentation
can be impaired. Also, LCMV intra-venal infected mice ,which normally re-
spond and kill the virus, have a reduced clonal expansion in the brain. These
data, even if still controversial, suggest a role of IP in the immune response
of LCMV infected mice.
This model offers an answer to some questions which are waiting to be
answered:
1. How is the diversity of T-cells restored and maintained after the IR?
The model suggests that the clone size re-distribution due to the IP-
effect lasts in the system for a short period. The IP has a higher
turnover with respect to the CP [Heink et al., 2005]. This suggests
that the functionality of the IP is required only for a short timescale.
2. Can the self-repertoire be involved in the activation of an IR? The
model suggests a positive answer. The-self repertoire may improve the
IR by favoring the proliferation of clones which were kept at lower sizes
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during the steady state. A more vigorous proliferation of the wanted
clone can be achieved if the self repertoire favoring the responding clone
is provided.
One can argue that this dependence of the IR on the distribution of the entire
repertoire involved in the IR can be detrimental, especially if the reshaping
of the distribution of peptides is a random process. For instance, a different
proteasome composition in the thymus might be dangerous because it will
influence the selection of the peripheral T-cell pool. Suppose that a different
initial condition is given, like an opposite situation in which more IP than
CP is present. The model predicts that increasing more the IP content will
not result in a better IR. On the contrary, we would expect a deletion of the
infection only if more CP is introduced. Basically our results suggest that
what is important is not how much CP and IP are present, but the change
in the peptide distribution arising from a gradient in the proteasome concen-
tration. This has also been suggested from experimental data [Kuckelkorn
et al., 2002].
What happens after the sixth decade of human life, when the thymic
output is compromised [Haynes et al., 2000, Nikolich-Zugich, 2005]? Future
investigation of T-cell dynamics over longer time scales is required. According
to general evidence, we would expect that the IR would be driven by very few
big clones. The IP can still play a role but probably there would be a more
undefined differentiation between high and low affinity clones. To investigate
such a problem, a more complex model which takes into consideration a more
variate clone distribution and higher number of clones is required. There is
evidence that the distribution of clones activated after a viral infection is
very heterogeneous, constituted by few big clones and a huge amount of low
frequency clones [Pewe et al., 2004]. According to our model, we expect
that this distribution changes over the course of the infection, selecting only
some clones which are able to take advantage of the peptide distribution
presented on the APC. A possible problem to face can be the level of cross-
reactivity characterizing the responding clones. We performed simulations
to investigate how cross-reactivity can influence the IP effect. As a trivial
result we found that the IP-effect is not efficient in defeating the infection for
high values of cross-reactivity. In fact, suppose that each clone has a finite
probability to recognize each peptide presented on the surface of APCs. This
would lead to a situation in which each clone compete against each other for
the same resources and no specific clone would be able to prevail over the
others. These results are very dependent on the characteristic of the affinity
matrix, which defines the cross-reactivity. A possible future direction can be
to define a random distribution of low affinity values for the T-cell MHCp
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interaction as well as of peptide amounts.
We conclude suggesting that it is not only the peptide amount, or its
affinity towards MHC binding grooves, or the clonal size of T-cells recogniz-
ing the peptides that defines the immunodominance hierarchy. The peptide
distribution, as a whole, is responsible as well in shaping the pathogen spe-
cific T-cell clone repertoire. A subdominant epitope can be so not because
it is expressed in less amount. As we have shown, its rank in the dominance
hierarchy during an IR depends on the dynamics of the clonal expansion.
These considerations are extremely important in designing vaccination
strategies. This model suggests that two clones recognizing the same peptide
with the same affinity can behave very differently. Thus, screening a naive
T-cell repertoire against MHC molecules mounting foreign epitopes, as can
be done with high throughput in vitro analysis of T-cell binding to MHC-
peptide complexes, might be misleading.
At the beginning of this new millennium, pathogens and cancer remain
one of the leading causes of death world-wide. The development of vaccines
to prevent diseases for which no vaccine currently exists, such as AIDS or
malaria, or to treat chronic infections or cancers, as well as the improvement
of efficacy and safety of existing vaccines, remains a high priority. In most
cases, the development of such vaccines requires strategies capable of stimu-
lating cytotoxic T lymphocytes and thus, to deliver antigen to MHC class I
molecules.
Summary
Competition for resources, such as MHCp, biological space and cytokines are
known to play an outstanding role in the dynamics of T-cell clone at the
steady state as well as during a pathogen challenge. We have proposed a
possible role for the IP in shaping the T-cell repertoire during an IR. We
showed how the capability to fight a pathogen can be improved by reshaping
the self peptide distribution for a short time period. The same pathogenic
condition, which may lead to chronic infection, can be defeated by a re-
shaping of the MHC-self peptide distribution driven by the change in the
intracellular immunoproteasome composition.
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Chapter 5
Clonal expansion and chronic
stimulation
Introduction
The clonal expansion is the result of a complex dynamical process in which
the main actors are the acute and the chronic antigenic stimuli, and the local
environment in peripheral tissues. The latter is characterized by the pres-
ence of several resource-competing T-cell clones, and the cytokinic network
[Jameson, 2005, Almeida et al., 2005, Freitas et al., 1996, Gaudin et al., 2004]
(see also Chapter 3 for a review of competition phenomena in T-cells dynam-
ics). The IS is obsessed with very large T-cell clones, which are oligoclonally
dominating the memory repertoire. There are some open questions:
• Why do these clones survive so long even if most of them are nonfunc-
tional?
• Why are they not sensitive to apoptosis?
• Which are the sources for these clones?
In this chapter we introduce a stochastic model to approach these issues over
long timescales, and under chronic antigenic stimuli. A possible scenario
based on phenomenological assumptions is proposed.
In the proposed scenario two main driving forces define the dynamics of
T-cell clones. The first is the acute antigenic stimulus (acute infection) which
impinges upon the T-cell clone via the T-cell recognition of antigenic stimulus
(via TCR), which causes the activation and then proliferation of cytotoxic
T-cells. The second is the chronic immune stress (CIS), consisting of endoge-
nous stimuli (self-antigens) and exogenous stimuli (non-self antigens), which
in turn affects the dynamics of the AE T-cell clone in two distinct ways: the
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T-cell receptor cross-reactivity and the inflammatory cytokine response. We
therefore define the CIS as the effects of the ceaseless and lifelong stimulation
of the IS due to the continuous challenge with antigenic stimuli.
The secretion of inflammatory cytokines is the hallmark of the natural
immunity, whose main actors are macrophages and natural killer cells, when
they are aspecifically challenged by every sort of antigenic stimuli. Inas-
much, the constitutive cytokine production plays as the principal factor in
the homeostasis (proliferation, survival) of antigen experienced (AE) T-cells.
The bursts of cytokine secretion is due to specific (antigen specific T-cells)
and aspecific (macrophage and natural killer cells) immune response. Such
cytokines contribute to generate a fluctuating “cytokine noise", which is ex-
pected to affect the long timescale dynamics of AE T-cell clones [Tough et al.,
1996].
Many authors suggested that the dynamics of AE T-cells can be af-
fected by i) MHC-mediated [Jameson, 2002, Kaech and Ahmed, 2001, Veiga-
Fernandes et al., 2000, Butcher and Picker, 1996, Tanchot et al., 1997] ii)
MHC non-mediated mechanisms [Murali-Krishna et al., 1999, Tough et al.,
2000, Ku et al., 2001, 2000, Tough et al., 1996, Jameson, 2005]. Concerning
the MHC mediated stimuli, it should be pointed out that the dynamic ex-
pansion of a AE T-cell clones is affected not only by specific peptides causing
high affinity TCR-MHC peptide binding, but also by cross-reactive antigens
that repeatedly stimulate the previously generated AE T-cell clone. On top
of that it has recently been shown that AE T-cell clones may not only expand
but also contract in response to a new antigen. This phenomenon, known as
attrition caused by “heterologous immunity", has relevant consequences for
our model [Chen et al., 2001a, Selin et al., 1999]. Regarding the MHC non-
mediated stimuli we recall the effect on T-cells of inflammatory cytokines
(such as IL-15 and its cognate network INFa,b,g, IL-12,IL-18) produced dur-
ing most immune challenges. These molecules can elicit “bystander effect",
i.e. stimulation of T-cell proliferation in the absence of a specific antigenic
stimulus [Jameson, 2002].
5.1 A model proposal
The model refers to a single AE T-cell clone located in an inflamed tissue
whose size (number of cells) is denoted by c(t). We introduce the variable
x(t) = log10 c(t) and its time variation, we denote by v(t).
The body of the model is a description of the homeostatic process as a
mechanism of relaxation to a given equilibrium size after the action of an
external antigenic stimulation. Changes of the clone size are due to both the
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acute antigenic stimulus, represented by an impulsive function, and the CIS
described as a stochastic process.
dx
dt
= v (5.1)
dv
dt
= F (t) + f0 + γξ(t)− βv − dV (x)
dx
(5.2)
The acute antigenic challenge is represented by the impulsive function F (t),
and acts for a time interval T , with constant mean load of intensity F0ω2
F (t) =
{
F0ω
2 for 0 ≤ t ≤ T
0 for t > T
(5.3)
ω−1 is a constant with the dimension of a time, T is the duration of the acute
antigenic insult. The CIS is composed by a constant mean intensity f0, and
a fluctuating term γξ(t), where ξ(t) is a white noise. The CIS is responsible
for the long timescale expansion or contraction (attrition) of the clone.
The last two terms of the equation Eq. (5.2) describe the interactions
between the clone and the local environment which are supposed to influ-
ence the rate at which the clone size evolves. Experimentally it has been
shown that the homeostasis of T-cell clone is a tissue dependent mechanism
[Ku et al., 2000, 2001, Harris et al., 2002, Tough et al., 2000, Kaech and
Ahmed, 2001]. The clone size grows or shrinks depending on a “bidirectional
cross-talk" between the T-cell clone and the immunological microenviron-
ment [Butcher and Picker, 1996].
The size-landscape function V (x) defines a collection of metastable states
for T-cells size, while −βv modulates the variation of the T-cell number
by reducing the very rapid changes in the rate of clonal expansion. The
parameter β fixes the timescale to restore the clone equilibrium size. In our
model its value has been fixed as β = .02 days−1, which correspond to a
timescale of 50 days. This is the typical timescale found during experiments
on T-cell expansion and down regulation in mice after secondary influenza
challenge[Marshall et al., 2001]
The values we choose in our numerical simulations without CIS are T = 24
days, F = 2 and β = ω = 0.1 days−1, which correspond to an oscillation
period of about 40 days and a decay period 2/β of 20 days as suggested
by experiment [Marshall et al., 2001]. For the general case, in which the
CIS is present, slightly different values have been chosen: T = 9 days, β =
.02 days−1 whereas we still have ω = .1. The small oscillations period is
approximately 2
√
2/ω ∼ 30 days. According to the hypothesis that the
“immunological space" (total number of T lymphocytes in the whole body) is
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Figure 5.1: Sinusoidal (left panel) and saw-tooth (right panel) size-landscapes
(upper curves) and effective landscape (lower curves). The effective landscape
function V eff (x) = V (x)−f0x includes the contribution of the mean antigenic
stress, which binds the plot of the size-landscape function.
finite, and that the total T-cell pool in a single organ cannot exceed a fraction
of the total mass of the organ itself, we introduce a size limit of the clone L
by using an infinite barrier in the size-landscape function corresponding to
that size. The estimate of the number of T-cell repertoire and of the tissue
mass can be used to guess this limit size.
The role of the size-landscape function
The function V can be seen as a sort of mean field approximation of local
interaction of the clone with other cells present in the periphery. For the
sake of simplicity we assume the function V (x) to be periodic and symmetric
with period 2pi/ω, with an excursion between the minima and maxima equal
to ω2. The shape of the function is not relevant once the period is fixed. We
have examined explicitly two different cases, the saw-tooth and the sinusoidal
function, as shown in Fig. 5.1.
V (x) =

ω2 |(x+ 1) mod 2− 1| 0 < x < L saw-tooth
ω2
1− cos(pix)
2 0 < x < L cosine
+∞ x < 0 x > L
(5.4)
In order to describe the homeostasis we only require the size-landscape func-
tion V (x) to have a sequence of minima, and the term −βv. The equilibrium
size of x follows the linear law x = n which implies an exponential increase
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in the clone size c, as suggested by experimental results [Marshall et al.,
2001]. The way x(t) rises during an acute antigenic impulse depends on the
shape of the size-landscape function, but the average growth is linear in t (ex-
ponential with the size of the clone), as suggested by experimental results.
Different shapes of the size-landscape-function would correspond to different
peripheral tissues.
A biological mechanism for the damping term
The term −βv prevents uncontrolled proliferation as well as the extreme
rapid depletion of cytotoxic T-cells during the oscillatory phase around the
steady state (see Fig. 5.2 and Fig. 5.3). A possible biological mechanism
which can cause such a phenomenon is the Fas-FasL mechanism. This is an
important peripheral mechanism for the regulation of apoptosis of activated
T-cells [Arnold et al., 1999, Pinkoski et al., 2002, Krammer, 2000] (see also
Chapter 3. We hypothesized that fluctuations in the CIS induce a gradient
in the concentration of Fas-FasL, and consequently a modification of the
Fas-Ligand expression in the peripheral microenvironment. For instance, If
the rate of the pro-inflammatory cytokines increases, the expression of Fas-
Ligand on the epithelial cells also increases and those T-cells expressing Fas
are more prone to apoptosis. On the other hand, in case of a temporary
reduction of the antigenic chronic stimulus, a reduction of Fas-L-inducing
cytokines may result in a reduced expression of Fas-Ligand on the epithelial
cells, giving rise to a moderate re-expansion of the T-cell number.
5.2 Results
Analytical solutions
The system of equations Eq. (5.1) and Eq. (5.2) can be analytically solved in
the strong damping approximation, namely high value of β (see also appendix
C). This means that the IS strongly counteracts any acute stimulus F (t),
which changes the homeostatic metastable equilibrium of the clone. With
the condition β  ω the term dv/dt is negligible, and the equation reduces
to
β
dx
dt
= −V ′(x) + F (t) (5.5)
If V (x) is zero, the clone expands linearly and its size c(t) grows exponentially.
When the acute stimulus is over the clone reaches the constant value x(T ) =
F0T/β, basically the clone grows proportionally to the antigenic impulse F0T .
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Landscape T1 T2 T3 T4
cosine 64 143 223 302
saw-tooth 52 116 180 244
approx Eq. (5.7) 50 116.6 183.3 250
Table 5.1: Comparison of the duration of the impulse, Tn, which allows to
jump after the maximum x = 2n− 1, for the cosine and the saw-tooth size-
landscapes. Parameters: ω = 0.1, β = 0.5, F0 = 2 so that β∗ =
√
2piω = 0.44
The case of the saw-tooth function can be analytically solved, the condition
for a jump to the interval [2n− 1, 2n + 1] between two subsequent maxima
is given by
1 + (n− 1)(1 + F0 − 1
F0 + 1
) ≤ T ω
2
β
(F0 − 1) < 1 + n (1 + F0 − 1
F0 + 1
) (5.6)
and the time needed to reach the maximum x = 2n− 1 at rest is
Tn =
β
ω2
n
F0 − 1 +
n− 1
F0 + 1
(
n
F0 − 1 +
n− 1
F0 + 1
)
(5.7)
The duration T of the impulse which allows the clone size to overcome the
maximum x = 2n − 1 without overcoming the next one x = 2n + 1 is
T2n−1 < T < T2n+1. In this case the clone remains trapped in the cor-
responding interval, and evolves asymptotically to the value x = 2n. We
have checked that the above conditions are approximately verified also for
a cosine function. In this case the critical damping value above which no
oscillations occur is β∗ =
√
2piω. In Table 5.1 we compare the jump time Tn
evaluated by accurate numerical integration of the exact equation with the
corresponding estimate Eq. (5.7). A comparison between the strong damp-
ing approximation and the weak damping approximation (β  ω) is shown
in Fig. 5.2 (see appendix C). The rise of x(t) during the acute stimulus is
monotonic and can be approximated by a linear function after an averaging
process. As one would expect, this corresponds to an exponential growth of
the clonal size c(t). In the strong damping case the rise is piecewise linear
and close to linear when Tω2F0/β  1.
Effect of the local environment
It is plausible that the parameters of the function V (timescale and equi-
librium sizes) might vary in different organs. Keeping the height of the
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Figure 5.2: Left panel: weak damping case (ω = 0.1, β = 0.02, F0 = 2ω2,
T = 9) T-cell clonal expansion in the case of a sinusoidal size-landscape
function V (x). Right panel: over damping case (ω = 0.1, β = 0.8, F0 =
2ω2, T = 150). The jump to the first minimum occurs for T ' 100 days,
whereas for the saw-tooth size-landscape the jump threshold is T = β/(F0−
ω2) ∼ 80 days.
Figure 5.3: Left panel: comparison of the clonal expansion for two different
sinusoidal size-landscape functions defined by V = 1
2
ω2 [1 − cos pi (1 − )x].
Parameter values are ω = 0.1, β = 0.1, F0 = 2, T = 24 and  = 0 for the first
landscape (grey curve) and  = 0.4 for the second landscape (black curve).
Right panel: same comparison as in the left panel for a clone undergoing two
antigenic impulses of the same duration and with a time delay of 100 days.
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maxima unchanged, we vary the periodicity from 2 to 2/(1 + ), namely
V = 1
2
ω2 [1− cos pi (1 + )x]. In Fig. 5.3 (right panel) we show the effect of
the antigenic insult with two different values of the parameters (ω, ), which
can be associated to two different organs where the infection takes place.
These curves are qualitatively similar to experimental data [Marshall et al.,
2001].
Chronic stress
The analysis of the chronic stochastic stimulus, f0 + γξ(t), has been made on
the basis of the analytical treatment of stochastic dynamical systems. The
probability density ρ(x, v, t) to obtain a certain solution x(t) of the clone size
at time t and rate of change v(t) satisfies the Fokker-Planck equation
∂ρ
∂t
+
∂(vρ)
∂x
− ∂
∂v
[(βv + V eff ) ρ ] =
γ2
2
∂2ρ
∂v2
(5.8)
The equilibrium configuration, reached as t→∞, is
ρ eq (s, v) =
1
Z
e
( −v
2
2kBT
)
e
(
−V eff
kBT
) (5.9)
where Z is a normalization constant (see calculations in appendix C) and
k
B
T = γ
2
2β
. To reach this configuration the system undergoes a relaxation
process. A diffusion with respect to the deterministic trajectory occurs with
a the diffusion coefficient D = 1
2
γ2 = βk
B
T . There is a finite probability
for the expansion of the T-cell clone to an equilibrium size x = 2, 4, . . . , 2N
by the action of a weak chronic stimulus. As a consequence, we can state
that the number of T-cells depends not only on the acute antigenic challenge
but also on the CIS impinging upon the IS continuously. The transition
time necessary to move among the equilibrium states can be estimated by
evaluating the time needed to complete this transition, which is given by the
Kramer’s formula [Risken, 1989]
τ = C exp
V eff (x2)− V eff (x1)
k
B
T
= C exp
2β(ω2 − f0)
γ2
(5.10)
where
C =
ω2n
2piω2n+1
[
−β
2
+
√
β
2
2
+ ω22n+1
]
(5.11)
ω2n = V
′′(x2n) and ω2n+1 = V ′′(x2n+1).
We define an effective size-landscape function by rewriting the function
V including the average chronic stress f0, V eff V −f0 x. This function simply
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Figure 5.4: Clonal expansion due to an acute antigenic load of intensity
F0 = 2, and duration T = 9 days, and chronic stress with average value
f0 = 0.02 and fluctuation amplitude γ = 0.0075. The remaining parameters
are ω = 0.1, β = .02. The pictures represent the probability density function
ρ, at a given time t, of having a clone size c = 10x. Initially, the clone
size is uniformly distributed around the value x0 = 6 with a spread ∆x =
0.35. With the stochastic stimuli the probability distribution of the clone
size evolves, and asymptotically peaks around the equilibrium values. The
histogram represents the simulation, whereas the continuous curve is the
analytical curve of the asymptotic solution of the Fokker-Planck equation.
There is a small but finite probability that the clone size decreases with
respect to the initial value. The histogram in the left panel refers to the
distribution at time t = 30 days, whereas the histogram in the right panel
corresponds to time t = 3000 days. The central rectangle in both panels
represents the initial distribution and is the same for both panels.
tells that the average effect of the stochastic term is to bend the curve cor-
respondent to the function V (see Fig. 5.1). This enhances the probability
of having large clones by reducing the activation threshold. The fluctuating
part of the CIS is responsible for jumps in the size-landscape function. This
stochastic effect leads to an asymptotic stationary state, where the probabil-
ity of having a clone of size c = 10x is peaked in at the minima of V eff x).
The height of the peaks increases with f0. In figure Fig. 5.4 the situation
in which both the acute stimulus and the CIS are present is shown. In the
absence of CIS the clone would reach a new equilibrium size after the acute
stimulus, and performs damped oscillations around it (see Fig. 5.3). If the
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stochastic term is considered, as shown in Fig. 5.4 (left panel), short after an
acute stimulus (of duration T = 9 days) the probability density of the clone
size is spread out. A first peak is found at the initial value (x = 6), and a
second broader peak between the next two equilibrium sizes. After a long
time (t = 3 years) the asymptotic stationary distribution is approached, as
shown by the comparison of the simulation with the analytical solution Eq.
(5.9) (Fig. 5.4 right panel). A longer time or a smaller damping (β = 0.01)
are required to reach more closely the equilibrium distribution. We can in-
deed estimate the relaxation time being proportional to β/ω2 according to a
strong damping estimate (see appendix C). Smaller clone sizes with respect
to its initial value x(0) = 6 are observed (see Fig. 5.4). This is due to the CIS
effect, which has a finite probability to be negative on a short time interval
(f0∆t+ γξ
√
∆t where ξ is here a random number uniformly distributed in [-
1,1] with variance 1). From a biological view point this negative contribution
causing a temporary reduction of the clone size, is acceptable since it has
been experimentally observed that under heterologous stimulations the clone
size can decrease (attrition) [Selin et al., 1999, Chen et al., 2001a]. From
a probabilistic point of view this mechanisms would imply that during the
homeostasis of a peripheral T-cell clone, the size does not grows monotoni-
cally but, due to further different environmental conditions, can even reduce,
in order to make possible the expansion of other specific T-cell clone. Clones
with a size several times the initial configuration value are observed within a
long time period. This phenomenon is enhanced by increasing the amplitude
of the chronic fluctuations. In Fig. 5.5 we analyze the effect of a change in
the average value of the chronic term f0. The right panel shows the results of
the probability density of the clone size for a value of f0 ten times bigger with
respect to the left panel. With larger value of f0 the probability of having
clones smaller than the initial value is practically zero, which means that the
attrition phenomenon is negligible. On the contrary, for the smaller value of
f0 the effect of the attrition is visible.
5.3 Discussion and conclusion
In this work we proposed a model to test the hypothesis that the maintenance
over long timescales of AE T-cell clones in the peripheral infected tissues can
be strongly affected by CIS. The CIS can also play a relevant role in the
reduction of the clone size caused by the attrition mechanism [Chen et al.,
2001a, Selin et al., 1999]. In this minimal model we have introduced the size-
landscape function in order to describe the interactions between competing
cells in infected organs during the proliferation and maintenance of AE T-
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Figure 5.5: Clonal expansion due to an acute antigenic stimulus with the
same parameters as in Fig. 5.4. Left panel: probability density ρ of the
clone size at time t = 1000 days for an average value of the chronic stress
f0 = 0.02 and a fluctuation amplitude γ = 0.008. Right panel: probability
density of the clone size at time t = 1000 days for an average value of the
chronic stress f0 = 0.2 and a fluctuation amplitude γ = 0.008. This figure
shows that by increasing the average value of the chronic stress the expansion
probability is strongly enhanced and the probability of reducing the clone size
becomes very small.
cell pool. Although a mechanistic explanation for this function is unknown,
we can recall that AE T-cells recruited to the site of the antigenic exposure
undergo a dynamic regulation which is dependent on the particular microen-
vironment that T-cell meet [Butcher and Picker, 1996, Harris et al., 2002].
The main idea is that the joint action of the function V and of the damping
term −βv works as a spring-dash pot system which describes, at least in
a first approximation, the complicated homeostatic process underlying the
T-cell clone dynamics over long timescale.
We found that Cytotoxic T-cell clones can differ in their expansion rates
even if the same antigenic insult is given. The housekeeping message we
propose is that chronic fluctuations of a generic stimulus can modify the
dynamics of the clonal expansion in a non-trivial and non-predictable fash-
ion. The model is adequate to describe the sensitivity and the differences
of the clone homeostasis with respect of the local environment as suggested
by recent experiments [Marshall et al., 2001]. Moreover, the recruitment
and the maintenance of T-cells in the periphery is not only due to acute
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challenges, but also to chronic non specific stimulations, which can strongly
modify the T-cell repertoire. This model confirms that cytokines can be en-
visaged as a major unspecific response of the IS to a chronic stimuli. This,
over tenth other function of cytokines, can be fundamental to keep the IS
alarmed. We therefore support the hypothesis that the antigenic specificity
is not the only important determinant of the long term survival of AE T-
cells clones [Jameson, 2005, Veiga-Fernandes et al., 2000, Tough et al., 2000,
1996]; Memory T-cells may follow a different rule with respect to the naive
pool. Their function to prevent dispendious energy activity of the IS against
previously encountered pathogens would probably be done more efficiently
without strong specificity. Together with the results presented in Chapter 4,
we conclude that the maintenance of AE T-cells can be a function of both
antigen specificity and generic environmental stimuli. The first gives a pre-
cise signal regarding what T-cells should combat, while the second shapes
the local environment, which influences the timing and the size of the IR. If
one speculates on the consequences that the clonal expansion may have on
ageing it could be pretty natural to envisage a detrimental effect. The loss of
diversity is the direct effect of a huge expansion of specific cells in a system
where the total amount of cells is kept almost constant. It is known that
clonal expansion is a major feature of immunosenescence. Some mathemati-
cal models [De Boer and Perelson, 1994] highlight the role of cross-reactivity,
being the safe-site of the clonal expansion of memory cells. Despite the cross-
reactivity as a positive sign of the clonal expansion, we suggest that the CIS
is one of the predominant forces driving immunosenescence [Franceschi and
Bonafe, 2003, Franceschi et al., 2000a]. We have shown that a specific AE
T-cell clone shrinks (with a low probability), as a consequence of the CIS
and subsequent attrition. This would suggest that during vaccine recalls the
size of the long lived AE T-cell pool could not change at all, or worst, could
even decrease in some individuals, with a negative effect on the maintenance
of the clone.
We are currently working on a 2-dimensional multi-agent system with the
aim to investigate mechanistically the clonal expansion of T-cells during an
infection. The result of this new approach should be to bridge the mean field
approximation, such as the model here proposed, and a more mechanistic
description based on cell-cell interaction. Recent data on the kinetics of T-
cell interaction with the APC may help in such an attempt. Competition
for epitopes, timing of the TCR-MHCp binding kinetics and the availability
of APCs can be modeled in a 2-D multi agent simulation. These approach
evidence new features which a mean field approach cannot easily detect.
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Summary
Although the IR against acute stimuli has been largely addressed, and simple
mathematical models provided quantitative results, the question of the T-cell
clone dynamics under chronic infections is still a matter of debate. Based on
phenomenological facts, we suggested a stochastic mathematical model for
the investigation of the T-cell dynamics over a long timescale. Moreover, the
role of chronic stimuli have been discussed.
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Part III
The immune system over long
timescale
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Chapter 6
Ageing and survival probability
Introduction
The focus of this chapter is ageing and the effect that T-cell dynamics during
chronic stimuli has on it. In previous investigations [Luciani et al., 2001b] we
hypothesized that lifelong, chronic immune stress (CIS) is the major driving
force of immunosenescence. CIS impacts on human lifespan by reducing the
number of naive antigen-non experienced (ANE) T-cells, and filling the im-
munological space with expanded clones of antigen-experienced (AE) T-cells.
A model has been proposed to relate CIS with the conversion rate from ANE
to AE CD8+ T-cells [Luciani et al., 2001b, Mariani et al., 2003]. In order to
account for individual variations of immunosenescence and lifespan, a noise
term has been introduced for the description of the individual fluctuations
of CIS. This model was able to follow with a reasonable approximation the
age-related decrease of ANE CD8+ T-cells, as well as human survival curves.
The quality of the fit of historical demographic data improves as we approach
recent the last decades of this century. Indeed, the almost linearity in the
increase of lifespan and in the decrease of the noise fluctuation amplitude
within this historical period data suggests that the improvement of life con-
ditions has steadily lowered the intensity of CIS and restricted its variability.
As a whole, this approach allows to appreciate when and how immunosenes-
cence has started to impact on survivorship and predicts its crucial role in
explaining human mortality in hygienized/economically-developed societies.
6.1 Ageing and immunosenescence
There are some hints suggesting that ageing is, at least in part, a consequence
of IS activity. We still don’t know much about it and therefore most of the
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models regarding ageing has been limited to demographical studies. We
attempt here to make a sort of bridge between demographic study and the
knowledge of the IS dynamics.
Physiological ageing is characterized by the decline in physiological ca-
pacity of the body. This decline can be approximated by a linear function.
Ageing is very heterogeneous. There is a remarkable difference in the individ-
ual patterns of physiological ageing and in the individual chance of survival.
Ageing is also characterized by elevated variance: genetically identical indi-
viduals in the same environment can have different patterns of physiological
ageing and different lifespans [Franceschi et al., 1999, 2000b,a]. In the last 50
years old-age mortality rates in the developed countries have steadily been
declining and life expectancy have been increasing. A general theory of age-
ing which accounts for all these aspects is still missing.
The immunosenescence
The IS exhibits profound age-related changes, which define the immunosenes-
cence [Franceschi et al., 1995]. The most visible of these changes is the decline
in protective immunity, which results from a complex interaction of primary
immune defects and compensatory homeostatic mechanisms. Many processes
that normally ensure optimal immune function are gradually compromised.
Immunosenescence manifests itself at several scales, from the organism to
the individual cells. Morbidity and mortality is increased in elderly humans
and old animals. These characteristics are associated to viral infections, such
as influenza, Varicella, Herpes simplex virus-1 pox viruses and to bacterial
diseases like pneumococci, E. coli, and Salmonella [Miller, 1996, Wick et al.,
2000]. Dysregulation of immunity plays a big and critic role in this processes.
Responsiveness to vaccination in the elderly is also diminished [Cohen, 2005].
Experimental data suggests that persisting pathogens are very important in
modulating the homeostasis and functions of T-cells as they results in an
ever increasing fraction of T-cells that are continuously stimulated [Pawelec
et al., 2004]. Antigen presentation has been reported to be diminished during
ageing [Pamer, 1999]. In principle, there is either a limit to the number of
divisions that each cell can undergo, or the stochastic accumulation of muta-
tions after n divisions (with n being highly variable even within the cells of
the same clone) simply produces replicative incompetent cells. In humans,
the age of 65 is usually taken as the beginning of senescence, as this is when
the incidence of severe infection diseases becomes elevated. Indeed, there is
a log linear decrease of in thymic output during middle age (20-60yr), and in
the seventh decade a rapid shrinkage of naive CD4+ and CD8+ T-cell pool
is observed. In the following sections we will first introduce the classical
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mathematical approach for the description of biological variables describing
biological ageing processes. Successively, we will present a new model in
which the T-cell dynamics will be introduced.
6.2 Gompertz: the first law
The first important work regarding demographic curves arising from the anal-
ysis of some quantity describing the state of the population has been proposed
by Gompertz in the nineteenth century [Gompertz, 1825]. Before compre-
hensive measurements and sophisticated experiments became possible, Gom-
pertz understood the importance of establishing consistency between phys-
iological and demographic theories of ageing. He proposed that there is an
hypothetic physiological index, called vitality, which some how reflects the
state of the population and its capacity to stay alive. This quantity decreases
with time according to an exponential law and correlates with the mortality
of the system. Today we know that physiological concepts like heterogeneity,
homeostasis and stochasticity are to be taken into account to describe and
explain the observed mortality data. The interesting fact is that this simple
model describes intriguingly well the human mortality curves in the range of
35-85 years old. Gompertz’s model supposes an exponential growth for the
mortality of the population, R and a survival probability, S which decreases
according to an exponential law [Gompertz, 1825]
R = R0 e
t/τ (6.1)
dS/dt = −R(t)S (6.2)
The solution is
S(t) = e−C(e
t/τ−1) (−C(et/τ−1) ), C = R0 τ (6.3)
6.3 Bio-markers of ageing: a model
We generalize this approach considering an ensemble of biological markers
which are governed by deterministic laws whose parameters can fluctuate
due to genetic mutations, and to the presence of external fields. We refer
to these quantity as bio-markers. Some of them may be correlated to the
mortality of the population. Basically, bio-markers tell us the state of the
evolving system.
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Waiting for the rationale of ageing to be clarified, the research of im-
munological bio-markers has been undertaken [Piantanelli et al., 2001, Yashin
et al., 2000, Luciani et al., 2001b, Weitz and Fraser, 2001]. The shortening
of telomers at the genetic level, the decrease of cytotoxic naive T-cells and
the reduction of the memory clones repertoire in the immune system have
proved to be correlated to ageing [Akbar et al., 2004]. An increase of het-
erogeneity at the level of DNA and of the organs has also been observed
and more generally, a spread of most biological variables around their mean
value. These processes are partly triggered and certainly enhanced by the
fluctuations (of physical conditions, antigenic load and stress) of the external
environment [Franceschi et al., 1999, 2000b, Luciani, 2000, Mariani, 2001].
The accumulation of small random fluctuations on a long timescale can lead
to important changes in the organism. A generalization of the model for the
vitality equation given by Gompertz can be given assuming a linear response
of the system to the external and internal fields. We neglect the fluctuations
of the parameters describing the interactions among the bio-markers. The
system of stochastic differential equations with additive noise read
dxk
dt
= Fk(x1, · · · , xn, α1, αp) +
n∑
j=1
Ck,j
(
fj(t) + jξj(t)
)
(6.4)
Here, xk is a general biological marker, Fk are generic operators representing
the deterministic effect of external stimuli on the bio-markers. The param-
eters αk are representative of the interaction between the n bio-markers.
Finally, the last term of the equation is the stochastic stimulus which has
an average fj and a fluctuation amplitude j. If the functions Fk are linear,
F = Ax, and the dependence on the parameters αk and the average fields
fk can be neglected, the above system can be analytically solved (see next
section). The matrix A must have eigenvalues with negative real part to
ensure asymptotic stability. In this case, the variance of the bio-markers xk
is also asymptotically bounded. The formulation of this type of models is
significant if there are in vivo experiments which allow to monitor the time
evolution of the bio-markers. However, this type of experiments over a long
timescale are onerous and time consuming. Having selected a significant
sample of bio-markers, we now define the function v = v(x1, · · · , xn) as the
vitality function, which is commonly used in demographic models [Yashin
et al., 2000]. A sharp threshold is assumed, chosen conventionally to be
zero, which marks the transition from life to death. Since our markers are
stochastic variables, the vitality is a random variable as well.
Starting with a cohort of genetically identical individuals living in the
same environment, it is natural to associate to each of them a vitality cor-
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Figure 6.1: Sketch of the trajectories of the concentration of the naive T-
cells as an example of bio-marker of mortality (Taken from Luciani et al.,
2001b).
responding to a realization of a stochastic process. This means that every
trajectory-realization of the stochastic process in the space of the bio-markers
Rn, corresponds to a trajectory for the vitality, which is represented by the
graph of v(t) (see for example Fig. 6.1). The survival probability S(t) can
be obtained starting from the distribution function ρ(v, t) of the stochastic
variable v according to
S(t) =
∫ ∞
0
ρ(v, t) dv =
∫
−〈v(t)〉/σ(t)
ρ
( 〈v(t)〉+ uσ(t), t ) du (6.5)
where we denote with 〈v(t)〉 and σ(t) the mean value and the variance of the
process.
The linear model
In order to have a better insight into the equations satisfied by v(t), it is con-
venient to introduce an invertible map of Rn defined by the set (v1, v2, . . . , vn)
of functions of x = (x1, . . . , xn) where v1 ≡ v. The system of equations Eq.
(6.4) in the new variables reads
dvi
dt
= Φi(v1, · · · , vn) +
n∑
k=1
Γik (v1, · · · , vn)
(
fk(t) + k ξk(t)
)
(6.6)
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The Fokker-Planck equation for the distribution function ρn(v1, · · · , vn, t) for
the above variables can be written according to the standard procedure (see
Risken [1989]) and the function ρ(v, t) is then the corresponding marginal
distribution
ρ(v, t) =
∫
Rn−1
ρ(v, v2, . . . , vn, t) dv2 · · · dvn (6.7)
A drastic simplification occurs if the functions Fk (see Eq. (6.4)) defining
the interactions among the bio-markers are linear. The vitality is in turn a
linear function of them, v = w ·x, where w is a constant vector of unit norm.
Letting W = (w1, · · · , wn) be an orthogonal matrix whose first column is
w1 ≡ w it is straight forward to verify that the stochastic system given by
Eq. (6.6), satisfied by the variables vi, are
dvi
dt
=
n∑
j=1
Bij vj +
n∑
k=1
Dik
(
fk(t) + k ξk(t)
)
, B = W˜ AW, D = W˜ C
(6.8)
In this case we write a Fokker-Planck equation whose solutions are Gaussian
distributions. They are specified by the mean values 〈vi(t)〉 and the covari-
ance matrix σ2ij = 〈 (vi − 〈 vi 〉) (vj − 〈 vj 〉) 〉. The marginal distribution for
v ≡ vi is given by
ρ(v, t) =
1√
2piσ2(t)
e
− (v−〈 v(t) 〉)2
2σ2(t)
„
− (v−〈 v(t) 〉)2
2σ2(t)
«
(6.9)
the survival probability takes a very simple form
S(t) =
1√
2pi
∫ ∞
−〈v(t)〉/σ(t)
e−
u2
2 du ≡ 1
2
Erfc − 1√
2
〈v(t)〉
σ(t)
(
− 1√
2
〈v(t)〉
σ(t)
)
(6.10)
A bio-marker of mortality: cells in a random environment
Consider a population of interacting cells (x1, . . . , xn) ≡ x in a random envi-
ronment. We assume that the deterministic equation is linear and the noise
is additive. From Eq. (6.4) we can write
dx
dt
= −A(t)x+ f(t) + dη
dt
(6.11)
dη
dt
= −βη + ξ(t) (6.12)
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where A is a positive semi-definite matrix and ξ(t) is a white noise. The
system experiences a colored noise of Ornstein-Uhlembeck type η. The first
term Af describes the exchanges among cells x due to mutual interactions,
the second term f(t) is the sum of two vector fields associated to the signaling
or control processes of the organism and to the average environmental stress.
The noise describes the rapid random fluctuations of the previous fields. In
the simplest case where A and f are time independent and in the absence of
noise, the system reaches an homeostatic equilibrium x∗ = A−1 f . If f varies
periodically with respect to a constant value, the populations x(t) undergo
periodic oscillations with the same frequency, provided that the equilibrium
reached when f = 0 is stable. For instance, this can be observed in periodic
viral attacks over the lifespan (such as Herpes virus infection) [Crough et al.,
2005, Dunn et al., 2002]. Let v = w · x be the bio-markers of interest, where
w is a constant unit vector. Following the general approach proposed (see
6.3 and Eq. (6.8)), we change Eq. (6.13) into a new set of equations by
introducing an orthogonal matrix W = (w,w2, · · · , wn). whose first column
is the vector w. The new vector v = W˜ x, whose first element is the vitality
v, satisfies the equation
dv
dt
= −B v + g(t) +  b ξ(t) B = W˜ AW (6.13)
where g = W˜f and b = W˜a. Assuming for simplicity that A is time indepen-
dent and the noise to be white β = 0, the probability density function (p.d.f.)
ρ(v, t), solution of the Fokker-Planck equation corresponding to the Langevin
equation Eq. (6.13), is a Gaussian whose parameters 〈 vi 〉 and 〈 (vi−〈 vi 〉)2 〉
can be explicitly determined. The marginal distribution ρ(v, t), obtained by
integration over (v2, . . . , vm) is
ρ(v, t) =
1√
2piσ2(t)
e
− (v−〈 v 〉)2
2σ2(t)
„
− (v−〈 v 〉)2
2σ2(t)
«
(6.14)
Let us suppose that v has a critical threshold vc strongly correlated to the
death of the organism. For the sake of simplicity by a simple translation we
can shift the threshold to 0 without affecting the results. As a consequence,
we assume that our bio-marker of mortality is positive and that the organism
death corresponds to v = 0 (see Fig. 6.1). In the absence of noise, a popula-
tion of identical organisms in an identical environment has the same lifespan
T defined by v(T ) = 0. The presence of fluctuations allows to personalize the
individual histories because every organism experiences its unique sequence
of random events which are responsible for changes during lifespan. It should
be noted that this is again a reasonable but strong approximation. It has
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been observed that individuals modified to have very similar genetic back-
ground, and living in a very similar environment show significant changes
in their lifespan [Brooks et al., 1994]. We define by T the average lifespan
〈 v(T ) 〉 = 0. For each organism death occurs at time t, when v first vanishes.
At subsequent time v might also be negative, but this mathematically defined
solution becomes meaningless from the biological viewpoint. In the language
of stochastic process we are facing a first passage problem, whose p.d.f. can
be obtained only by a numerical procedure. If we consider the probability
distribution function defined by Eq. (6.14) for a fixed t and 0 < v < c,
integrating it on [0, c], we do not obtain the percent of our identical organ-
isms born at time t = 0 whose bio-marker at time t are in the interval [0, c].
Therefore, we do not obtain the percentage of organisms still alive at time
t. In this case we are overestimating the real number, since we count as
alive also those organisms whose bio-marker has previously become negative,
recovering a positive value at time t. This upper bound can be computed
analytically, and proves to be very close to the exact value for small values
of the fluctuation amplitude. The upper bound S(t) to the exact survival
probability S ex (t) is given by
S(t) =
1√
2pi
∫ +∞
x(t)
e
−u22
du ≡ 1
2
Erfc
x(t)√
2
(6.15)
where
x(t) = −〈 v 〉(t)
σ(t)
(6.16)
We recall that the mortality is related to the survival probability S(t) by
R(t) = − 1
S(t)
dS
dt
(6.17)
6.4 Vitality: stochastic equation
We shall compare three cases of the generic model described above (See Sec.
6.3);
• the Wiener process, suitable to explain the anomalous survival queues
observed in simple organisms [Weitz and Fraser, 2001]
• the Ornstein-Uhlenbeck process, proposed for the naive CD8+ cytotoxic
T-cells [Luciani et al., 2001b]
• a stochastic process whose survival curve is very close to Gompertz law,
which describes most of the demographic data for different organisms.
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In order to simplify the analysis, we consider the general model given in Eq.
(6.6) in the case m = 1. The Langevin equation for the bio-marker v is
dv
dt
= −a v − f0 − f1t+ dη
dt
(6.18)
dη
dt
= −bη + ξ(t) (6.19)
where η is is the noise term.
f b = 0 the equation for the stochastic variable is known as Wiener process.
The general solution for the average of the stochastic process v(t) is given by
〈 v(t) 〉 = v0e−at + f1
a
− f0
(
f1
a
− f0
)
1− e−at
a
− f1
a
t (6.20)
Moreover, in the following special cases,
〈 v(t) 〉 =

v0e
−at − a−1 f0(1− e−at) case a) f1 = 0
v0e
−at + a−2(1− at− e−at) case b) f0 = 0
v0 − f0t− 12f1t2 case c) a = 0
(6.21)
the function 〈 v(t) 〉 decreases monotonically in all cases if the parameters
a, f0, f1 are positive. The curve is convex in case a), concave in case c), and
in case b) convex if a2v0 < f1, and concave if a2v0 > f1. The noise term is
given by
η(t) =
∫ t
0
e−b(t−s) ξ(s) ds (6.22)
and it is not difficult to check that the mean square deviation σ is given by
σ2(t) = 〈 (v(t)− 〈 v(t) 〉)2 〉 (6.23)
=
1
(b− a)2 [
b
2
(1− e−2bt)
+
a
2
(1− e−2at)− 2ab
a+ b
(1− e−(a+b)t)] (6.24)
For b = 0 and a = b the variance becomes
σ2(t) =
1− e−2at
2a
(b = 0) (6.25)
σ2(t) =
1
4a
[
1− e−2at(1− at+ a2t2)] (b = a) (6.26)
We now consider three distinct relevant cases, characterized with only two
parameters, the mean lifetime T , and the noise amplitudes .
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1. Gompertz-like model (GM). The model is defined by a = f0 = 0 and
f1 = 2/T
2, b = 3/T .
dv
dt
= − 2t
T 2
+  dη
dt
(6.27)
dη
dt
= −3η
T
+ ξ(t) (6.28)
Next we will show that the survival curve obtained from this model
presents very similar features of the standard Gompertz curve. Fur-
thermore, it will be shown that the rate of mortality increases as a
power law, R(t) ∝ tk for t→∞ (see Fig. 6.6)
2. The Wiener model (WM). The following model has been recently pro-
posed to describe mortality plateau in species where individuals could
reach a lifespan up to ten times the average[Weitz and Fraser, 2001].
This model is defined by f0 = −1/T and f1 = a = b = 0
dv
dt
= − 1
T
+  ξ(t) (6.29)
In this case the solution becomes
〈 v(t) 〉 = v0 − f0t σ(t) = 
√
t (6.30)
and, as it will be shown later on, the survival curve exhibits a long
tail and the mortality rate has a slow asymptotic increase. The rate of
mortality, therefore, can present an asymptotically constant plateau,
R(t) ∝ 1 for t→∞.
3. The Immuno-Model (IM) [Fagnoni et al., 2000, Mariani et al., 2003,
Luciani et al., 2001b]: defined by f1 = b = 0 and T = 1/a. With the
further constraint f0 = T−1 (e− 1)−1 we have
dv
dt
= − v
T
− 1
T
(e− 1) + ξ(t) (6.31)
The rate of mortality has an exponential asymptotic decrease R(t) ∝
e−t/T for t→∞.
6.5 The immuno-model
This model is based on the hypothesis that the loss of some of the immune
system functions are responsible for the reduced functioning of the body
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Figure 6.2: Markers of Naive, CD95−, and Memory-Effector, CD95+, T lym-
phocytes for both the CD4+ (Helper) and the CD8+ (cytotoxic) pool. This
sketch has been derived from experimental results [Fagnoni et al., 2000].
during ageing. The vitality function has been identified with the Naive T-
cell concentration v = V/(V +M). Several data showed that defects in the
IS functions arise from the T-cell senescence. In particular human ageing is
characterized by a strong reduction of naive T-cell repertoire [Fagnoni et al.,
2000, Nikolich-Zugich, 2005]. A shrinkage of the total T-cell clone repertoire
has been reported [Franceschi et al., 1995, 2000a]
We recall that T lymphocytes split into two groups: the cytotoxic and
helper T-cells. The former attacks and destroys intracellular infected cells,
while the latter contributes to extracellular antigenic response and to reg-
ulate the immune response. They are labeled by CD8+ (cytotoxic) and
CD4+ (helper) respectively, according to the surface markers used to identify
them. We are interested in the dynamics of two populations, the antigen non-
experienced (ANE) naive T-cells, and the antigen experienced (AE) T-cells,
which are identified by the CD95− and CD95+ surface markers respectively
[Fagnoni et al., 2000] (see Fig. 6.2). The deterministic part of the model
describes the decrease of the ANE CD8+ T-cells concentration, in agreement
with experimental data[Fagnoni et al., 2000, 1996]. The stochastic forcing,
describing the chronic stress [Franceschi et al., 2000b,a], allows to obtain in-
dividual histories. The model here described is intended to introduce some
improvements of a previous model [Luciani et al., 2001b], by taking into ac-
count the remodeling of the immune system during the lifespan. The model
shows a further improvement, especially for the early stage, were the simpli-
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fied model was not adequate. The model is defined by
dV
dt
= −αV − βM + µ e−λ t +  cos2(θ ) ξ (t) (6.32)
dM
dt
=
αV + βM
1 + γ M+
+  sin2(θ ) ξ (t) (6.33)
V denotes the number of ANE (Naive) CD8+ T-cells and M the number of
AE CD8+ T-cells, M+ = M if M > 0 and M+ = 0 if M < 0. The parameter
α gives the conversion rate of ANE cells due to primary antigenic insults,
whereas β is the reactivation rate of AE cells due to secondary antigenic
stimulus. AE cells re-expand and occupy a larger quota of the space avail-
able. On the other hand, the total T-cell repertoire remains almost constant.
Therefore, an inhibitory effect on the ANE cells caused by the reactivation of
AE clone during a secondary antigenic stimulus has been considered. Indeed,
it has been shown that during ageing the T-cell pool undergoes a small but
well defined shrinkage [Franceschi et al., 2000a]. In order to account for this
phenomenon, an inhibition effect with the term −βM has been introduced.
This reduces the size of ANE cells as the number of AE clones rises. Finally,
we supposed the conversion and reconversion terms of AE pool, α and β, to
be proportional to (1 + γM+)−1, in order to account for the shrinkage of the
T-cell repertoire. The term µ e−λt describes the production by the thymus,
which is assumed to decay exponentially [Nikolich-Zugich, 2005]. Finally, the
stochastic term
〈ξ(t)〉 = 0 〈ξ(t) ξ(t′)〉 = δ(t− t′) (6.34)
represents the stochastic fluctuations to the conversion rates. The mixing
angle θ weights this term among the ANE and AE compartments. The re-
sults are compared with experimental data (see Fig. 6.3 and Fig. 6.4). The
stochastic term generates a family of immunological histories. Their spread
is measured by the variance. In Fig. 6.3 the effect of the mixing angle is
shown. When θ grows, the root mean square (rms) spread σ
V
decreases,
whereas the rms spread σ
M
of M increases. In Fig. 6.4 the effect of thymus
and of the shrinkage are shown. The graph of 〈V (t) 〉 exhibits a peak at
t = (log λ− logα)/(λ− α) if V (0) = 0. The peak disappears when the thy-
mus contribution vanishes. Experimental evidences suggest that newborns
undergo a rapid proliferation in the T-cell poll, followed by a slower rate
which define the homeostatic level [Grossman et al., 2004]. The shrinkage re-
duces considerably the increase of 〈M(t) 〉, whereas it does not affect 〈V (t) 〉.
Fixing the parameters in a range of values compatible with the experimental
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Figure 6.3: Comparison with CD95 data [Turchetti et al., 2002, Luciani,
2000] of naive (ANE) and memory plus effector (AE) populations for the
model without shrinkage and thymus for two different mixing angles. The
parameters are α = 0.02, β = 0.005,  = 10, V (0) = 400 and θ = 0 (left
figures) and θ = 45o (right figures). The curves are 〈V (t) 〉 + kσ
V
(t) and
〈M(t) 〉 + kσ
M
(t) with k = −2, 0, 2.
Figure 6.4: Comparison with CD95 data [Luciani et al., 2001b, Mariani, 2001]
of naive (ANE) and memory plus effector (AE) populations for the model
with shrinkage and thymus. The parameters are α = 0.025, β = 0.01,  =
15, θ = 35o. On the left side we consider the contribution of thymus with
λ = 0.05, µ = 15, γ = 0 and V (0) = 50 . On the right side the contribution
of shrinkage is shown for γ = 0.004, µ = 0 and V (0) = 400. The curves are
〈V (t) 〉 + kσ
V
(t) and 〈M(t) 〉 + kσ
M
(t) with k = −2, 0, 2.
data [Fagnoni et al., 2000, Luciani et al., 2001b], we find that the leading
statistical properties of v(t) (average and variance) can be described with a
more simple model for the concentration of AE cells
dv
dt
= −(α− β)v − β + ξ(t) (6.35)
This corresponds to our general model (Eq. (6.20)) with f0 = β, a =
α − β,f1 = b = 0. In the next section the survival curves and mortality
rates obtained from these three models for the vitality equation will be dis-
cussed. A very important difference is found with respect to the classical
Gompertz survival law [Gompertz, 1825]: the rate of mortality vanishes ini-
tially and asymptotically, whereas it increases exponentially in the Gompertz
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Figure 6.5: Naive cells population 〈V (t) 〉 ± 2σ
V
(t) with v∞ = −0.5, T = 67
and ˆ = 0.016 (left). Corresponding survival curve (center) and mortality
rate (right). These values correspond to α = 0.022, β = 0.0075,  = 6.5 γ =
µ = 0 and V (0) = 400
law. This explains the presence of very long lived individuals (centenarians),
and supports the biological hypothesis of a depletion in the ANE T-cells pool
[Franceschi et al., 2000a, 1995, 2000b].
6.5.1 The survival probability
In the theory of stochastic processes, the simplified model for the concentra-
tion of T-cell clones given by equation Eq. (6.35) is known as the Ornstein-
Uhlembeck process. The probability density function satisfies the Fokker-
Planck equation, and has an explicit solution (see appendix C)
〈 v 〉(t) = v∞ + (1− v∞)e−t/T (6.36)
ρ(v, t) = 1√
2piσ2(t)
e
»
− (v−〈 v 〉(t) )2
2σ2(t)
–
(6.37)
where
T = (α− β)−1, (6.38)
v∞ = −β T
σ2(t) =
1
2
ˆ2 T (1− e−2t/T )
The survival probability S(t) (see Eq. (6.15)) has been applied to demo-
graphic data [Mariani et al., 2003, Turchetti et al., 2003]. The lower integra-
tion end-point x(t) can be written as
x(t) = C
1− e t∗−tT√
1− e−2t/T (6.39)
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Figure 6.6: Left frame: plot of the survival curves in a semilogarithmic scale
for a cohort of mad-flies (circles).We compare the best-fits with Gompertz
law (purple curve 2), with the Gompertz-like model i (green curve 1) where
T = 20,  = 0.55 and with the Wiener model ii (red curve 3) where T =
19.3,  = 0.1. Right frame: plot of the demographic data for a cohort of
Danish (circles). We compare the best-fits with a Gompertz law (purple curve
1), with the Gompertz-like model i (green curve 2) where T = 75,  = 0.1
and with the immunological model iii (red curve 3) where T = 75,  = 0.015.
where
C =
1
ˆ
(
2
T
)1/2 (v∗ − v∞) (6.40)
In this formalism t∗ is the age at which death occurs 〈 v(t∗) 〉 = v∗, namely
e−t∗/T = (v∗ − v∞)/(1 − v∞). We notice that S(t) is a three parameters
function. In Fig. 6.5 the fit of the demographic data of human males using
Eq. (6.15) has been performed. The parameters values have been chosen very
similar to the values obtained from the fit of the CD8+ T-cells concentrations
[Fagnoni et al., 2000]. The mortality rate is not monotonically increasing, as
in the Gompertz model, but decreases after reaching a maximum (see Fig.
6.5).
6.6 Analysis of demographic data
The proposed models have been applied to different sets of data: a population
of mad-flies, [Carey et al., 1992, Turchetti et al., 2002], and a cohort of
Danish, born at the beginning of last century [Vaupel and Jeune, 1996]. The
GM and WM models have been compared for the first data set, and the GM
model with the IM model for the second data set. For the GM model, the
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function x(t), which defines the survival curve, is given by
x(t) = − A 1− (
t
T
)2
(1− e−6t/T )1/2 A = 
−1 (
6
T
1/2
) (6.41)
and the mortality rate grows like t3. For the WM model, a constant
mortality rate is obtained for t → ∞. According to asymptotic studies
(see appendix D) the following approximation for the mortality rate can be
written:
R(t) ' − S˙
S
=
v0
2
√
2pi
e
−v02

2
t
t3/2
(6.42)
The WM has x(t) = −t−1/2(1 − t/T )/, and the asymptotic mortality rate,
Eq. (6.42), is constant.
In the Fig. 6.6 we note that, for a simple organism (respect to species
presenting a more complex immune system) like a mad-fly, there is a non-
negligible fraction of the population which is long lived (many times the mean
lifetime). As a consequence, the Gompertz law and our GM model, which
is very close to the former, fits only the early period 0 < t < 1.5T . The
WM model takes into account also the long lived fraction of the population
0 < t < 5T , whereas the very small fraction of the extremely long lived insects
5T < t < 10T requires a more sophisticated model where the mortality rate
decreases after reaching a constant value. In the human population, we
observe that the IM model, intended to explain the behavior of the ANE
CD8+ T-lymphocytes, describes correctly the survival curve for T < t < 2T .
This model gives a mortality rate which decreases after that a maximum at
t ' 120 years is reached.
The inverse problem
The proposed approach allows to infer some properties of the mortality bio-
markers starting from demographic data. Indeed, given a survival probability
curve, the ratio 〈 v(t) 〉/σ(t), and the value of T can be obtained by computing
the inverse of the error function
x(t) ≡ −〈 v(t) 〉
σ(t)
=
√
2Erfc−1(2S(t)) (6.43)
Assuming a law for the evolution of the mean 〈 v(t) 〉 of the bio-marker,
its variance would be determined by the correspondent survival curve. The
comparison between the variance σ(t) determined by the experimental values
of the bio-marker and the value determined by the survival curves, can be a
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reliable test for the accuracy of the correlation between the bio-marker and
the mortality rate. The plot of the ratio x(t) is useful to analyze the survival
data, and is exempt from the interpolation uncertainties, which affect the
computation of the mortality rates from demographic data.
Summary
This Chapter is an attempt to look at ageing highlighting the events charac-
terizing the changing of the IS during the whole lifespan (immunosenescence).
We propose a generalization of a standard mathematical scheme to approach
the modeling of survival curves and mortality rates of a given population.
We focused on stochastic models of demographic data, and we show how im-
portant features of ageing can be explained from models describing the T-cell
dynamics. Chronic antigenic load explains the spread of antigen experienced
T-cells in a given population, and the flattening of the survival probability
curves at very advanced ages. Within this scenario, a decrease of the fluctu-
ations of the chronic stimuli implies a reduction of the spread of individual
immunological histories around a mean value. Moreover, a decrease of the
average value of chronic stimuli corresponds to a decrease of the conversion
rate from antigen unexperienced to antigen experienced T-cells. This leads
to an increase of the average value of the lifespan. These studies suggest that
prevention of chronic antigenic stimuli, such as by prophylactic vaccination
might be an effective strategy to prevent declining immune competence in
the elderly. Future demographic models on immune system dynamics should
reinforce these results, and pave the way to a better understanding of the
immunosenescence.
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Part IV
Conclusions
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In this thesis we drew the attention towards two main facts. First, we show
that the kinetics of antigen processing is of outstanding importance for the
dynamics of T-cell clones during an IR. T-cell dynamics has been shown to
be remarkably influenced by competition for resources and that the IS may
take advantage of this events to mount an efficient and effective IR. Second,
investigating the long timescale dynamics of the T-cell clones, we suggest
that chronic unspecific stimuli can strongly change the homeostasis of clones
in peripheral tissue. We evidenced how the antigen presentation and the
heterogeneity of antigenic stimuli are both important variable to be taken
into consideration for the study of the T-cell response. This thesis provides
a scenario for the improvement of vaccination strategies, which are known to
suffer for their incapability to deal, at least for the moment, with the very
diverse immune cell repertoire at different age and with the very different
environmental conditions characterizing each individual. The efficiency of a
vaccine is also due to its capability to induce an appropriate diverse T-cell
repertoire. Multiple epitope vaccines should therefore be designed with par-
ticular care regarding the dynamics of the IR and not only on the specificity
of peptides.
The proteasome kinetics
The proteasome is the major protease involved in the intracellular protein
degradation. The influx rate of protein substrates and the exit rate of the
fragments/products is regulated by the size of the axial channels. Opening
the channels is known to increase the overall degradation rate and to change
the length distribution of fragments. We develop a mathematical model with
a flux that depends on the gate size and a phenomenological cleavage mecha-
nism. The model has Michaelis-Menten kinetics with a Vmax that is inversely
related to the length of the substrate, as observed in in vitro experiments. We
study the distribution of fragment lengths assuming that proteasomal cleav-
age takes place at a preferred distance from the ends of a protein fragment,
and find multi-peaked fragment length distributions similar to those found
experimentally. Opening the gates in the model increases the degradation
rate, increases the average length of the fragments, and increases the peak
in the distribution around a length of 8 − 10 amino acids, as observed with
proteasomes equipped with regulatory subunits such as PA28. Finally, we
study the effect of re-entry of processed fragments in the degradation kinetics
and conclude that re-entry is only expected to affect the cleavage dynamics
when short fragments enter the proteasome much faster than the original
substrate. In summary, these results capture the known characteristics of
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proteasomal degradation, and can therefore help to quantify MHC class I
antigen processing and presentation.
Recently, mathematical models have shown how the antigen processing
pathway strongly depends upon kinetic parameters [Bulik et al., 2004]. Pre-
dictions of epitopes presented on the MHCs are made with the help of algo-
rithms based on the sequence specificity of proteins containing MHC ligand,
while algorithms based on the only proteasome cleavage specificity result in
a poor predictability. These algorithms perform very well when proteasomal
cleavage predictions are combined with TAP transportability prediction al-
gorithms [Tenzer et al., 2005, Kesmir et al., 2002, Kuttler et al., 2000]. More-
over, a recent work suggests that immunoproteasome is not much involved
in generating new ligands for the MHC molecules but simply improves the
kinetics for those peptides which have a better affinity with the TAP trans-
porter, and therefore a higher immunogenicity [Tenzer et al., 2005]. These
algorithms dedicated to the prediction of peptide sequence specificity can also
be reliable tools to envisage specific features of the entire peptide distribu-
tion characterizing the landscape of the APC surface. Predictions algorithms
may therefore ameliorate the kinetic approach, and help to understand more
appropriately the mechanisms behind antigen presentation.
The immunoproteasome and the
T-cell dynamics
While ultimately described by a steady state equation in which cellular influx
equals egress, the fascinating complexities of managing size and composition
of lymphocyte populations have proved fertile ground for investigation. Un-
derstanding the mechanisms which control the dynamics of cytotoxic T cell
response against infectious pathogens is to date a central goal in immunol-
ogy. Strategical methodology such as the intracellular antigen processing
have been evolutionary selected to improve the efficiency of the IR
Mathematical models may help to quantify and predict the main features
of this machinery. As a leitmotiv we followed in our approach the concept
of competition for resources. T-cells perform their functions and are kept
homeostatically in the system only if enough space, food and information to
fight or to be quiescent are available.
It has been proposed that changes in the MHC complexes on the surface of
APCs could serve as an indicator of a stress-danger for the cell, and therefore
a strong and fast signal to alarm the IS [Gleimer and Parham, 2003]. We have
shown that the IP may have an immunological role in changing the normal
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antigen distribution, and in activating a T-cell response against stressed cells.
Competition, diversity and homeostasis
Lymphocyte diversity associated with polyclonal stimulation may prevent
clonal dominance and immune-pathology by a few self-reactive clones. Mul-
tiple infections therefore are needed for at least two reasons: to keep the clone
repertoire diverse enough to prevent that a pauci-clonal repertoire increases
the probability of clonal expansion, and to fixate self-reactive clones, which
in absence of competition might become dominant and induce pathology.
For instance, there is an inverse correlation between the world incidence of
autoimmune diseases and the frequency of infectious diseases. Therefore, it
should be stressed that the IS is under continuous re-shaping due to infec-
tions. A global re-assessment of the cell repertoire and therefore a strong
competition for resources can be an intrinsic and smart way to keep the
repertoire diverse and dynamic.
Recently it has been shown that the IS loses its homeostatic size and its
functionality by depletion of lymphocytes (lymphopenia caused by chemoter-
apic treatments or rediations). A strong correlation between the immune
replenishment with newly produced lymphocytes and the incidence of au-
toimmune disease is observed [King et al., 2004]. Clearly, in this condition
the organism does not impose a strong limit on the proliferating cells which
are somehow licensed to spread without control. Competition is therefore
intrinsically related to a functional immune repertoire.
Physiological conditions (ageing) and several pathological situations (HIV
infection/highly active antiretroviral therapy (HAART), T-cell leukemia and
bone-marrow transplantation) yield different lymphocyte homeostasis and
reduced TCR diversity. Phenomenology of these conditions is often similar.
T-cell clones, invariably of the T-cell phenotype, tend to expand, forming
T-cell clonal expansions that take over the space and thereby reduce diver-
sity of the remainder of the T-cell pool. These states represent potentially
informative models to dissect further the relationship between T-cell recep-
tor diversity and T-cell precursor frequency in pathogen resistance and to
investigate mechanisms that regulate peripheral maintenance of T-cell diver-
sity. We have shown that competition for resources and immunoproteasome
are important mechanisms in shaping the T-cell repertoire and they can be
further investigated in the context of these particular states in which T-cell
repertoire suffers a different homeostasis and probably a different antigen
processing kinetics.
Chronic stimuli are the other side of the coin. The antigen is the first sig-
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nal capable of initiate an IR. Costimulatory signals design the power and the
timing of an IR. Daily, we face small fluctuating changes in the interactions
between our IS and the external environment. Physical entities, hygienic con-
ditions, food, bacteria etc. all contribute to the chronic fluctuating stress.
This chronic antigenic stress and the subsequent inflammatory burden have
a major impact on survival and frailty. The most important characteristic
of immunosenescence is the filling of the immunological space with antigen
experienced cells as a consequence of exposure to a variety of antigens. We
proposed, even if in a phenomenological way, a possible scenario in which
chronic stress can be described from a mathematical point of view. We show
that the size of T-cell antigen experienced clones varies between individuals
and that it can be strongly influenced by the chronic fluctuations without
that any specific restimulation is considered. We believe that this result can
at least provoke interest in such a topics and pave the way to new necessary
studies. In this regard, one should hold in mind that, to date, one of the
strongest limit of vaccination strategies is the incapability to maintain the
immunological memory in the whole population, especially in old individuals
[Cohen, 2005], which are characterized by a less diverse and more oligoclonal
repertoire. We believe that these strategies should account for the effect over
long timescale dynamics of chronic antigenic stress which is an important
and inevitable issue of ageing.
Finally, there is enormous evidence that the improvement of life quality
has strongly elongated the human lifespan. The IS of very old individuals
presents a new scenario in the lymphocyte repertoire, in which a partial
shrinkage is accompanied with a reshaping of the IS and sometimes even an
improvement of some functions [Franceschi et al., 2000a, De Martinis et al.,
2005]. It is known that ageing is strongly influenced by the IS activity. In
this thesis we have shown how the IS features can be reliable factors for the
description of demographic data and that these studies can be improved by
the knowledge on the IS.
Closure
Although focused on general aspects of the kinetics of degradation, our work
reinforces the message given by the predictions algorithm of epitopes pre-
sented by MHCs, which are based on the MHC-peptide processing pathway.
We suggest that a more careful and quantitative analysis of the kinetics of
antigen processing and presentation should be faced. We highlight the role of
the gate of the proteasome in shaping the length distribution of peptides and
in regulating the degradation rate of substrates. These studies have inspired
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new experiments which are currently under investigation 1. Preliminary data
show how the degradation rate during in vitro degradation depends on the ra-
tio proteasome vs substrate concentration. Moreover, these experiments have
confirmed that the degradation rate fairly depends on the substrate length al-
though sequence specificity is an important variable for the prediction of the
cleavage sites. We have also evidenced that proteasomes equipped with regu-
latory particle, such as PA28, perform a fairly different kinetics with respect
to the normal 20S proteasome. The influence of the kinetics of degradation,
such as the gate opening effect (see Chapter 2) or the immunoproteasome
replacement (see Chapter 4) have strong effects on the IS dynamics. Future
works should investigate these phenomena in more immunological details.
This thesis can be a reliable tool to fuse the kinetics of proteasome degrada-
tion with T-cell dynamics, and therefore be a good starting point for a more
quantitative and detailed model which investigates the IR and the role that
antigen processing kinetics has in this regard.
1Together with M. Mishto we performed in vitro experiment in the laboratory of Prof.
Kloetzel, Department of Biochemistry, Charite, Berlin. A mathematical model which
explains the data is under investigation.
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Appendix A
Proteasome
A.1 Simplified model of proteasome degrada-
tion
To simplify the mathematical model given in Chapter 2, let N be the con-
centration of substrate outside and n the concentration of substrate inside
the CP. The length of the substrate is L. Define p as the total product con-
centration present at time t in the CP. For simplicity, assume that the length
of these products is always smaller than θ, so the efflux of products can be
assumed to not depend strongly on the product lengths. The equations for
the substrate dynamics are
dN
dt
= −aˆ(1− (p+ n)vL)N + n (A.1)
dn
dt
= aˆ(1− (p+ n)vL)N − cn− n
dp
dt
= cn− e¯p
where aˆ is the influx rate of the substrate, c is the cleavage rate, v is the
scaling factor for the volume of the proteasome (see Table 4.1). Let  be the
slow exit rate of the substrate. Long substrates hardly exit the proteasome
without being cleaved, i.e.  = 0, however, for short substrates  can be
larger than zero. This simplified model resembles the full model given that
the average efflux rate of the fragments is e¯ (see Section 2.3). Assuming that
the substrate and the products inside the CP are in the quasi steady state
(i.e., dn/dt = dp/dt = 0), one obtains
nq =
e¯aˆN
aˆvL(c+ e¯)N + e¯(c+ )
, pq =
caˆN
aˆvL(c+ e¯)N + e¯(c+ )
,
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where nq and pq are the quasi steady state concentrations of the substrate
and the products, respectively. This leads to:
dN
dt
= − caˆe¯N
aˆvL(c+ e¯)N + e¯(c+ )
(A.2)
which is a Michaelis-Menten function with a maximum degradation rate
Vmax =
e¯c
vL(c+e¯)
when N → ∞, and approaches to aˆ c
c+
if N << Km. If
the exit rate of substrate is equal to the cleavage rate, the degradation is
reduced by 50%. The Michaelis-Menten constant, i.e., the substrate con-
centration at which dN/dt is half of the maximum, is Km = e¯(c+)aˆvL(c+e¯) . For
long substrates,  → 0 holds and we obtain Km ' Vmax/aˆ and the linear
dependence dN/dt ' aˆN for low substrate concentrations.
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Appendix B
T-cell dynamics
B.1 Reaction scheme for the T-cell-MHCp ki-
netics
In Chapter 4 the equations for the T cell dynamics are derived from the
following reaction scheme
Ni + Fj
ka


kd
CNij
kp
N
→ T ∗i + Fj (B.1)
Ei + Fj
ka


kd
CEij
kp
E
→ 2Ei + Fj (B.2)
T ∗
k∗→2φNi + 2(1− φ)Ei (B.3)
i, j are indexes for the T cell and for the MHCp specificity. Fj is the amount
of free sites j, CNi,j and CEi,j are the complexes formed between T-cell and
MHC-peptide complex for the N and E pool respectively. The kinetics of
complex formation are described by the reaction kinetics with association and
dissociation constant kai,j and kdi,j respectively. For simplicity we consider
the same complex formation kinetics for both the Naive and Effector pool.
Effector cells proliferate with the rate kpE > kpN .
Following De Boer and Perelson [1997, 1994] we can obtain the equations
for dNi
dt
and dEi
dt
with a Quasi Steady State (QSS) approximation applied to
the kinetics of the complex formation, namely dC
N
i,j
dt
=
dCEi,j
dt
= 0.
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CNij
dt
= −kpN CNij + kai,jFj Ni − kdi,jCNij (B.4)
CEij
dt
= −kpE CEij + kai,jFj Ei − kdi,jCEij (B.5)
With the QSS assumption we get
CNij =
kai,j
kp
N + kdi,j
Fj Ni (B.6)
CEij =
kai,j
kp
E + kdi,j
Fj Ei (B.7)
we can then define the reaction constant KNi,j and KEi,j
KNi,j =
kai,j
kp
N + kdi,j
KEi,j =
kai,j
kp
E + kdi,j
(B.8)
In the next step, we assume that the kinetics of the activated cells T ∗i is
faster than the other reactions. Therefore, we can consider the activation -
differentiation process in only one reaction
Ni + Fj 
 CNi,j→2φNi + 2(1− φ)Ei + Fj (B.9)
We can now write
dNi
dt
= 2φ kp
N
Npep∑
j=1
CNij +
Npep∑
j=1
(kdi,jC
N
ij − kai,jFjNi) (B.10)
dEi
dt
= 2(1− φ) kpN
Npep∑
j=1
CNij
+
Npep∑
j=1
(2kEpC
E
ij + k
d
i,jC
E
ij − kai,jFjEi) (B.11)
Substituting Eqs. (B.6-B.7) into Eqs. (B.10-B.11), and adding the death
terms δN and δE, and the thymic output Hi we finally have
dNi
dt
= Hi + (2φ− 1) kpN
Npep∑
j=1
KNij FjNi − δNNi (B.12)
dEi
dt
= 2(1− φ) kpN
Npep∑
j=1
KNij FjNi +
Npep∑
j=1
kEpK
E
ij FjEi − δEEi(B.13)
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B.2 The kinetics of peptides
Peptides are generated intracellularly by the degradation of intracellular pro-
teins via the proteasome machinery. Moreover, these proteasome products
are processed further in the ER, where they bind to MHC molecules. We
assume that peptides are processed intracellularly by the APCs at the site
of infection. The homing mechanism of the APC from the site of infection
to the secondary lymphoid tissue is considered to evolve with a fast kinetics.
This hypothesis allows to consider only a generic APC presenting all peptides
on its surface. We can then write
Pi + E
k+


k−
Si (B.14)
Z = MT −
Npep∑
j=1
Sj (B.15)
where k = k
−
j
k+j
, MT is the total amount of MHC molecules available in
the intracellular environment of APCs. Si is the total number of MHCp
complexes which mount the peptide i. Pi is the available peptide abundance,
and Z is the number of free MHC molecules. The equation for MHC-peptide
complexes is obtained from Eq. (B.14)
dSi
dt
= k1 ∗ Pi(MT −
Npep∑
j=1
Sj)− k−1Si) (B.16)
Substituting the last equation in the Eq. (B.15), and considering the QSS
approximation dSi
dt
= 0 the following equation is obtained
Si =
kiPiMT∑
kjPj + 1
(B.17)
Finally, the number of free sites can be written as
Fj = Sj −
Nclone∑
j=1
(CNi,j + C
E
i,j) (B.18)
Substituting in the last relation the steady state values for CNi,j and CEi,j
(Eqs. (B.6-B.7), the equation for the free MHC-peptide complex Fj read
Fj =
Sj
1 +
∑Nclone
l=1 (K
N
l,jNl +KEl,jEl)
(B.19)
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Appendix C
Clonal expansion
C.1 Fokker-Planck equation for the Ornstein-
Uhlembeck process
The Fokker Planck equation for the Ornstein Uhlembeck [Risken, 1989] read
∂p
∂t
− ∂kxp
∂x
=
D
2
∂2p
∂x2
(C.1)
writing
x = v′ k = 1 D = γ2σ2T (C.2)
p(x, t;x0, t0) = ρ (C.3)
we obtain
∂ρ
∂t′
− ∂v
′ρ
∂v′
=
γ2Tσ2
2
∂2ρ
∂v′2
(C.4)
Let consider the following initial condition
p(x, t0;x0, t0) = δ(x− x0) (C.5)
The solution can be easily obtained writing the characteristic function for
the joint probability p defined as the average value of the variable eisx
φ(t, s) = 〈e(isx)〉 =
∫ +∞
−∞
p(x)eisxdx (C.6)
The Fokker Planck equation written for φ(s, t) now is
∂φ
∂t
+ ks
∂φ
∂s
= −1
2
Ds2φ (C.7)
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This is obtained from the following property of the Fourier operator F
F (
∂np
∂xn
) = −isnF (p) (C.8)
We are now left with a hyperbolic partial differential equation of the first
order. We can therefore apply the method of the characteristic equation.
Consider the space S defined from the variables s, t, φ, and two manifolds
defined by
u(s, t, φ) = a v(s, t, φ) = b (C.9)
Writing J(s, t, φ) = θ(s, t) − φ the solution of Eq. (C.7) can be found in an
implicit form solving the equation
J(s, t, φ) = 0 (C.10)
namely the solution is found through all the manifolds φ(t, s) = F (u, v),
which are defined in the generic point P (t, s, φ) of the space S in the tangent
plane pi
d∂φ
∂t
+ e∂φ
∂s
= c (C.11)
d = 1
e = ks
c = −1
2
Ds2φ
Imposing the invertibility of the function J , the linear relation between
the normal versors to the two manifolds defined by u e v, and using the
equation for the tangent plane, we obtain
dt
1
=
ds
ks
= − dφ1
2
Ds2φ
(C.12)
he integrals of these equations are
s(t) = aekt φ(s) = be
Ds2
4k (C.13)
We note that the dependence of the characteristic curves t(x), s(x) with x is
not explicit, therefore, we can take as evolution parameters the two generic
surface u e v. Supposing a generic relation v = g(u) we obtain
φ(s, t) = e−
Ds2
4k g
[
se−kt
]
(C.14)
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the function g is determined by the initial condition on p
p(x, 0|x0, 0) = δ(x− x0) (C.15)
this implies
φ(s, 0) = eix0s (C.16)
g(s) = e
Ds2
4k
+ix0s (C.17)
Substituting the last equation in Eq. (C.14)
φ(s, t) = exp
[
−Ds
2
4k
(
1− e−2kt)+ isx0e−kt] (C.18)
The solution is a Gaussian function in the space defined by the variable s.
Anti-transforming φ, a Gaussian function is found as well, characterized by
〈x(t)〉 = x0e−kt (C.19)
σ2(t) =
D
2k
[
1− e−2kt]
we can now write the solution for the vitality v
ρ(v) =
exp− (v−<v>(t))2
2σ2(t)√
2piσ2(t)
(C.20)
clearly, the stationary solution is obtained in the limit t → ∞. the mean of
the vitality and its standard deviation are then 0 e D
2k
σ2(t) = γ2σ2
T
2
(1− e−2t/T ) (C.21)
< v > (t) = v∞ + (1− v∞)e−t/T
C.2 Strong damping approximation
Such approximation for the proposed deterministic model
dx
dt
= v (C.22)
dv
dt
= −βv + F (t)− V ′(x) (C.23)
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consists in neglecting the term dv/dt when β−1 is small with respect to a
typical time scale of the system without damping. We have chosen both
F (t) and V (x) proportional to ω2, where ω−1 defines such a scale. Indeed if
F = 0 the period of oscillations around the minima scales as ω−1. If V = 0
such a scale is given by the pulse duration T , as one can check directly by
solving the linear equation, and we choose T of order ω−1.
When β  ω the equations (C.23) are approximated by the first order
equation
β
dx
dt
= F (t)− V ′(x) (C.24)
Taking into account the definition for F (t) and V (t) given in Chapter 5,
introducing the rescaled time t′ = t ω2/β and pulse duration T ′ = T ω2β
equation (C.24) reads
dx
dt′
=
{
σ(x) + F0 t
′ < T ′
σ(x) t′ > T ′
(C.25)
σ(x) =
{
−1 2n− 2 < x < 2n− 1
1 2n− 1 < x < 2n
Solving with initial condition x(0) = 0 we obtain
x(t′) = (F0 − 1) t′ 0 < t ≤ t′1 =
1
F0 − 1 (C.26)
x(t′) = 1 + (F0 − 1) (t′ − t′1) t′1 < t ≤ t′2 = t′1 +
1
F0 + 1
(C.27)
x(t′) = 2 + (F0 + 1) (t′ − t′2) t′2 < t ≤ t′3 = t′2 +
1
F0 − 1 (C.28)
where x(t′1) = 1, x(t′2) = 2, x(t′3) = 3 and so on until some n such that
t′2n−1 < T
′ < t′2n+1. Then, for T ′ < t′2n, the point reaches x = 2n and stops;
in the last interval [x(T ′), 2n] the points slows down changing its speed to
1. Instead, for T ′ > t′2n, the point overcomes the equilibrium point and after
reaching x(T ′) > 2 comes back, with speed 1, to the equilibrium point. In
Fig. C.1 we show the piecewise linear trajectories which can be followed to
reach a minimum of V (x).
The times at which the maxima 2n− 1 and the minima x = 2n of V (x)
are reached are given by the recurrence
t′2n−1 = t
′
2n−2 +
1
F0 − 1 t
′
2n = t
′
2n−1 +
1
F0 + 1
(C.29)
158
Figure C.1: Sawtooth landscape and time evolution x(t). Left panel : t′3 <
T ′ < t′4 the second minimum is not overcome. Left panel : t′4 < T ′ < t′5 the
second minimum is overcome and it is reached after an expansion up to a
larger value. For this figure ω = 1 has been chosen.
whose solution reads
t′2n =
n
F0 − 1 +
n
F0 + 1
t′2n+1 =
n+ 1
F0 − 1 +
n
F0 + 1
(C.30)
so that the condition for the trajectory to end in the interval [2n− 1, 2n+1]
stopping at the minimum x = 2n is t′2n−1 < T ′ < t′2n+1 from which equations
(C.26-C.28) follow.
Weak damping approximation
An analytical study of the the problem is still possible in the weak damp-
ing approximation (β  ω), which is basically a first order perturbative
expansion in β. We show only how to construct the solution in the interval
0 < x < 1, starting with initial conditions x(0) = v(0) = 0. The equations
are
dx
dt
= v (C.31)
dv
dt
= −βv + ω2(F0 − 1) 0 < x < 1
In order to compute the solution, the function H wis introduced, which
satisfies the following equation
H =
v2
2
− ω2(F0 − 1)x dH
dt
= −βv2 (C.32)
The unperturbed solution, β = 0, reads x(t) = 1
2
ω2 (F0 − 1) t2, and the time
to reach x = 1 is t1 = ω−1
√
2/(F0 − 1). The first order of the perturbative
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expansion is computed according to
H(x, v)−H(0, 0) ≡ v
2
2
− ω2(F0 − 1)x = −β
∫ t
0
ω4 (F0 − 1)2 t′2 dt′
= −β ω4(F0 − 1)2 t
3
3
(C.33)
where t is expressed in terms of x using the unperturbed solution. As a
consequence
v = ω
√
2(F0 − 1)x1/2 1− 4
3
β x1/2
ω
√
2(F0 − 1
(
1− 4
3
β x1/2
ω
√
2(F0 − 1
)1/2
(C.34)
' ω
√
2(F0 − 1)
x1/2 − 2
3
βx (C.35)
Solving dx/dt = v(x) by separation of variables we find at the first order in
β the solution x(t) and the time t1 at which the first maximum is reached
(provided that T1 < T )
x =
ω2
2
(F0 − 1) t2 − 3
4
β t3
(
t2 − 3
4
β t3
)
t1 =
1
ω
√
2
F0 − 1 +
3
4
β
ω(F0 − 1)
(C.36)
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Appendix D
Ageing
D.1 Asymptotic expansions
The survival probability is 1/2 at the time T where the average of the vitality
vanishes.
S(T ) =
1
2
Erf(0) =
1
2
〈 v(T ) 〉 = 0 (D.1)
The next properties are related to the as asymptotic behavior of S(t) for
t→ 0 and t→ +∞. In order to obtain them we need asymptotic expansion
of the error function E(x) [M.Abramowitz and Stegun, 1972] for x→ +∞
E(x) ≡ 1√
2pi
∫ +∞
x
e−u
2/2 du =
e−x
2/2
x
√
2pi
1− 1
x2
+
3
x4
+ . . .
(
1− 1
x2
+
3
x4
+ . . .
)
(D.2)
and for x→ −∞
E(x) = 1−E(−x) = 1+ e
−x2/2
x
√
2pi
1− 1
x2
+
3
x4
+. . .
(
1− 1
x2
+
3
x4
+ . . .
)
(D.3)
When t approaches 0 the survival S(t) approaches 1 with an horizontal tan-
gent. The mortality rate exponentially goes to zero (exp(−1/t)). In order to
prove it, we notice that the mean value of v(t) tends to a constant, whereas
the variance is σ(t) = 
√
t. This behavior is also found in a Wiener process
when t tends to 0. As a consequence writing S(t) = E(x(t) where
x(t) = −〈 v 〉
σ(t)
' − v0

√
t
(D.4)
and using the asymptotic expansion Eq. (D.2), we have
S(t) = 1− exp(−
v02
2 t
)
2pi v0

√
t
(D.5)
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The mortality rate for t→ 0 is given by
R(t) ' − S˙
S
=
v0
2
√
2pi
exp(−v02
2 t
)
t3/2
(D.6)
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